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I. Introduction 
   
 
 
I. Introduction 
 
In the developing and the adult nervous system, cells have to interact in a precise and 
regulated manner. Starting during early embryogenesis, cellular interactions are temporally 
and spatially modulated for generating neuronal induction, migration of neural progenitor 
cells and morphogenesis during the development of the nervous system. Formation of cellular 
polarity and the constitution of synaptic contacts establish a functional and ordered tissue. 
Even after termination of developmental processes, cellular contacts still implicate variability. 
Crucial stages of plasticity in adults including learning, memory consolidation and neuronal 
regeneration require structural flexibility of the nervous system. Synaptic plasticity and 
axonal outgrowth are generated by contact-mediated attraction or repulsion of nerve cells or 
nerve-glia-cell contacts. Neuronal and non-neuronal recognition molecules have been 
identified to be associated with the modulation of these regulated cell interactions. Several 
protein families are among these adhesion molecules like cadherins (Kemler and Ozawa, 
1989; Takeichi, 1991), integrins (Hynes, 1992; Reichardt and Tomaselli, 1991), members of 
the extracellular matrix (ECM) (Sanes, 1989; Reichardt and Tomaselli, 1991) and proteins 
belonging to the immunoglobulin superfamily (IgSF) (Williams and Barclay, 1988; 
Brümmendorf et al., 1993). Functionality of a recognition molecules is determined by several 
factors such as expression in different cell types, different developmental stages of the animal 
and the spatial distribution determine the function of a cell recognition molecule whether it 
can act as an attractive or a repellent modulator. 
 
I.1. The immunoglobulin superfamily of cell adhesion molecules (CAMs) 
 
This very prominent family of cell recognition molecules comprises immunoglobulin (Ig)-like 
domains in their extracellular portion. The presence of one or more copies of this highly 
conserved motif defines a large protein family of cell surface molecules which is involved in 
a diverse array of functions. They are expressed in a number of tissues during development 
and in the adult revealing importance in embryogenesis (Edelman and Crossin, 1991; 
Edelman, 1993; Sanes, 1989), control of hemostasis (Parise, 1989), circulation of 
lymphocytes (Dustin and Springer, 1991; Zimmerman et al., 1992) and in alterations of 
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invasive and metastatic behavior of malignant tumor cells (Zetter, 1990; Honn and Tang, 
1992). The superfamily of Ig-like recognition molecules includes several subfamilies which 
have been categorized according to the number of Ig-like domains, the presence and number 
of fibronectin type III-like repeats, the mode of attachment to the cell membrane and the 
presence of catalytic domains (Figure 1). Cell recognition molecules containing Ig-like 
domains within their extracellular region are functionally subgrouped into primarily adhesion-
related proteins as indicated in Figure 1 for the first subfamily of CAMs. IgSF molecules 
containing catalytical properties in their intracellular domain are grouped into subfamilies of 
receptor-type phosphotyrosine phosphatases (RPTPs) and receptor tyrosine kinases (RTKs). 
 
 
 
Figure 1: Subfamilies of several neuronal members of IgSF 
Representatives of the three main subgroups, namely cell adhesion molecules (CAMs), receptor-type 
phosphotyrosine phosphatases (RPTPs) and receptor tyrosine kinases (RTKs) are shown. NCAM, L1, MAG and 
DCC are transmembrane members of the CAM subgroup, of which only TAG-1 is GPI-anchored. RPTPµ and 
DPTP69D represent the IgSF subgroup containing a catalytic phosphotyrosine phosphatase domain (PTP) in 
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their intracellular region. FGFR and EPH are molecules of the RTK subgroup containing an intracellular 
catalytic tyrosine kinase (TK) domain. Species homologues of IgSF members are given below. CR, cysteine-
rich. (Walsh and Doherty, 1997). 
 
Evolutionary relationship between CAMs and Igs. The prototypical examples of this 
family are antibodies (Edelman et al., 1969) and additional proteins, like the MHC-antigens, 
involved in the humoral and non-humoral immune defence in vertebrates (Orr et al., 1979). 
Many of these Ig-molecules in the immune system like the T-cell receptor (Kronenberg et al., 
1986) are contributing to highly specific cell-cell recognition events (Springer, 1990). The 
first adhesion molecule that was fully characterized was the neural cell adhesion molecule 
NCAM that describes a prototypical representative of this protein superfamily (Brackenbury 
et al., 1977; Hoffman et al., 1982). Gene-cloning studies and subsequent protein sequencing 
revealed an evolutionary relationship between NCAM and immunoglobulins (Hemperly et al., 
1986). Such observations supported the hypothesis that the duplication and diversification of 
genes for only a limited number of molecules has led to the generation of large families of 
recognition molecules playing key roles in the immune system, the development of nervous 
system and other tissues as well (Williams and Barclay, 1988). The completion of the human 
genome sequencing has provided the answer to the question by how many members the 
immunoglobulin superfamily is composited. Using criteria defined by the InterPro database 
(http://www.ebi.ac.uk/interpro), a final score has been estimated that 765 human genes 
contain Ig domains, which means that the immunoglobulin superfamily represents one of the 
largest protein superfamilies in the human genome (Lander et al., 2001). Furthermore, Ig 
domains show a high tendency to be presented in large modular multidomain proteins, which 
is illustrated by the observation that Ig domains occur along with more than 60 different other 
domains (as defined by Pfam database http://www.sanger.ac.uk/Software/Pfam/index.shtml) 
(Brümmendorf and Lemmon, 2001). The human genome encodes five times more IgSF 
members than the Drosophila melanogaster genome and twelve times more IgSF members 
than the Caenorhabditis elegans genome. This might be due to the fact that immunoglobulins 
are involved in the invention of the immune system and it can also be caused by the higher 
complexity of developmental processes in vertebrates in which IgSF members also participate 
(Venter et al., 2001). 
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I.2. Neuronal cell adhesion molecules of the immunoglobulin superfamily 
 
Adhesive properties of cell-cell or cell-extracellular matrix (ECM) interactions can affect 
neuronal development including cell migration, proliferation and differentiation. In addition 
to adhesive or repellent functions, binding of CAMs can affect intracellular signalling. As 
mentioned before, the neural cell adhesion molecule (NCAM) was the first Ig-like cell 
adhesion molecule that was isolated and completely characterized (Brackenbury et al., 1977; 
Thiery et al., 1977). It demonstrates the prototypical representative of neural cell adhesion 
molecules of the Ig superfamily including a number of common functions also shared by 
other members of this protein family. The extracellular domain of NCAM is involved in 
various Ca2+ independent cell-cell and cell-extracellular matrix interactions, mediates cell 
migration (Rutishauser and Jessell, 1988), proliferation (Sporns et al., 1995), neurite 
outgrowth (Doherty et al., 1990) and axon fasciculation (Cremer et al., 1997). NCAM-
dependent hippocampal remodeling (Itoh et al., 1995) and impaired long-term plasticity of 
hippocampal mossy fibers in NCAM-deficient mice (Joergensen, 1995) demonstrates further 
importance of NCAM-mediated cellular interactions. NCAM binding can alter second 
messenger signalling (Williams et al., 1994b) and influences kinase pathways implicating 
receptor tyrosine kinases and non-receptor kinases (Williams et al., 1994a; Beggs et al., 
1994). 
 
Structural features of neuronal IgSF molecules. Typical members of the neuronal Ig SF are 
depicted in Figure 2. The number of Ig-like domains varies from only one motif presented in 
P0 increasing to a module including six Ig-like domains arranged at the N-terminus of L1 and 
CHL1. Many, if not most cell adhesion molecules in the nervous system such as NCAM, L1 
and CHL1 are composed not only by repetetive Ig-like domains, but combine these structures 
with other repeated motifs. One of these motifs is the fibronectin subtype III repeat (FN-III) 
that is present in NCAM, L1 and CHL1 as shown in Figure 2. Combination of repetetive 
domain structures is not only a common feature of immunoglobulin SF molecules. Typical 
members of extracellular matrix molecules such as Tenascin-C (Fischer et al., 1997), 
Tenascin-R (Fuss et al., 1993) and laminin (Mayer et al., 1993) contain a large number of 
EGF-like motifs combined with a varying number of FN-III domains of different subtypes. As 
 4
I. Introduction 
   
 
 
shown in Figure 2, neural IgSF molecules are attached to the cell surface via different ways 
including either a transmembrane domain or a glycosylphosphatidyl inositol (GPI-) anchor. In 
case of NCAM, three different major isoforms are generated via alternative splicing of a 
primary transcript from a single gene (Owens et al., 1987). Two transmembrane isoforms of 
180 kDa and 140 kDa and a third isoform of 120 kDa that is GPI-linked are described. 
Several further isoforms result from alternative splicing in the extracellular domain which are 
specifically expressed in distinct tissues and/or at developmental stages (Cunningham et al., 
1987; Owens et al., 1987; Small et al., 1988; Small and Akeson, 1990).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Members of neuronal CAMs belonging to the immunoglobulin superfamily 
Typical representatives of cell adhesion molecules are shown as either transmembrane or GPI-linked molecules. 
The structural motif of one or more Ig-like domains is shared by all family members, other motifs are found only 
for distinct members such as the FN-III domain is not present in P0 or MAG isoforms. Glycosylation sites are 
present in all CAMs listed above. 
 
A common feature that is shared by all members of Ig SF molecules is the high number of 
glycosylation sites which are present within the extracellular region. As many neural 
recognition molecules and adhesion molecules of the immune system, NCAM, L1 and CHL1 
can carry the HNK-1 carbohydrate epitope which contains sulfated glucuronic acid. The α-2, 
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8-linked polysialic acid (PSA) is a carbohydrate not found to be associated with other proteins 
of vertebrate origin than the neural cell adhesion molecule. Developmentally regulated and 
functionally significant alterations in the amount and distribution of PSA attached to NCAM 
is of outstanding importance for NCAM function (Schachner and Martini, 1995). The PSA-
carbohydrate epitope seems to decrease the adhesive cues of NCAM and to increase its 
neurite outgrowth promoting features (Rutishauser and Landmesser, 1996). 
 
Common functional features of neuronal IgSF molecules. Neural cell adhesion molecules 
(CAMs) of the immunoglobulin superfamily modulate cell-cell-interactions at key sites 
during early development and in the adult. Additionally to solely adhesive or repellent 
functions, binding of CAMs can affect intracellular signalling and therefore influence 
developmental events, including cell migration, proliferation and differentiation. In general, 
three categories can be considered regarding CAM function (Crossin and Krushel, 2000). The 
first category describes phenotypic effects of CAMs and includes all developmental and 
morphological events like neurite outgrowth, axonal pathfinding and neurite fasciculation at 
early developmental stages (Kamiguchi and Lemmon, 1997; Brümmendorf et al., 1998). In 
adult, phenotypic CAM function comprises structural alterations after induction of long-term 
potentiation and is further contributed to morphological changes after learning and memory 
consolidation (Lüthi et al., 1994; Scholey et al., 1995). Implication of IgSF molecules in 
nerve regeneration presents a further important function of such cell adhesion molecules in 
adults. The second feature of IgSF molecules with regard to function is the effect on second 
messenger systems which are altered following CAM binding. Early studies on PC12 cells 
gave the first indication that IgSF binding can affect second messenger cascades (Schuch et 
al., 1989). Reduction of intracellular pH, elevated levels of intracellular calcium concentration 
and alterations in inositol phosphate metabolism were described for PC12 cells, primary 
cerebellar neurons, dorsal root ganglion neurons and for transformed Schwann cells (von 
Bohlen und Halbach et al., 1992; Frei et al., 1992; Schuch et al., 1989). Specific tyrosine 
kinases have further been implicated in the effects of CAMs on neurite outgrowth (Doherty 
and Walsh, 1994) suggesting that CAM binding promotes neuritogenesis by activation of 
tyrosine kinases as an upstream regulator of G proteins and calcium channels (Williams et al., 
1994b). These findings led to the hypothesis that effects of Ig CAMs on neurite outgrowth 
could be mediated by stimulation of the fibroblast growth factor receptor (FGF-R) (Williams 
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et al., 1994a; Williams et al., 1994b; Williams et al., 1995). Furthermore, the role of non-
receptor tyrosine kinases for the CAM-dependent stimulation of neurite outgrowth has 
received recent support. NCAM-dependent neurite outgrowth was impaired in neurons from 
pp59fyn knockout mice (Beggs et al., 1994). Immunoprecipitations revealed an functional 
complex between the 140-kDa isoform of NCAM and p59fyn. Another tyrosine kinase, FAK, 
became associated to the complex following crosslinking by secondary antibodies. Activation 
of this pathway has recently been shown to activate ras/MAPK signalling and subsequent 
phosphorylation of ERK1 and ERK2 kinases (Schmid et al., 1999). In contrast to this, L1-
dependent neurite outgrowth was diminished in cells from pp60src mice, suggesting that this 
non-receptor tyrosine kinase may be a downstream mediator of L1-signalling (Beggs et al., 
1994). Multiple phosphorylation sites within the intracellular domain of L1 (Sadoul et al., 
1989) pronounce an association with kinases including p90rsk (Wong et al., 1996b), Raf-1, 
ERK-2 (Schaefer et al., 1999) and the casein kinase II (Wong et al., 1996a). Finally, the third 
category that summarizes functions of IgSF molecules addresses the alterations in gene 
expression followed by Ig CAM binding and IgSF-mediated activation of transcription 
factors. Binding of a particular IgSF molecule can alter not only the expression of other 
CAMs (Mauro et al., 1994), but also of other genes including hox and pax and further 
transcription factors as well as ribosomal and metabolic genes (Crossin et al., 1996; Crossin et 
al., 1997; Krushel et al., 1998). Several cell adhesion molecules of the IgSF, including 
NCAM, L1 and CHL1 are upregulated following neural injury (Daniloff et al., 1986; Rieger 
et al., 1985; Chaisuksunt et al., 2000; Zhang et al., 2000). These CAMs can promote neurite 
outgrowth, enhance neural regeneration and might have effects on processes such as astrocyte 
proliferation since that might also be important for regeneration. In fact, NCAM homophilic 
binding inhibits the proliferation of astrocytes cultured in vitro (Sporns et al., 1995) and can 
inhibit the proliferation of neural stem cells (Amoureux et al., 2000). Genes and intracellular 
pathways were determined to be involved in the NCAM-dependent suppression of astrocyte 
proliferation using substractive hybridization analysis (Crossin et al., 1997). As observed in 
neurons, levels of NCAM mRNA are decreased following homophilic NCAM binding 
indicating a feedback loop in astrocytes. Additionally, levels of mRNA for glutamine 
synthetase and calreticulin are elevated following NCAM binding to astrocytes. 
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I.3. The cell adhesion molecule L1 
 
The neural cell adhesion molecule L1 was originally identified in the early 1980s (Rathjen 
and Schachner, 1984). L1 is a phosphorylated, integral membrane glycoprotein that can be 
recovered from mouse brain tissue in a distinct set of polypeptides with apparent molecular 
masses of 200, 180, 140 and 80 kDa (Sadoul et al., 1988). It was originally recognized as a 
cell adhesion molecule being involved in granule neuron migration in the developing mouse 
cerebellar cortex (Lindner et al., 1983), fasciculation of neurites (Fischer et al., 1986) and 
neurite outgrowth on other neurites and Schwann cells (Chang et al., 1990; Seilheimer and 
Schachner, 1987). Recent studies on L1-knockout mice have confirmed that L1 is an 
important molecule for the development of the nervous system (Dahme et al., 1997). Its 
importance in human and mouse ontogenesis is underlined by the severity of neurological 
disorders associated with mutations in the L1 gene or a complete loss of L1 in the mouse 
model. These include hydrocephalus and mental retardation and have recently been 
summarized under the acronym CRASH syndrome (Fransen et al., 1995). This syndrome 
characterizes a neurological disorder with a clinical spectrum of corpus callosum hypoplasia, 
retardation, adducted thumbs, spastic paraparesis and hydrocephalus. L1 expression was also 
found on normal and transformed cells of hematopoietic origin in mouse and human (Kowitz 
et al., 1992; Kowitz et al., 1993) and on certain epithelial and endothelial cell types 
confirming L1 functionality in non-neuronal tissues (Thor et al., 1987; Pancook et al., 1997). 
Interaction studies demonstrated that L1 binding is mediated by several mechanisms 
including homophilic binding of L1 - L1 (Kadmon et al., 1990a; Kadmon et al., 1990b), 
assisted homophilic binding of L1 and L1/NCAM complexes on surfaces of adjacent cells 
(Kadmon et al., 1990a; Kadmon et al., 1990b) and finally a number of heterophilic 
interactions like L1-binding of axonin-1 (Kuhn et al., 1991) and the L1-interaction with the 
GPI-anchored molecule CD24 (Kadmon et al., 1995). L1 was also identified as a ligand for 
several RGD-binding integrins such as α5β1, αvβ1, αvβ3 as well as the platelet integrin 
αIIbβ3 (Ruppert et al., 1995; Montgomery et al., 1996; Ebeling et al., 1996; Felding-
Habermann et al., 1997; Blaess et al., 1998). Integrin-mediated cell binding and migration is 
supported by the RGD motif localized in the sixth Ig-like domain of L1 (Ruppert et al., 1995; 
Montgomery et al., 1996; Duczmal et al., 1997). Homophilic interaction of L1 induces neurite 
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outgrowth that requires activation of second messengers cascades in the stimulated cells 
(reviewed in Doherty et al., 1995). They have provided evidence suggesting that a G-protein-
dependent activation of Ca2+ channels is involved in neurite outgrowth on L1-substrate such 
as on N-cadherin- and NCAM-substrate but not on laminin (Doherty et al., 1991; Saffell et 
al., 1992; Williams et al., 1992). A model has been proposed in which neurite outgrowth 
stimulated by these adhesion molecules requires a cis interaction with the FGF receptor 
(Doherty and Walsh, 1996; Green et al., 1996). Other signalling pathways might be activated 
following L1-binding since L1 associates with the serine/threonine kinases casein kinase II 
(Wong et al., 1996a) and the S6 kinase and is phosphorylated at serine residues serine1181 and 
serine1152 (Wong et al., 1996c). Tyrosine kinases have also been suggested to regulate L1 
function including a partial role for pp60src in L1-mediated axonal outgrowth (Ignelzi, Jr. et 
al., 1994) and a putative role of the receptor-type phophotyrosine phosphatase (RPTP) 
phosphacan/RPTPζ/β has been proposed (Milev et al., 1994). 
 
I.4. The L1 subfamily of neuronal IgSF molecules 
 
L1 is a representative and the founder of a neural subfamily of immunoglobulin superfamily 
proteins (Brümmendorf and Rathjen, 1996; Hortsch, 1996) which is currently composed of 
four mammalian members – L1 (Moos et al., 1988), the recently described close homologue 
of L1 (CHL1) (Holm et al., 1996), the neuron-glia cell adhesion molecule (NgCAM)-related 
cell adhesion molecule (NrCAM) (Grumet et al., 1991) and neurofascin (Volkmer et al., 
1992). Two invertebrate cell adhesion molecules such as Drosophila neuroglian and leech 
tractin are also belonging to the L1 subfamily (Bieber et al., 1989; Huang et al., 1997). Not 
listed are the rat homologue of L1 (NILE) (Prince et al., 1991), the human homologue of 
CHL1 (CALL) (Wei et al., 1998) and the zebrafish homologues of L1 (L1.1 and L1.2) 
(Tongiorgi et al., 1995). Only those L1-related proteins including a transmembrane domain 
are considered here. Besides the transmembrane L1-family members, several GPI-linked L1-
related molecules exist such as F3/F11/contactin (Ranscht, 1988; Gennarini et al., 1989; 
Brümmendorf et al., 1989), the brain-derived immunoglobulin superfamily molecule (BIG-
1)/plasmacytoma-associated glycoprotein (PANG) (Yoshihara et al., 1994; Connelly et al., 
1994), BIG-2 (Yoshihara et al., 1995) and the transiently expressed axonal glycoprotein 1 
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(TAG-1)/TAX-1/axonin-1 (Furley et al., 1990; Zuellig et al., 1992; Hasler et al., 1993). Only 
transmembrane members contributing to the L1 subfamily of neuronal IgSF molecules are 
depicted in Figure 3. 
 
 
 
Figure 3: The L1-subfamily of neuronal cell adhesion molecules 
Schematic representation of the L1-subfamily that is currently composed of four members identified in mouse 
(L1, CHL1, NrCAM and neurofascin) and two invertebrate members (neuroglian and tractin). Only the chicken 
L1-homologue NgCAM is depicted in brackets, other species homologues are mentioned in the text. The 
structure of six Ig-like domains is common among all family members and is combined with a varying number 
of FNIII-like domains. All members of the L1 subfamily shown here are transmembrane proteins with a highly 
conserved intracellular region of only approximately 110 kDa. Horizontal bars and dark boxes indicate 
alternatively spliced segments. PAT, proline/alanine/threonine-rich; PG, proline/glycine-rich. (Brümmendorf et 
al., 1998) 
 
The structure of L1-like proteins. The structural hallmark of the L1 subfamily is the 
presence of six immunoglobulin (Ig)-like domains. The expression of four to five fibronectin 
type III (FNIII)-like domains, a single transmembrane stretch and a highly conserved 
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cytoplasmic portion of approximately 110 amino acids further defines the subgrouping of L1-
like molecules. The number of FNIII-like domains is varying since L1, the chicken 
homologue NgCAM and Drosophila neuroglia contain five repeats, NrCAM, neurofascin and 
the invertebrate tractin comprise only four repetetive modules of FNIII-like domains. The 
CHL1 protein and its human homologue CALL – cell adhesion L1-like – (Wei et al., 1998) 
display only a half of the fifth FNIII-like repeat. This feature of only partially expression of a 
domain is still of unknown biological significance, but is shared by isoforms of neurofascin 
(Hassel et al., 1997) and NrCAM (Lane et al., 1996). Alternative splicing of the pre-mRNA is 
used to generate these variations in number and composition of domain arrangement in the L1 
subfamily. Human L1 reveals only two short segments of alternative splicing which are 
evolutionary conserved in vertebrates (Jouet et al., 1995), whereas other family members such 
as neurofascin (Hassel et al., 1997) and NrCAM (Lane et al., 1996) are expressed in multiple 
isoforms. A systematic analysis of neurofascin gene expression reveals nine alternatively 
spliced exons generating more than fifty different protein isoforms which are developmentally 
and spatially regulated in their expression in the chicken brain. 
 
Posttranslational modification of L1-subfamily members. Putative protease cleavage sites 
are described for L1, the homologue of L1 in chicken NgCAM, NrCAM and the invertebrate 
tractin (Faissner et al., 1985; Sadoul et al., 1988; Nybroe and Bock, 1990; Kayyem et al., 
1992; Burgoon et al., 1995; Huang et al., 1997). They have been shown to be sensitive to 
posttranslational cleavage within a particular motif localized in the third FNIII-like domain. A 
potential cleavage site has also been observed between the Ig- and FNIII-like region in 
chicken neurofascin (Volkmer et al., 1992). Such cleavage of L1 results in an extracellular 
amino-terminal fragment of approximately 140 kDa and a transmembrane fragment of 80 
kDa. Both fragments have been detected in developing and adult mouse brain since the 
functional significance of L1 cleavage still remains to be determined. Studies concerning the 
posttranslational modifications of L1 revealed a potential role of the plasminogen system 
being involved in the cleavage of L1. The addition of plasmin to cell lines results in a dose-
dependent loss of surface L1 with simultaneous appearance of soluble L1 fragments. Addition 
of plasminogen to primary neurons leads to the generation of plasmin and the concomitant 
release of L1 fragments with an apparent molecular weight of approximately 140 kDa 
(Nayeem et al., 1999). More recently, studies regarding the ectodomain shedding of L1 
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underlined that a disintegrin and metalloproteinase (ADAM 10) is involved in the constitutive 
release of L1 from the cell surface by membrane-proximal cleavage (Beer et al., 1999; 
Mechtersheimer et al., 2001). Impaired migration of L1-transfected cells after inhibition of 
ADAM 10 was demonstrated indicating a functional role of L1 shedding for migration 
processes. 
 
L1-related proteins interact with the actin-based cytoskeleton. L1 (NgCAM) has been 
demonstrated to co-localize with filamentous actin in filopodia and lamellipodia of growth 
cones of cultured chick DRG neurons (Letourneau and Shattuck, 1989). A linkage to the 
actin-based cytoskeleton has consistently been shown for several L1 subfamily members. The 
primary structure of the cytoplasmic portion of family members is highly conserved and 
contains a binding motif for ankyrin, a linker protein to the spectrin cytoskeleton (Davis and 
Bennett, 1994). A pentameric amino acid sequence (phe-ile-gly-gln-tyr [FIGQY]) that is 
conserved within the L1 subfamily except CHL1 has been mapped to be involved in ankyrin 
binding. Instead of FIGQY, the pentameric motif FIGA1185Y implicating an amino acid 
variation of glutamine to adenine is described for CHL1 (Holm et al., 1996). Thus, an 
interaction of CHL1 to the actin cytoskeleton via ankyrin-binding is of outstanding interest 
since CHL1 binding of ankyrin was not described so far. Interestingly, the linkage of L1-like 
proteins to ankyrin appears to be regulated by tyrosine phosphorylation (Garver et al., 1997). 
When neurofascin in rat neuroblastoma cells is tyrosine phosphorylated in the ankyrin-
binding motif, neurofascin interaction with ankyrin is completely eliminated. Phosphorylation 
of the cytoplasmic portion at this particular tyrosine residue slightly increases the lateral 
mobility of neurofascin within the plasma membrane indicating a reduced interaction between 
membrane-spanning neurofascin and cytoskeleton-associated ankyrin (Garver et al., 1997). 
Phosphorylation of neurofascin was found highest during embryogenesis, suggesting that at 
later developmental stages the neurofascin-ankyrin interaction is stabilized to consolidate 
neuronal structures.  
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I.5. A new member of L1-related proteins: The close homologue of L1 (CHL1) 
 
Screening of a λgt11 expression library for cDNA clones encoding the cell adhesion molecule 
L1 with a polyclonal anti L1 antibody identified the clone 311 that revealed only 34.1 % 
homology to L1 (Lipman and Pearson, 1985). A particular DNA fragment derived from this 
clone was used for screening a different cDNA library and subsequently six independent 
clones were isolated. Two clones of 4.2 kb and 4.4 kb inserts contained the entired coding 
region of a close homologue of L1 (CHL1) (Holm et al., 1996). The 4.4 kb insert encodes a 5’ 
untranslated region of 295 bp, an open reading frame of 3627 bp and a 3’ untranslated region 
of 518 bp. Translation of the open reading frame leads to a protein of 1209 amino acids and a 
calculated molecular mass of 134.9 kDa. The putative extracellular portion is composed of 
1081 amino acids containing 18 potential N-glycosylation sites and more than 60 possible 
sites for O-glycosylation. Hydropathy analysis according to Kyte and Doolittle (Kyte and 
Doolittle, 1982) identifies a single transmembrane segment of 23 amino acids followed by an 
intracellular portion that is composed of 105 amino acids. The extracellular domain comprises 
two structural motifs which are characteristic features of L1-subfamily: A stretch of 585 
amino acids displays homology with Ig-like domains while a region composed of 472 amino 
acids shows homology with FNIII-like domains. Typical conserved amino acid residues 
assigned the Ig-like domains within the CHL1 sequence as Ig-subclass C2. Highly conserved 
tryptophan and tyrosine/phenylalanine residues define four FNIII-like domains. Since a fifth 
FNIII-like motif is only partially expressed in the CHL1 sequence, this new member of L1-
subfamily introduces a new structural feature to the subclass of L1-related molecules. Further 
structural features are present in the extracellular region of CHL1 including an RGD motif in 
the second Ig-like domain that may contribute to integrin binding (Ruoslahti and 
Pierschbacher, 1987). CHL1 also contains a DGEA sequence in the β-strand C of the sixth Ig-
like domain that is not found in other members of the L1-subfamily. This sequence was also 
described to be involved in integrin binding as α2β1 integrin recognition of type I collagen 
contains this motif (Staatz et al., 1991). Western blot analysis using antisera raised against an 
extracellular fragment of CHL1 revealed an expression pattern of CHL1 in three distinct 
fragments of 185, 165 and 125 kDa. The 185 kDa fragment was only weakly detectable in 
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non-detergent soluble brain fraction indicating that this might be the membrane-spanning 
form of CHL1 whereas the 165 kDa and 125 kDa fragments can be considered to be 
proteolytically released fragments (Holm et al., 1996). Deglycosylation analysis showed that 
N-linked carbohydrates contribute approximately 20 % to the molecular mass of CHL1. 
Furthermore, by immunoprecipitation of CHL1 the HNK-1 epitope was identified to be 
present in CHL1 as it has been described for other cell adhesion molecules (Keilhauer et al., 
1985; Kunemund et al., 1988; Hall et al., 1993; Hall et al., 1995). Evaluation of structural 
homologies of CHL1 with other L1-related molecules revealed that CHL1 is most similar to 
chicken NgCAM in the extracellular domain (37% identity) and to mouse NrCAM in the 
intracellular domain (64% identity). The degree of identity is not sufficient to consider these 
proteins as species homologues, therefore CHL1 was defined as a new, the fourth member of 
the L1 family in mouse with L1, NrCAM and neurofascin (Moscoso and Sanes, 1995). 
 
Expression of CHL1 in primary cell cultures and in the nervous system. The systematic 
analysis of CHL1 expression in certain neuronal cell types reveals a distinct but also 
overlapping expression pattern compared to L1 expression. Both molecules are detectable in 
subpopulations of primary cultures of hippocampal neurons, cortical neurons, mesencephalic 
neurons and neurons derived from the dorsal root ganglion. In spinal cord neurons, both 
proteins are expressed but CHL1 is only weakly detectable compared to the strong L1 
expression while small cerebellar neurons express L1 but not CHL1. Remarkable differences 
in CHL1 expression exist in glial cells since astrocytes only express CHL1 but not L1. Non-
mature oligodendrocytes also show CHL1 expression that becomes down-regulated during 
development to mature oligodendrocytes (Hillenbrand et al., 1999). Differences in protein 
expression on glial cells suggest distinct functions of CHL1 and L1 with regard to 
regeneration processes since gliosis is a functional feature during nerve regeneration 
(reviewed in McGraw et al., 2001). Localization analysis of CHL1 using in situ hybridization 
of cerebellar cortex and hippocampal cortex partially confirmed an overlapping expression 
pattern of CHL1 and L1. Only in few subpopulations a distinct distribution of CHL1 was 
observable since CHL1 was not detected in granule cells of the dentate gyrus where L1 is 
weakly expressed. Furthermore, CHL1 mRNA appears to be less abundant in hippocampal 
pyramidal cells in the CA2 and CA4 regions while L1 was evenly detectable throughout this 
area. In the cerebellar cortex, CHL1 and L1 transcripts are distributed in a more similar 
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pattern with the only exception that hardly any CHL1 labelling is visible in the inner 
molecular layer, where L1 mRNA is strongly expressed (Holm et al., 1996; Hillenbrand et al., 
1999). 
 
Functional features of CHL1. The question was addressed whether CHL1 can interact in a 
homophilic manner as it was described for several cell adhesion molecules like L1, neuroglian 
or TAG-1 (Kadmon and Altevogt, 1997; Hortsch et al., 1995; Malhotra et al., 1998). 
However, cell aggregation assays could neither demonstrate a homophilic interaction between 
CHL1-CHL1 molecules nor a heterophilic interaction between CHL1 and L1 (Hillenbrand et 
al., 1999). The identification of an extracellular receptor of CHL1 is still of current interest 
since no extracellular binding partner of CHL1 has been isolated so far. When CHL1 is given 
as a substrate for neurite outgrowth, it stimulates neuritogenesis of cultured hippocampal and 
cerebellar neurons suggesting the presence an unknown receptor of CHL1 involved in CHL1-
dependent neurite outgrowth (Hillenbrand et al., 1999). A recent study investigated the effect 
of CHL1-Fc fusion protein on the survival of cultured murine cerebellar granule and 
hippocampal neurons of rat embryos. Serum deprivation induces apoptosis that can be 
prevented by either soluble or substrate-coated CHL1 fusion protein. Addition of CHL1 
increased the number of surviving neurons by about 45 % (Chen et al., 1999). Several studies 
also focused on the CHL1 expression in neurons and glial cells following nerve injury in the 
peripheral and the central nervous system. Crush or cut and subsequent ligation of the sciatic 
nerve provokes a strong upregulation of CHL1 mRNA levels in the injured motor neurons and 
in small to medium sized sensory neurons. Interestingly, no CHL1 upregulation was observed 
in large primary sensory neurons of DRG after sciatic nerve crush. After dorsal root injury a 
modest and transient increase in CHL1 mRNA expression was detectable in DRG neurons 
and a remarkable upregulation of CHL1 was seen in satellite cells around the DRG neurons 
after sciatic nerve or dorsal root injury. CHL1 upregulation was also observed in putative 
Schwann cells and astrocytes following dorsal root injury (Zhang et al., 2000). Recent studies 
demonstrated on the one hand a CHL1 upregulation in thalamic neurons following 
implantation of a living graft and on the other hand an enhanced CHL1 mRNA expression 
levels in regenerating neurons of the thalamic reticular nuclei (TRN). Furthermore, many glial 
cells display upregulated CHL1 mRNA levels at the brain/graft interface at early survival 
times up to two weeks after operation underscoring once more the importance of CHL1 in 
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nerve regeneration (Chaisuksunt et al., 2000). The cloning and chromosomal localization of 
the human CHL1 homologue CALL (Wei et al., 1998) suggests an important role of CHL1 in 
neurological disorders since the CALL gene was mapped to the chromosome 3p26 locus, a 
region that is associated with mental retardation in 3p- patients (Asai et al., 1992). 
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II. Aim of the study 
 
The new member of the L1-subfamily of immunoglobulin superfamily proteins, the close 
homologue of L1 (CHL1) is a recently described neuronal cell adhesion molecule that 
prossesses typical structural and functional features assigning CHL1 to this important family 
of cell recognition molecules. Functional properties including promotion of neurite 
outgrowth, prevention of neuronal cell death and the upregulation of CHL1 expression during 
regeneration events after peripheral and central nerve injury suggest an important role of 
CHL1 for cellular processes during nervous system development. Recent studies have 
confirmed the involvement of CHL1 during development of the nervous system, since the 
human homologue of CHL1 (CALL) has been implicated in neurological disorders of the 3p- 
and the ring chromosome 3 syndrome leading to mental retardation. Although several studies 
addressed the question of the extracellular binding mechanisms of CHL1, the identification of 
a CHL1 receptor still failed. Binding studies using only the extracellular portion of this cell 
adhesion molecule could demonstrate that homophilic binding activity of CHL1 as well as a 
heterophilic interaction between CHL1 and L1 can be excluded. Intracellular interactions of 
CHL1 have not been described so far, although putative binding sites for ankyrin and for the 
binding of integrins have been identified in the intracellular domain of CHL1. The 
identification of a receptor/ligand binding to CHL1 could give insights in the mechanisms by 
which this cell adhesion molecule mediates cell-cell interactions and by which CHL1 is 
involved in the formation of an intracellular network composed of transmembrane cell 
adhesion molecules and the cytoskeleton. Finally, the identification of an intracellular binding 
partner would help to understand how CHL1 can affect intracellular signalling cascades. 
 
In this study, binding analyses using recombinant CHL1 fusion proteins were performed with 
the aim to isolate a putative binding partner. For this purpose, the extracellular domain of 
CHL1 was produced in eucaryotic CHO cells whereas the intracellular portion of CHL1 was 
prepared from a bacterial expression system. The recombinant fusion proteins were purified 
according to their fusion tags and subjected to a number of biochemical in vitro binding 
studies including an affinity-chromatography analysis with the immobilized CHL1 fragments 
and an overlay binding approach using the soluble intracellular domain of CHL1 as a probe 
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for binding to separated brain fractions. After isolation and identification of a putative CHL1 
binding protein, the interaction should be confirmed using alternative binding assays while for 
the functional analysis of the CHL1 interaction the binding site either within the intracellular 
domain of CHL1 or within the sequence of the binding partner should be identified. For the 
further understanding of this important feature of CHL1, mutants which are deleted in the 
putative binding site should be investigated to characterize the functional role of this 
interaction. 
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III. Material 
 
III.1. Chemicals 
 
All chemicals were purchased from the following companies in p.a. quality: GibcoBRL (Life 
Technologies, Karlsruhe, Germany), Macherey-Nagel (Düren, Germany), Merck (Darmstadt, 
Germany), Serva (Heidelberg, Germany) and Sigma-Aldrich (Deisenhofen, Germany). 
Restriction enzymes were obtained from New England biolabs (Frankfurt am Main, 
Germany) and MBI Fermentas (St. Leon-Rot, Germany), molecular weight standards were 
obtained from GibcoBRL (Life Technologies). DNA purification kits were purchased from 
Life Technologies, Pharmacia Biotech (Freiburg, Germany), Macherey & Nagel and Qiagen 
(Hilden, Germany). Plasmids and molecular cloning reagents were obtained from Clontech 
(Heidelberg, Germany), Invitrogen (Groningen, The Netherlands), Pharmacia Biotech, 
Promega (Mannheim, Germany), Qiagen and Stratagene (La Jolla, California, USA). 
Oligonucleotides were ordered from Metabion (Munich, Germany). All oligonucleotides used 
were listed in the appendix. Cell culture material was ordered from Nunc (Roskilde, 
Denmark), Life Technologies and PAA Laboratories GmbH (Cölbe, Germany). 
 
III.2. Solutions and buffers 
(in alphabetical order) 
 
Antibody dilution buffer   0.1  % (w/v) BSA in TBS 
(immunocyto-/histo-chemistry) 
 
Antibody dilution buffer   3  % (w/v) BSA in TBS 
(Western blotting)     0.1  % (v/v) Tween-20 
 
BCA-Reagent A     1  % (w/v) Bicinchoninacid  
(BCA kit)          disodium salt 
        1,7  % (w/v) Na2CO3 × H2O 
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        0,16  % (w/v) Natriumtartrat 
        0,4  % (w/v) NaOH 
        0,95  % (w/v) NaHCO3 pH 11.25 
 
BCA-Reagent B     4  % (w/v) CuSO4 × 5 H2O 
(BCA kit) 
 
Blocking buffer     1  % (w/v) BSA in TBS 
(immunocyto-/histo-chemistry) 
 
Blocking buffer     3  % (w/v) BSA in TBS 
(Western blotting) 
 
Blocking buffer     0,2  M  Glycine pH 8.0 
(CNBr activated sepharose) 
 
Blotting buffer     25  mM  Tris 
(Western blotting)     192  mM  Glycine 
        0.01  %  SDS 
        10  %  Methanol 
 
Coupling buffer     0,1  M  NaHCO3 pH 8.3 
(CNBr activated sepharose)   0,5  M  NaCl 
 
Developer solution    7,5  g  Na2CO3 
(silver stain)      30  µl  Formaldehyde∗ 
up to 250 ml H2O (∗freshly added) 
 
DNA-sample buffer (5x)   20  %(w/v) Glycerol in TAE buffer 
(DNA-gels)      0,025 % (w/v) Orange G 
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dNTP-stock solutions    20  mM  each dATP, dCTP,  
(PCR)            dGTP, dTTP 
 
Ethidiumbromide solution   10  µg/ml Ethidiumbromide in 1xTAE 
(staining solution DNA gels) 
 
Elution buffer     0,1  M  Acetate pH 4.0 
(fusion protein production) 
 
Elution buffer     0,1  M  Glycine pH 2.7 
(affinity chromatography/   0,5  M  NaCl 
immunoprecipitation) 
 
Fixation solution     75  %  Ethanol 
(silver stain)      25  %  Acetate acid 
 
Homogenisation buffer    0.32  M   Sucrose 
(raft preparation)     1  mM  CaCl2 
1  mM  MgCl2 
1  mM  NaHCO3 
5  mM  Tris-HCl pH 7.4 
 
Incubation buffer     75  ml  Ethanol 
(silver stain)      17  g  Sodium acetat 
        1,25  ml  Glutaraldehyde (25 % w/v)∗ 
        0,5  g  Na2S2O3 x H2O∗ 
            up to 250 ml (∗ freshly added) 
 
IPTG       1  M  238 mg/ml results in 1000x stock 
(protein expression) 
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Ligation buffer (10x)    200  mM  Tris-HCl pH 7.9 
        100  mM  MgCl2 
        100  mM  Dithiothreitol (DTT) 
        6  mM  ATP 
 
Lysis buffer      20   mM  Na3PO4 pH 7.4 
(cells for co-      150  mM  NaCl  
immunoprecipitation)     0,2  mM  CaCl2 
        1  mM  MgCl2 
        1  mM  ADP 
        1  %  Triton X-100 
 
Native lysis buffer     50  mM  NaH2PO4 pH 8.0 
(bacterial lysis)     300  mM  NaCl  
        10  mM  Imidazole 
 
Denaturing lysis buffer    8  M  Urea 
(bacterial lysis)     0,1  M  NaH2PO4 
        0,01  M  Tris-HCl pH 8.0 
 
Phosphate buffered saline    150  mM  NaCl 
(PBS)       20   mM  Na3PO4 pH 7.4 
 
Phosphate buffered saline   20   mM  Na3PO4 pH 7. 4 
with Ca2+ and Mg2+    150  mM  NaCl  
(PBS+Ca/Mg)     0.2  mM  CaCl2 
        1  mM  MgCl2 
 
Protease inhibitors    1 tablet COMPLETE resuspended in 2 ml PBS 
(COMPLETE)     results in a 25 x stock solution 
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RIPA-buffer       50   mM  Tris-HCl pH 7.4 
(cell lysis)      150  mM  NaCl 
1  mM  EGTA 
10  mM  NaF 
2  mM  Na3VO4 
1  % (w/v)  Triton X-100 
        1  x  complete protease inhibitor mix 
 
Running gel 10%     3.92  ml  deionized water 
(protein gels)      5.26  ml   1 M Tris pH 8.8 
0.14   ml    10% SDS 
4.70  ml   30% Acrylamide – Bis 37:1 
70.0  µl    10% APS 
7.00  µl    TEMED 
 
Sample buffer (5x)    0.312 M   Tris-HCl pH 6.8 
(protein-gels)      10  % (w/v) SDS 
        5  % (w/v) β-Mercaptoethanol 
        50  % (v/v) Glycerol 
        0.13  % (w/v) Bromphenol Blue 
 
SDS running buffer (10x)   0.25  M  Tris-HCl pH 8.3 
(protein-gels)      1.92  M  Glycine 
        1  M  SDS 
 
Silvering buffer     0,5  g  AgNO3 
(silver stain)      50  µl  Formaldehyde (37 % w/v) ∗ 
up to 250 ml H2O (∗freshly added) 
 
Stacking gel 5%     3.77  ml     deionized water 
(protein gels)      0.32  ml    1 M Tris pH 6.8 
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0.05   ml    10% SDS  
0.83  ml    30% Acrylamide – Bis 37:1 
25.0   µl  10% APS 
7.00   µl   TEMED 
 
Staining solution     40  % (v/v) Ethanol 
(protein gels)      10  % (v/v) Acetic acid 
        0,1  % (w/v) Serva Blue R250 
 
Stopping solution     1  % (w/v) Glycine in H2O 
(silver stain) 
 
Stripping buffer     0.5  M  NaCl 
(Western blots)     0.5  M  Acetic acid 
 
TAE (50x)      2  M  Tris-Acetat pH 8.0 
(DNA gels)      100  mM  EDTA 
 
TBF1       100  mM  RbCl 
(competent E.coli)     50   mM  MnCl2 
        30  mM  potassium acetate 
        10  mM  CaCl2 
        15  % (v/v) Glycerol  
adjust pH 5.8 
 
TBF2       10  mM  MOPS 
(competent E.coli)     10  mM  RbCl 
        75  mM  CaCl2 
        15  % (v/v) Glycerol  
adjust pH 8.0 with KOH 
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Tris plus buffer     5  mM  Tris-HCl pH 7.4 
(lipid raft isolation)    1  mM  CaCl2 
1  mM  MgCl2 
1  mM  NaHCO3 
 
TNE buffer      20  mM  Tris pH 7.5 
(brain homogenisation    150  mM  NaCl 
for affinity chromatography)  1  mM  EDTA 
        1  mM  EGTA 
        1  % (v/v) Triton X-100 
        1  x  complete protease inhibitor mix 
 
Tris buffered saline (TBS)   10   mM  Tris HCl pH 8.0 
        150   mM  NaCl  
 
Washing buffer 1     0,1  M  Tris pH 8.0 
(fusion protein production)   0,5  M  NaCl 
 
Washing buffer 2     25   mM  Tris pH 6.8 
(fusion protein production) 
 
Washing buffer     0,1  M  Acetate pH 4.0 
(CNBr activated sepharose)   0,5  M  NaCl 
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III.3. Bacterial media 
(Media were autoclaved and antibiotics were supplemented prior to use) 
 
LB-medium    10 g/l  bacto-tryptone pH 7.4  
      10 g/l  NaCl 
      5 g/l   yeast extract 
 
LB/Amp-medium   100 mg/l ampicillin in LB-Medium 
 
LB/Amp-plates   20 g/l  agar in LB-Medium 
      100 mg/l ampicillin 
 
LB/Kan-medium   25 mg/l kanamycin in LB-Medium 
 
LB/Kan-plates   20 g/l  agar in LB-Medium 
      25 mg/l kanamycin 
 
III.4. Cell culture media 
 
Media were prepared from a 10X stock solution purchased from Gibco GBL 
 
CHO cell Medium   Glasgow MEM (GMEM) (with nucleotides) 
      supplemented with  
      10 % (v/v) fetal calf serum (FCS) 
      50 U/ml  penicillin/streptomycin 
      4 mM   L-glutamine 
 
N2A cell Medium   Dulbecco MEM (DMEM) 
      supplemented with  
      10 % (v/v) fetal calf serum (FCS) 
      50 U/ml  penicillin/streptomycin 
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      1 mM  pyruvate 
 
Versene     Gibco GBL 
 
HBSS     Gibco GBL 
 
III.5. Bacterial strains and cell lines 
 
Escherichia coli DH5α    Clontech 
deoR, endA1, gyrA96, hsdR17(rk-mk+), recA1,relA1, 
supE44, thi-1, ∆(lacZYA-argFV169),Φ80lacZ∆M15, F- 
 
Escherichia coli M15[pREP4]  QIAGEN 
NaIS, StrS, RifS, Lac-, Ara-, Gal-, Mtl-, F-, RecA+,Uvr+, 
Lon+ 
 
Escherichia coli BL21(DE3)  Novagene 
        F-, ompT, hsdSB (rB-mB-), gal, dcm (DE3) 
 
Escherichia coli XL1-Blue   Stratagene 
recA1, endA1, gyrA96, thi-1, hsdR17, supE44, relA1, 
lac[F´, proAB, lacqZ∆M15, Tn10 (Tetr)] 
 
CHO-K1       Chinese Hamster Ovary 
        dehydrofolatereductase deficient hamster cell line 
 
N2A       Mouse neuroblastoma cell line 
established from the spontaneous tumor of a strain A  
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III.6. Molecular weight standards 
 
1kb DNA ladder   14 bands within the range from 200-10000 bp 
      (Gibco) 
 
BenchMark    6 µl of the BenchMark Protein Ladder (Life 
Protein Ladder    Technologies) were loaded on the SDS-PAGE gel 
 
Band No. apparent molecular weight (kDa)
1 220 
2 160 
3 120 
4 100 
5 90 
6 80 
7 70 
8 60 
9 50* 
10 40 
11 30 
12 25 
13 20* 
14 15 
15 10 
*20kDa and 50 kDa proteins are more 
prominent for proper identification 
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BenchMark     6 µl of the BenchMark Prestained Protein Ladder (Life 
Prestained Protein   Technologies) were loaded on the SDS-PAGE gel 
Ladder  
 
Band No. apparent molecular weight (kDa)
1 173 
2 121 
3 80 
4 62* 
5 49 
6 36 
7 25 
8 21 
9 15 
10 9.0 
*Orientation band (pink in color) 
 
III.7. Plasmids 
 
pBluescript SK+ plasmid used for cloning and blue/white selection on X-gal 
containing plates. Amp-resistance (Stratagene) 
 
pQE30 prokaryotic expression plasmid for recombinant expression of 
proteins, carrying a RGS-motif followed by a hexahistidine-
domain (6xHis) at the 5’ end of the multiple cloning site for 
purification. Amp-resistance (Qiagen) 
 
pET28 prokaryotic expression plasmid for recombinant expression of 
proteins, carrying a pentahistidine motif at each side of the 
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multiple cloning site and a thrombin protease site between 
multiple cloning site and his-tag. Kan-resistance (Novagen) 
 
pcDNA3 mammalian expression vector for transfection of eucaryotic 
cells. Amp-resistance (Invitrogen) 
 
EGFP  Mammalian expression plasmid encoding for the enhanced 
green fluorescent protein. Kan-resistance (Clontech) 
 
III.8. Antibodies 
 
anti-CHL1 rabbit polyclonal antibody raised against the extracellular 
domain of mouse CHL1-Fc (produced in the lab of M. 
Schachner) 
Immunoblotting (IB):   1:10000 (crude serum) 
Immunocytochemistry: 1:500 (ProteinA-purified fraction) 
Immunohistochemistry:  1:10 (affinity-purified fraction) 
 
anti-L1 rabbit polyclonal antibody raised against the extracellular 
domain of mouse L1-Fc (produced in the lab of M. Schachner) 
IB:  1:5000 
 
anti-hsc70 affinity-purified goat polyclonal antibody (Santa Cruz, clone   
sc-1059), raised against a peptide mapping the carboxy terminus 
of human hsc70 (identical to mouse sequence)  
IB: 1:2500 
 
anti-hsp70 mouse monoclonal antibody (Santa Cruz, clone sc-24), derived 
by fusion of immunized BALB/c spleen cells with NS-1 mouse 
myeloma cells (Santa Cruz) 
IB:  1:4000 
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anti-RGS HisTM mouse monoclonal antibody, recognizes RGS(H)4 epitope 
encoded by pQE30 vector (Qiagen) 
IB: 1:2500 
 
anti-Penta HisTM mouse monoclonal antibody, recognizes five consecutive 
histidine residues (Qiagen) 
IB: 1:2000 
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IV. Methods 
 
IV.1. Cell culture of cell lines 
 
IV.1.1. Stable transfected CHO cells  
 
CHO cells were stably transfected with pEE 14 expression vector (Bebbington, 1991) 
containing the portion of the CHL1 gene encoding the extracellular part of CHL1 (Chen et al., 
1999). For purification, the human Fc portion was fused to the C-terminus of the protein. The 
stably transfected clones were kindly provided by Dr. Suzhen Chen. 
 
IV.1.2. Cell culture of stable transfected CHO cells  
 
CHO cells were cultured in GMEM with 10 % FCS (fetal calf serum) and 2% 
penicillin/streptomycin (P/S) at 37°C, 5 % CO2 and 90 % relative humidity in 75 cm2 flasks 
(Nunc) with 15 ml medium. Cells were passaged when they were confluent (usually after 3-4 
days). Medium was removed and cells were detached by incubation with 4 ml Versene for 5 
min at 37°C. Cells were centrifuged (200xg, 5 min, RT) and the pellet was resuspended in 10 
ml fresh medium. For production of CHL1-Fc, cells were seeded in 175 cm2 flasks and 
medium was exchanged against GMEM containing 2 % ultra low IgG FCS with gentamycin 
(f.c. 0.015 mg/ml) and l-glutamine (f.c. 2mM). 
 
IV.1.3. Transient transfection of cells  
 
For transient transfection of CHO or N2A cells (Hawley-Nelson et al., 1993), the 
Lipofectamine Plus kit (Life Technologies) was used. One day before transfection, 2 x 105 
cells were seeded per 35 mm dish. When cells had grown to 80-90% confluency (usually after 
18-24 h), they were washed with HBSS and medium was exchanged against GMEM without 
FCS and antibiotics. Cells were transfected with 2 µg total DNA per 35 mm well. 6 µl Plus 
reagent and 4 µl Lipofectamine were used per transfection assay. Transfection was performed 
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as described in the manufacturers protocol according to the literature (Shih et al., 1997). 
Transfection was terminated after 4 h by addition of an equal volume of GMEM, 10 % FCS, 
2% P/S. Twentyfour h after transfection, cells were detached with 250 µl Versene per well 
and split either 1:2 for biochemical analysis or 1:6 for immunocytochemistry on coverslips. 
 
IV.1.4. Lysis of transfected cells 
 
Fortyeight hours after transfection of CHO or N2A cells, the medium was removed and cells 
were washed once with ice-cold HBSS. Cells were lysed in 250 µl RIPA buffer containing 1 
% Triton X-100 or in PBS containing 1 % Triton X-100 and 1mM ADP per 35 mm well. 
Cells were scraped off the wells and transferred into a 1.5 ml Eppendorf tube. Debris was 
removed by centrifugation (15.000 x g, 4°C, 10 min) and the protein concentration of the 
supernatant was determined by using the BCA kit (Pierce). The supernatant was stored at –
20°C. 
 
IV.1.5. Co-immunoprecipitation from transiently transfected CHO or N2A cells 
 
Cells were transfected with the plasmids coding for wildtype CHL1 or one of the mutated 
CHL1 constructs. For immunoprecipitation, cells from three confluent 35 mm dishes were 
used. 48 h after transfection, cells were lysed in 750 µl PBS containing 1 % Triton X-100 and 
1 mM ADP. Debris was removed by centrifugation (15.000 x g, 4°C, 10 min) and the 
supernatant was transferred to a 1.5 ml Eppendorf tube. The supernatant was diluted with PBS 
without Triton X-100 to give a final concentration of 0.5 %. For co-precipitation experiments, 
the cell lysate was pre-cleared with 25 µl ProteinA dynabeads for 1 hour at 4°C with constant 
agitation. The beads were removed by centrifugation and 20 µl of polyclonal anti CHL1 
antiserum was added to the cell lysate supernatant and incubated at 4°C overnight with 
agitation. On the second day, 25 µl ProteinA dynabeads were added to the samples and 
incubated for further 2 hours at 4°C with agitation. Beads were collected after this time period 
by using a Dynal magnet. Cell lysate was removed completely and beads were washed 5 x for 
5 min with PBS containing 0.1 % of Triton X-100 and 1 mM ADP. The immunocomplex was 
eluted from the beads with 45 µl glycine buffer pH 2.7 and neutralized with 5µl 1 M Tris pH 
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8.0. Precipitates were subjected to SDS-PAGE and Western blotting and analyzed for the 
presence of hsc70. 
 
IV.2. Cell culture of primary hippocampal neurons 
 
IV.2.1. Preparation of dissociated hippocampal cultures 
 
For preparation of dissociated hippocampal cultures, mice of postnatal day 1 – 4 were used. 
Hippocampi were prepared by Galina Dityateva. Preparations were performed as described 
(Brewer et al., 1993; Lochter et al., 1991). 
In brief, the procedure was performed as followed: 
1) Dissection 
Mice were decapitated and brains removed from skull. Brains were cut along the midline, 
hippocampi were prepared and split into 1 mm thick pieces. 
2) Digestion 
Hippocampi were washed twice with dissection solution and treated with trypsin and 
DNAseΙ for 5 min at RT. Digestion solution was removed, hippocampi were washed 
twice and the reaction was stopped by adding trypsin inhibitor 
3) Dissociation 
Hippocampi were resolved in dissection solution containing DNAseΙ. Tituration with 
pasteur pipettes having successively smaller diameters dissociated hippocampi to 
homogeneous suspensions. 
4) Removal of cell debris and plating of cells 
By subsequent centrifugation  (80 x g, 15 min, 4°C) and resuspension in dissection buffer, 
cell debris was removed. Cells were counted in a Neubauer cell chamber and plated to 
provide a densitity of 1.000 cells/mm2. 
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IV.2.2. Neuritogenesis of hippocampal neurons 
 
Hippocampi were prepared as described before and plated on 96-well-plates. The wells were 
pre-coated with 0.01% poly-L-lysine (Sigma) overnight at 4°C and washed three times with 
cold HBSS. Antiserum, ProteinA-purified IgG fraction or protein was coated in different 
dilutions overnight at 4°C. As a positive control, laminin was coated and as a negative control 
only poly-L-lysine was given as substrate for neurite outgrowth. The solutions were removed 
and the wells were washed and dried under the hood. Dissociated hippocampal neurons were 
plated in 100 µl with densities of 5.000 – 7.500 cells per well. Cells were allowed to grow for 
24 hours at 37°C and 5% CO2. After this time period, cells were fixed by adding 10 µl 25% 
glutaraldehyde (f.c. 2.5%) and stained with 1% toluidine blue in 1% borate buffer for 2 hours 
at RT. Cells were washed twice with H2O and dried at RT. Cells were imaged with a Kontron 
microscope (Zeiss) and analysed with Carl Zeiss Vision KS 400 V2.2 software. For each 
experimental value, neurites of at least 50 cells with neurites longer than the cell body 
diameter were measured (Lochter et al., 1991; Müller-Husmann et al., 1993). 
 
IV.2.3. Transfection of hippocampal neurons 
 
For transfection of hippocampal neurons, cells were plated on coverslips (diameter 12 mm) 
which were placed in 24 well plates and pre-coated with either poly-L-lysine or anti CHL1 
IgG fraction obtained from polyclonal antiserum. Cells were allowed to attach for at least 4 
hours. For transfection of primary cells, CaPO4 transfection was carried out using the 
Stratagene Mammalian Transfection Kit. Six hours before the transfection was started, the 
temperature of the CO2 incubator was reduced to 35°C and CO2 concentration was changed to 
3%. 10 – 20 µg of total DNA was used per approach. In case of co-transfection with EGFP, 
CHL1-DNA was applied in 5-fold excess. Transfections were performed according to the 
instruction manual (Stratagene). Twentyfour hours after the first transfection, cell were re-
transfected. Finally, cells were kept in culture for additional 6 hours before they were fixed as 
described below. All images of hippocampal neurons were obtained with a Zeiss LSM510 
argon-crypton confocal laser-scanning microscope equipped with a 63x oil-immersion 
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objective lens. Images were quantified using the image processing software Scion Image 
(Scion Corporation). 
 
IV.3. Immunocytochemistry 
 
IV.3.1. Immunocytochemistry of living cells 
 
Coverslips with the attached cells were washed with PBS+Ca/Mg and placed on Parafilm in a 
humid chamber. Cells were blocked with TBS/BSA 1% for 30 min at RT. 100 µl TBS/BSA 
1% containing the primary antibody in the appropriate dilution were added on the coverslips 
and incubated at RT for 20 min. Afterwards, coverslips were placed into 12-well dishes and 
washed for three times with TBST. Then coverslips were covered with 100 µl TBS/BSA 1% 
containing the flourescent dye-coupled secondary antibody in a 1:250 dilution and incubated 
for 20 min at RT in the dark. Finally, coverslips were washed three times again with TBS, 
fixed as described below and embedded on slides with Aqua Poly/Mount medium 
(Polysciences Inc). 
 
IV.3.2. Fixation of cells  
 
The medium was removed from the coverslips and cells were fixed with 1 ml 4% para-
formaldehyde in PBS for 10 min at RT. Cells were washed twice with PBS and stored in PBS 
at 4°C.  
 
IV.3.3. Immunocytochemistry of fixed CHO cells and hippocampal neurons 
 
Coverslips were placed on Parafilm in a humid chamber and incubated with 100 µl blocking 
buffer for 1 hour at RT. The blocking buffer was removed by aspiration and the coverslips 
were covered with 100 µl antibody solution containing the appropriate primary antibody and 
incubated overnight for 1 hour at RT in a humid chamber. Coverslips were washed three 
times with TBS/BSA 1% and incubated with 100 µl antibody solution containing the 
fluorescent dye-labeled secondary antibody (Cy3, Cy5, FITC) for 1 – 2 hours at RT in the 
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dark. Finally, cells were washed three times with TBS and mounted on objectives with Aqua 
Poly/Mount medium (Polysciences Inc.). Coverslips were stored in the dark at 4°C.  
 
IV.4. Immunohistochemistry 
 
All immunohistochemical experiments were performed by Bettina Rolf and Dr. Udo Bartsch. 
Four- to six-week-old CHL1 deficient mice (Montag et al., 1997) and wild-type littermates 
were deeply anesthetized and perfused through the left ventricle with 4% paraformaldehyde in 
PBS pH 7.4. Brains were removed and post-fixed in the same fixative overnight at 4°C. 
Indirect immunofluorescence was performed as described (Weber, 1999). In brief, 40µm thick 
slices were blocked in PBS containing 1% BSA for 2 hours at RT followed by incubation 
with affinity-purified antibody against CHL1 (ΙΙΙ.6.4) in 1:10 dilution with PBS/0.1% BSA 
overnight at RT. After washing three times for 10 min at RT with PBS/0.1% BSA, sections 
were incubated with Cy3-conjugated antibodies against rabbit IgG (1:250 in PBS/0.1% BSA) 
for 1 hour at RT washed and mounted with Aqua-Poly/Mount (Polysciences, Warrington, 
PA). Indirect immunofluorescence for the detection of CHL1 was also performed on cryostat 
sections as described (Bartsch et al., 1992b). Briefly, cryostat sections were prepared from 
fresh frozen brains in 12 µm thin slides, placed onto poly-L-lysine coated coverslips and air-
dried for 1 hour at RT. Afterwards, sections were fixed in methanol at –20°C and blocked in 
PBS/0.1% BSA. Primary antibodies against CHL1 (1:10 in PBS/0.1% BSA) were incubated 
overnight at 4°C. Sections were washed and incubated with Cy3-conjugated antibodies 
against rabbit IgG (1:250 in PBS/0.1% BSA), washed again and mounted onto slides. Imaging 
and analysis of tissue was performed with an Axiophot fluorescence microscope (Zeiss, 
Oberkochen, Germany) 
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IV.5. Generation of polyclonal antiserum from rabbit 
 
IV.5.1. Immunization 
 
In presence of Complete Freund’s Adjuvant (CFA, Sigma), two rabbits were injected 
intramusculary with 5 mg of E.coli cell lysate of transformed bacteria expressing CHL1 as 
priming immunization. Four weeks after the priming immunization, booster immunizations 
were started and continued at 2 – 3 weeks intervals. For each booster immunization, 2 mg of 
purified CHL1-Fc mixed with 2 ml of Incomplete Freund’s adjuvants (IFA, Sigma) per rabbit 
were applicated. After the fifth booster immunization, the animals were bled. 
 
IV.5.2. Preparation of serum from blood 
 
Immediately after bleeding, a wooden stick was applied to each blood sample. Samples were 
allowed to incubate for 4 hours at RT to form a clot. Afterwards, they were placed overnight 
at 4°C to retract the clot. It was removed carefully by the wooden stick after complete 
aggregation and serum was transferred to a 50-ml centrifugation tube. Remaining blood cells 
and debris were pelleted by centrifugation (2700 x g, 10 min, 4°C) and the supernatant was 
stored in aliquots at –20°C. 
 
IV.5.3. Preparation of IgG fraction from crude serum 
 
Preparation of IgG fraction with saturated ammonium sulfate (SAS) 
 
One volume of saturated ammonium sulfate solution was added dropwise to two volumes of 
antiserum with constant stirring at 4°C. A precipitate was allowed to form at 4°C for 4 hours 
under constant stirring. Afterwards, the sample was centrifuged (12.000 x g, 20 min, 4°C) and 
the pellet was washed twice by subsequently resuspending in 33 % SAS and centrifugation. 
After the last centrifugation step, the pellet was resolved in PBS. A convenient volume for 
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resuspension was 5 – 10 % of the original antiserum volume. The IgG fraction was finally 
dialyzed against three changes of PBS to fully remove the ammonium sulfate. 
 
Preparation of IgG fraction with ProteinA sepharose 
 
Freeze-dried ProteinA sepharose was reswollen and prepared as described in the 
manufacturer’s protocol. 10 ml of crude antiserum were applicated with 1 – 2 ml of reswollen 
ProteinA sepharose and incubated overnight at 4°C with constant agitation. Serum was 
removed by centrifugation (200 x g, 5 min, 4°C) and beads were washed four times for 5 min 
at 4°C. Bound immunoglobulins were eluted with acidic glycine buffer and neutralized with 1 
M Tris pH 8.0. Buffer was exchanged against PBS by using a Amicon ultrafiltration unit and 
the protein concentration was determined using the BCA kit (Pierce). 
 
IV.5.4. Affinity purification of IgG fraction 
 
Coupling of mouse CHL1-Fc and human IgG to CNBr-activated sepharose 
 
Coupling of recombinant proteins to activated sepharose was performed as described (affinity 
chromatography, ΙΙΙ.5.18) according to the manufacturer’s instructions. 2 mg of ProteinA-
purified recombinant CHL1-Fc and 2 mg of commercially available human IgG fraction was 
conjugated covalently to sepharose. Suspensions were transferred into empty glass columns 
and beads were allowed to settle under slow buffer flow to build up a homogeneously packed 
column bed. 
 
Affinity purification 
 
5 ml of a ProteinA-purified IgG fraction obtained from anti CHL1 polyclonal serum was 
initially loaded onto a sepharose 4B pre-column to remove components binding unspecifically 
to the matrix. Successively, the flow through was applied first to the human IgG column and 
finally to the CHL1-Fc column. By the human IgG column, those immunoglobulins were 
extracted which recognize the human Fc tag of the CHL1 fusion protein. Thus, the flow 
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through of the human IgG column solely contains immunoglobulins which specifically bind 
to the CHL1 portion of the fusion protein. Both columns were washed with approximately the 
10-fold volume of column bed volume and were eluted with acidic glycine buffer pH 2.7. 
Only the eluate of the CHL1 column was neutralized and used for immunohistochemystry 
(see ΙV.4). 
 
IV.6. Molecular biology 
 
IV.6.1. Bacterial expression system (pQE 30, Qiagen) 
 
For recombinant expression of proteins in E. coli (Ausubel, 1996; Sambrook et al., 1989), the 
corresponding cDNA of a protein was inserted in frame with a ATG start codon and a 
purification tag of the convenient expression plasmid. The appropriate E. coli strain was 
transformed with the expression construct and streaked on LB plates supplemented with the 
indicated antibiotic. 20 ml of LB pre-culture containing the appropriate antibiotic were 
inoculated by a single colony and incubated overnight at 37°C with constant agitation. 
Afterwards, the 20 ml were transferred into a 400 ml LB culture and incubated at 37°C under 
constant agitation until the culture had reached an optical density of 0.6. Protein expression 
was induced by adding IPTG (f.c 1 mM.) to the culture with further incubation for 2-6 h at 
37°C. Bacteria were collected by centrifugation (4000 x g, 10 min, 4°C) and stored at –20°C. 
Protein expression was monitored by removing 1 ml aliquots of the culture every hour after 
IPTG induction. Bacteria were pelleted, lysed in sample buffer and applied on an SDS gel for 
Coomassie staining. 
 
IV.6.2. Production of competent bacteria 
 
DH5α, M15[REP4] or XL1-Blue bacteria were streaked on LB-plates containing the 
appropriate antibiotics and incubated overnight at 37°C. Single colonies were picked and used 
for inoculation of 10 ml of an overnight culture. 1 ml of the overnight culture was added to 
100 ml of pre-warmed LB broth containing antibiotics and shaked until an optical densitiy of 
OD600 of 0.5 was reached (approximately 90 – 120 min). The culture was cooled down on ice, 
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transferred to sterile round-bottom tubes and centrifuged at low speed (4000 x g, 5 min, 4°C). 
The supernatants were discarded and the cells were resuspended in cold TBF1 buffer (30 ml 
for a 100 ml culture). The suspension was kept on ice for additional 90 min. Then the cells 
were collected by centrifugation (4000 x g, 5 min, 4°C), the supernatant was discarded again 
and the cells resuspended in 4 ml ice-cold TBF2 buffer. Aliquots of 100 µl were prepared, 
frozen in dry ice-ethanol mix and stored at –80°C. 
 
IV.6.3. Transformation of bacteria 
 
To 100 µl of competent DH5α or M15[pREP4], either 50-100 ng of plasmid DNA or 20 µl of 
ligation mixture were added and incubated for 30 min on ice. After a heat shock (2 min, 
42°C) and successive incubation on ice (3 min), 800 µl LB-medium were added to the 
bacteria and incubated at 37°C for 30 min. The cells were then centrifuged (10000 x g, 1 min, 
RT) and the supernatant removed. Cells were resuspended 100 µl LB medium and plated on 
LB plates containing the appropriate antibiotics. Plates were incubated overnight at 37°C. 
 
IV.6.4. Plasmid isolation of E.coli 
 
Small scale plasmid isolation of E. coli (Miniprep) 
 
3 ml LB/Amp-Medium (100 µg/ml ampicillin) was inoculated with a single colony and 
incubated overnight at 37°C with constant agitation. Cultures were transferred into 2 ml 
Eppendorf tubes and cells were pelleted by centrifugation (12,000 rpm, 1min, RT). Plasmids 
were isolated from the bacteria according to the manufacturers protocol. The DNA was eluted 
from the columns by addition of 50 µl 10 mM Tris-HCl pH 8.0 with subsequent 
centrifugation (12,000 rpm, 2 min, RT). 
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Large scale plasmid isolation of E. coli (Maxiprep) 
 
For preparation of large quantities of DNA, the Qiagen Maxiprep kit was used. A single 
colony was inoculated in 2 ml LB/amp (100 µg/ml ampicillin) medium and grown at 37°C for 
8 h with constant agitation. Afterwards, this culture was added to 500 ml LB/amp medium 
supplemented with 100 µg/ml ampicillin and the culture was incubated overnight at 37°C 
with constant agitation. Cells were pelleted in a Beckmann centrifuge (6,000g, 15 min, 4°C) 
and DNA was isolated as described in the manufacturers protocol. Finally, the DNA pellet 
was eluted in 600 µl of prewarmed (70°C) 10 mM Tris-HCl pH 8.0 and the DNA 
concentration was determined. 
 
IV.6.5. Enzymatic modification of DNA 
 
Digestion of DNA 
 
For restriction, the DNA was incubated with twice the recommended amount of appropriate 
enzymes in the recommended buffer for 2 h. Restriction was terminated by addition of sample 
buffer and the sample was applied on a agarose gel. If two enzymes were incompatible with 
each other, the DNA was digested successively with the enzymes. The DNA was purified 
between the two digestions using the rapid purification kit (Life Technologies).  
 
Dephosphorylation of plasmid DNA 
 
After restriction, the plasmid DNA was purified and SAP buffer (Boehringer Ingelheim) and 
1 U SAP (shrimps alkaline phosphatase) per 100 ng plasmid DNA were added. The reaction 
was incubated at 37°C for 2 h and terminated by incubation at 70°C for 10 min. The plasmid 
DNA was used for ligation without further purification. 
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Ligation of DNA fragments 
 
Ligation of DNA fragments was performed by mixing 50 ng vector DNA with the fivefold 
molar excess of insert DNA. 1 µl of T4-Ligase and 2 µl of ligation buffer were added and the 
reaction mix was brought to a final volume of 20 µl. The reaction was incubated either for 2 h 
at RT or overnight at 16°C. The reaction mixture was used directly for transformation without 
any further purification. 
 
IV.6.6. Polymerase chain reaction (PCR) 
 
Amplification of DNA fragments was performed in a 50 µl reaction mix with thin-walled 
PCR tubes in MWG-PCR cyclers. Turbo-Pfu-Polymerase and the appropriate reaction buffer 
were obtained from Stratagene. The following reaction mixture was used: 
 
Template     2-10 ng 
Primer 1 (10pM)   1 µl 
Primer 2 (10pM)   1 µl 
Nucleotides (dNTPs)  1 µl 
(20 mM) 
PCR-buffer (10 x)   5 µl  
Turbo-pfu- Polymerase  2,5 U 
ddH2O     ad 50 µl 
 
The PCR was performed with the following step gradient: 
 
1) Initial denaturing   94°C  1 min 
2) Denaturing     94°C  1 min 
3) Annealing    Tm-4°C  1 min 
4) Synthesis    72°C  1 min/ 1kb DNA 
5) Termination    72°C  10 min 
6) Cooling     4°C 
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The amplification procedure (steps 2-4) was repeated 30 times. 
The melting temperature of the primers depends on the GC content and was calculated by the 
following formula: 
 
Tm = 4 x (G+C) + 2 x (A+T) 
 
If the two primers had different melting temperatures, the lower of both was used. 
Afterwards, the quality of the PCR product was monitored by gel electrophoresis and the PCR 
product was purified with the rapid PCR purification kit. 
 
IV.6.7. DNA gel electrophoresis 
 
DNA fragments were separated by horizontal electrophoresis cambers (BioRad) using agarose 
gels. Agarose gels were prepared by heating 1-2 % (w/v) agarose (Gibco) in 1xTAE buffer, 
depending on the size of DNA fragments. The gel was covered with 1xTAE buffer and the 
DNA samples were pipetted into the sample pockets. DNA sample buffer was added to the 
probes and the gel was run at constant voltage (10V/cm gel length) until the orange G dye had 
reached the end of the gel. Afterwards, the gel was stained in an ethidiumbromide staining 
solution for 20 min. Finally, gels were documented using the E.A.S.Y. UV-light 
documentation system (Herolab, Wiesloh, Germany). 
 
IV.6.8. Extraction of DNA fragments from agarose gels 
 
For isolation and purification of DNA fragments from agarose gels, ethidiumbromide-stained 
gels were illuminated with UV-light and the appropriate DNA band was excised from the gel 
with a clean scalpel and transferred into an Eppendorf tube. The fragment was isolated 
following the manufacturer’s protocol. The fragment was eluted from the column by addition 
of 50 µl prewarmed (70°C) Tris-HCl (10 mM, pH 8.0). The DNA-concentration was 
determined using the undiluted eluate. 
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IV.6.9. Purification of DNA fragments 
 
For purification of DNA fragments, the Rapid PCR Purification kit was used according to the 
manufacturer’s protocol. The DNA was eluted from the column by addition of 50 µl 
prewarmed (70°C) Tris-HCl (10 mM, pH 8.0). The DNA-concentration was determined using 
the undiluted eluate.  
 
IV.6.10. Determination of DNA concentrations 
 
DNA concentrations were determined spectroscopically using an Amersham-Pharmacia 
spectrometer. The absolute volume necessary for measurement was 50 µl. For determining the 
concentration of DNA preparations (III 1.2), the eluate was diluted 1:50 with water and the 
solution was pipetted into a 50 µl cuvette. Concentration was determined by measuring the 
absorbance at 260 nm, 280 nm and 320 nm. Absorbance at 260 nm had to be higher than 0.1 
but less than 0.6 for reliable determinations. A ratio of A260/A280 between 1,8 and 2 indicated 
a sufficient purity of the DNA preparation.  
 
IV.6.11. DNA sequencing 
 
DNA sequencing was performed by the sequencing facility of the ZMNH using Step-by-Step 
protocols for DNA-sequencing with Sequenase-Version 2.0, 5th ed., USB, 1990. For 
preparation, 1 µg of DNA was diluted in 7 µl ddH20 and 1 µl of the appropriate sequencing 
primer (10 pM) was added.  
 
IV.6.12. Site-directed mutagenesis 
 
As template DNA for site-directed mutagenesis, full length CHL1 cloned in pcDNA3 was 
provided by Dr. Birthe Schnegelsberg. For mutation of single amino acids within a DNA 
fragment, the Quickchange Site-directed mutagenesis kit (Stratagene) was used. For detailed 
information, see the manufacturer’s instructions. For vector cards, primer design and location 
of mutated amino acids, see appendix. 
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In brief, primers were designed such that: 
1) they contained the desired mutation and annealed to the same sequence on opposite strands 
of the plasmid. 
2) the primers had a length between 25 and 45 bases and the melting temperature was greater 
than 78°C. 
3) the desired mutation (deletion or insertion) was in the middle of the primer with 10~15 
bases of correct sequence on both sites. 
 
During PCR reaction, it was important to keep primer concentrations in excess. Therefore, the 
amount of template was varied while primer concentrations were kept constant. The reaction 
mixture was prepared as followed with 3 different template concentrations: 
 
Template    10, 20, 50 ng 
Mutation-Primer 1   (10 pM)  1 µl 
Mutation-Primer 2  (10 pM)  1 µl 
Nucleotides (dNTPs)  (20 mM)  1 µl 
PCR-buffer (10 x)     5 µl  
Turbo-pfu- Polymerase    1 µl (2,5 U) 
ddH2O       ad 50 µl 
 
The following step gradient was applied for mutagenesis: 
 
1) Initial denaturing  94°C  30 sec 
2) Denaturing    94°C  30 sec 
3) Annealing   55°C  1 min 
4) Synthesis   72°C  2 min/ 1kb DNA 
5) Cooling    4°C 
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The number of cycles (steps 2-4) was set to 18 to minimize undesired mutations. For 
determining the length of step 4, the sizes of the insert and the plasmid have to be taken into 
account. After PCR reaction, 5 µl of the mixtures were applied on an agarose gel to check for 
sufficient amplification. The template DNA (e.g. non mutated DNA) in the amplification 
reaction was digested by adding 1 µl of Dpn I restriction enzyme directly into the 
amplification reaction with subsequent incubation for 1h at 37°C. Afterwards, the 
amplification reaction was transformed into competent XL1-Blue bacteria as described. 
Single colonies were picked from the plate and inoculated into 3 ml cultures. Plasmid DNA 
was prepared and the mutation was verified by sequencing. 
 
IV.7. Proteinbiochemistry 
 
IV.7.1. One-dimensional SDS-polyacrylamide gel electrophoresis 
 
Separation of proteins was performed by means of the discontinuous SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) using the Mini-Protean III system (BioRad). The size of the 
running and stacking gel was as followed: 
 
Running gel:  height 4.5 cm, thickness 1 mm 
  10 % - 12 % acrylamide solution 
 
Stacking gel:  height 0.8 cm, thickness 1 mm 
  4 % - 5% (v/v) acrylamide solution 
  15-well combs or without combs for preparative gels 
 
After complete polymerization of the gel, the chamber was assembled as described in the 
manufacturer’s protocol. Up to 35 µl sample were loaded in the pockets and the gel was run at 
constant voltage of 80 V for 10 min and then at 140 V until the bromphenol blue line had 
reached the end of the gel. Gels were then either stained or subjected to Western blotting. 
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IV.7.2. Two-dimensional SDS-polyacrylamide gel electrophoresis 
 
The option of two-dimensional gel electrophoresis was recommended in case of preparative 
gels, since resolution of protein mixtures is highly increased by the use of this method. In the 
first dimension, brain homogenates were separated by isoelectric focussing on an immobilized 
pH gradient (IPG). The principles of isoelectric focusing on IPGs are described in detail 
elsewhere (Westermeier, 1993). Briefly, due to the net charge, amphoteric molecules like 
proteins can migrate in an electric field. Proteins focus at a specific pH value, where all 
negative and positive charges are compensated and the molecule is not charged anymore 
(isoelectric point). Afterwards, pH gradient stripes were equilibrated in SDS sample buffer 
and applied to vertical SDS gel electrophoresis. In the second dimension, proteins were 
separated due to their molecular weight. For separation of proteins in the first dimension, 
commercially available IPG stripes with varying pH ranges and different stripe lengths were 
used. Initially, IPG stripes with wide pH range (pH 3 – 10) were used to determine the 
approximate isoelectric point of the protein of interest. Finally, for the isolation of a protein, a 
narrow pH range (pH 4 – 7) on large 18 cm-stripes was used. All IPG stripes were purchased 
by Amersham Pharmacia Biotech. After separation in the second dimension, gels were 
subjected to Western blotting for either an overlay assay, an immunological detection of a 
particular protein or for silver staining. 
 
IV.7.3. Coomassie staining of polyacrylamide gels 
 
After SDS-PAGE, the gels were stained in staining solution (1h, RT) with constant agitation. 
The gels were then incubated in destaining solution until the background of the gel appeared 
nearly transparent. 
 
IV.7.4. Silver staining of polyacrylamide gels 
 
After SDS-PAGE, gels were fixed and incubated with freshly prepared glutaraldehyde and 
thiosulphite in acetate/ethanol solution for 30 min at RT with constant agitation. Gels were 
washed intensively for at least three times for 5 min and subsequently silvered for 20 min. 
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Afterwards, gels were developed with sodium carbonate and reaction was stopped with 
glycine buffer. 
 
IV.7.5. Electrophoretic transfer of proteins on nitrocellulose membranes 
(Western blotting) 
 
Proteins were transferred from the SDS-gel onto a nitrocellulose membrane (Protran 
Nitrocellulose, Schleicher & Schüll) using either a MINI TRANSBLOT-apparatus or a 
ProteanΙΙ apparatus for blotting of 18 cm gels after 2-dimensional separation (both BioRad). 
After equilibration of the SDS-gel in blot buffer for 5 min, the blotting sandwich was 
assembled as described in the manufacturer’s protocol. Proteins were transferred 
electrophoretically in blot buffer at constant voltage (85 V for 120 min or 35 V overnight at 
4°C). The prestained marker BenchMark (Gibco BRL) was used as a molecular weight 
marker and to control the efficiency of the electrophoretic transfer.  
 
IV.7.6. Immunological detection of proteins on nitrocellulose membranes 
 
After electrophoretic transfer, the membranes were removed from the sandwiches and placed 
protein-binding site up in glass vessels. Membranes were washed once in TBS and incubated 
in blocking buffer for 1 h at room temperature. Afterwards, the primary antibody was added 
in the appropriate dilution either for 2 h at RT or overnight at 4°C. The primary antibody was 
removed and membranes were washed five times for 5 min with TBST. The appropriate 
secondary antibody was applied for 2 h at RT. Membranes were washed again five times for 5 
min with TBST and immunoreactive bands were visualized using the enhanced 
chemiluminescence detection system (ECL). 
 
IV.7.7. Overlay approach  
 
Instead of incubation with a primary antibody, nitrocellulose membranes were incubated with 
recombinantly expressed proteins in an appropriate dilution. Proteins were allowed to interact 
with a putative binding partner that was separated in gel electrophoresis and transferred to 
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nitrocellulose membrane. Protein-protein interaction was detected with primary antibodies 
against the fusion tag of the recombinant molecule and visualized with HRP-conjugated 
secondary antibody by ECL detection system. 
 
IV.7.8. Immunological detection using enhanced chemiluminescence (ECL) 
 
The immunocomplex composed of nitrocellulose membrane bound protein, primary antibody 
and secondary antibody coupled with horse-raddish peroxidase (HRP) was detected using the 
enhanced chemiluminescence detection system (Pierce). The membrane was soaked for 1 min 
in detection solution (1:1 mixture of solutions I and II). The solution was removed and the 
blot was placed between two Saran wrap foils. The membrane was exposed to X-ray film 
(Biomax-MR, Kodak) for varying time periods. 
 
IV.7.9. Enzyme-linked Immunosorbent assay (ELISA) 
 
Several antigens were immobilized on polyvinylchloride surface in 96-well microtiter plate in 
a wide range of dilutions (1 ng/µl to 0.2 µg/µl) overnight at 4°C under constant agitation. 
Non-absorbed proteins were removed and the wells were washed five times for 5 min at RT. 
The wells were blocked for one hour at RT with 1 % BSA in TBS and subsequently incubated 
with the putative binding protein for a further hour at RT. Non-bound proteins were removed 
and the wells were washed five times for 5 min at RT to remove unspecifically bound 
proteins. Specifically bound proteins were detected with certain primary antibodies and the 
appropriate HRP-linked secondary antibodies. Protein binding was visualized by the detection 
reaction of HRP with ABTS reagent that resulted into a coloured product that was quantified 
using an ELISA reader at 562 nm. 
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IV.7.10. Expression of recombinant proteins in Escherichia coli 
 
In general, expression of recombinant proteins in E. coli can be obtained by introduction of 
desired cDNA coding for a protein of interest into an appropriate expression vector 
(Sambrook et al., 1989). The choice of the vector depends on the desired position of a fusion 
tag, on the presence of a reporter protein function, whether internal protease site are required 
and how DNA fragments will be inserted in the correct reading frame. The expression 
construct is created by ligation of digested vector and insert and then transformed into the 
appropriate host cells carrying a repressor plasmid. Transformed host cells were streaked out 
on LB plates supplemented with antibiotics. A 20 ml LB pre-culture with the appropriate 
antibiotic was inoculated with a single colony and incubated overnight at 37°C with constant 
agitation. Afterwards, the pre-culture was transferred into a 400 ml expression culture and 
incubated at 37°C under constant agitation until the culture had reached an optical density of 
OD600 of 0.6. Protein expression was induced by adding IPTG (f.c 1 mM) to the culture with 
further incubation for 2-6 h at 37°C. Bacteria were collected by centrifugation and stored at –
20°C. Protein expression was monitored by removing small aliquots of the culture every hour 
after IPTG induction. Bacteria were pelleted, lysed in sample buffer and applied on a SDS 
gel. 
 
IV.7.11. Expression in E. coli using the pQE-system 
 
The cDNAs encoding for several proteins (intracellular domain of CHL1, intracellular domain 
of NCAM 180 and NCAM 140 (both provided by Dr. Markus Delling) and hsc 70 (provided 
by Dr. Christine Knuehl, Charité, Berlin ) were cloned into the pQE expression vector and 
transformed into E. coli M15 [pREP4] host cells. All protein were expressed with an N-
terminal 6xHis affinity tag for purification and detection. Induction of protein expression, 
production and purification of the proteins via Ni-NTA column was performed according to 
the QIAexpressionist handbook. 
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IV.7.12. Expression in E. coli using the pET-system 
 
The cDNA encoding the intracellular domain of L1 was cloned into the pET28 expression 
vector. pET28/L1-ICD constructs were transformed into the host strain BL21 (λDE3 
lysogen), in which the T7 RNA polymerase is under control of IPTG-inducible lacUV5 
promotor. Therefore, the target gene is under control of T7 promotor. L1-ICD was 
constructed with the his-tag located N-terminal. Production and purification were performed 
as described in the QIAexpressionist handbook. 
 
IV.7.13. Lysis of bacteria 
 
Sonification 
 
Small scale bacterial cultures were centrifuged (8000 x g, 4°C, 10 min) and the pellet was 
resuspended in 2x SDS sample buffer. The suspension was lysed using a sonificator (Branson 
Sonifier B15, level 6, 50% pulse, 5 x 20 s, on ice) and the debris was removed by 
centrifugation (10000 x g, 4°C, 10 min. The supernatant was subjected to SDS-PAGE and the 
gel was subsequently stained with Coomassie blue. 
 
French press 
 
Bacteria cultured for expression in large scale were pelleted (8000 x g, 4°C, 10 min) and 
resuspended in native lysis buffer (20 ml lysis buffer per 400 ml culture). The suspension was 
transferred into a precooled French-Pressure-20K-chamber (capacity: 40 ml). Bacteria were 
compressed (Spectronic Instruments/SLM Aminco, 10000 psi, 5 min) and lysed by opening 
the valve carefully. The procedure was repeated 3 times and then the suspension was 
centrifuged (15.000xg, 10 min, 4°C) in a Beckman centrifuge. 
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IV.7.14. Expression of recombinant proteins in stable transfected CHO cells  
 
The expression vector pEE 14 coding the extracellular part of mouse CHL1 fused to human 
Fc tag was constructed and provided by Dr. Suzhen Chen. The isolation of stable transfected 
clones was under control of the glutamine synthetase selection system (CELLTECH Ltd., 
UK, 1990). Further culturing of cells under selection conditions were performed according to 
the instruction manual. Stably transfected cells secreted the Fc-tagged fusion proteins into the 
cell supernatant which was harvested after 4 – 5 days in culture before medium became 
yellow. The supernatant was centrifuged (500 x g, 15 min, 4°C) to remove detached cells and 
subsequently centrifuged (10.000 x g, 15 min, 4°C) to remove cell debris or other particles. 
The supernatant was loaded onto a ProteinA sepharose column with a loading velocity of 0.25 
ml/min. The column was washed with at least the 20-fold volume of the column bed with two 
different washing buffers. Specificly bound fusion protein was eluted with acetate buffer pH 
4.0, collected and neutralized with 1 M Tris pH 8.0. The buffer was exchanged against PBS 
using an Amicon ultrafiltration unit and protein concentration was determined using the BCA 
protein concentration determination kit (Pierce) 
 
IV.7.15. Determination of protein concentration (BCA) 
 
The protein concentration of cell lysates was determined using the BCA kit (Pierce). Solution 
A and B were mixed in a ratio of 1:50 to give the BCA solution. 10 µl of the cell lysate was 
applied to 200 µl BCA solution in microtiter plates and incubated for 30 min at 37°C.  BSA 
standards ranging from 100 µg/ml to 2 mg/ml were co-incubated. The extinction of the 
samples was determined at 562 nm in a microtiter plate by an ELISA reader. 
 
IV.7.16. Brain homogenisation 
 
Brains were prepared from C57BL/6J mice of different ages varying from 3 – 4 postnatal day 
up to 3 weeks after birth. Mice were decapitated, brains were removed from skulls and 
immediately tranferred into a Dounce homogenizer (Weaton, Teflon pestle, 0.1 µm). Brains 
were homogenized in TNE buffer containing 1 % Triton X-100 and protease inhibitor diluted 
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to the appropriate concentration and subjected to affinity chromatography or 
immunoprecipitation. For application of brain homogenates to sucrose gradients, brains were 
homogenized in HEPES buffer containing sucrose without detergent or protease inhibitors. 
Depending on the further experiments, brains were either ultracentrifuged subsequently with 
100.000 x g, 1 hour, 4°C to obtain fractions (non-detergent soluble, detergent-soluble or 
Triton insoluble fraction) or were applied as crude homogenates to the experiment without 
any further centrifugation step. 
 
IV.7.17. Preparation of membrane subfractions 
 
The preparation of raft subfractions was performed by Dr. Ralf Kleene. Brains were removed 
from 7-day old or adult mice. All following steps were carried out at 4°C. Brains were 
homogenized in 3 ml homogenisation buffer applying 12 up-and-down. The homogenate was 
centrifuged (1.000 x g, 10 min, 4°C) and supernatant was further centrifuged at 17.500 x g for 
15 min. The resulting pellet was resuspended in homogenisation buffer and was applied on 
top of a sucrose step gradient (1.2 M, 1.0 M, 0.85 M and 0.65 M). The 1.000 x g-pellet was 
resuspended in homogenisation buffer and the sucrose concentration was adjusted to 1 M 
using 2.34 M sucrose stock solution. This solution was laid on 1.2 M sucrose and was 
overlaid with homogenisation buffer. The sucrose gradients were ultracentrifuged at 100.000 
x g for 2 hours using a SW28 rotor. The bands at the 1.0/1.2 M interfaces which contained 
synaptosomes were collected, diluted at least two times with Tris plus buffer and 
subsequently centrifuged at 100.000 x g for 30 min. The pellet was resuspended in Tris plus 
buffer and incubated for 30 min in ice in order to osmotically shock the synaptosomes. 
Membranes were isolated by centifugation at 100.000 x g for 30 min, resuspended in Tris plus 
buffer, pooled and applied to a sucrose step gradient (1.2 M, 1.0 M, 0.85 M and 0.65 M) and 
centrifuged as described. The band at the 1.0/1.2 M interface which contained synaptosomal 
membranes was collected, diluted at least two times with Tris plus buffer and centrifuged at 
100.000 x g for 30 min. The membranes were resuspended in Tris plus buffer and incubated 
for 30 min on ice in the absence or presence of 0.15 M NaHCO3, pH 11. Mock-treated and 
alkali-treated membranes were re-isolated by ultracentrifugation, resuspended in Tris plus 
buffer and incubated for 30 min on ice after addition of Triton X-100 (f.c. 1%). The samples 
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were centrifuged at 120.000 x g for 1 hour using a SW55Ti rotor. The resulting supernatant 
was subjected to a methanol-chloroform protein precipitation performed as described (Wessel 
and Flugge, 1984) while the pellets were resuspended in Tris plus buffer. Parts of these 
suspensions were used to isolate low density Triton-insoluble membrane subdomains (rafts). 
The sucrose concentration was adjusted to 1.2 M and the suspensions were overlaid with 1.1 
M sucrose and 0.3 M sucrose. The gradient was centrifuged at 120.000 x g for 1 hour. The 
protein layer from the 0.3/1.1M interface which contained the lipid rafts and from the 1.1/1.2 
M interface which represented the non-raft fraction were collected, diluted at least three times 
and centrifuged at 120,000 g for 20 min. The resulting pellets were used for further analysis. 
 
IV.7.18. Affinity chromatography 
 
Coupling gels for ligand immobilization 
 
For affinity chromatography, recombinant CHL1-Fc or CHL1-ICDhis6 was immobilized on 
activated CNBr sepharose 4B by covalent conjugation via primary amino groups of the 
proteins. The coupling procedure was carried out according to the instruction manual. 
 
In brief, the coupling was performed as followed: 
1) The required amount of freeze-dried powder was suspended in 1mM HCl and the 
active CNBr-sepharose 4B was allowed to swell completely 
2) Protein buffer was exchanged against sodium carbonate buffer pH 8.3.  
Protein : gel ratio was 2 : 1 
3) Protein-gel suspension was incubated overnight at 4°C with constant agitation 
4) Remaining active groups of the gel were blocked by addition of glycine buffer 
5) Coupling was finished by alternate washing with basic carbonate buffer or acidic 
acetate buffer to remove an excess of absorbed protein 
 
For affinity chromatography, coupled sepharose gel was transferred into an empty glass 
column and placed at 4°C. For immunoprecipitations, beads were stored in Falcon-tubes at 
4°C and applied in aliquots to the experiment. 
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Affinity chromatography 
 
Brain homogenates were applied to the affinity columns either containing CHL1-Fc- or 
CHL1-ICDhis6 -conjugated beads. In case of CHL1-Fc affinity chromatography, membrane 
fractions were loaded after dilution with detergent-free homogenisation buffer to obtain a 
final concentration of 0.2 % Triton X-100. The total amount of brain protein varied between 
20 – 40 mg of membrane fraction. The CHL1-ICDhis6 column was loaded with non-detergent 
soluble fraction with comparable amounts of protein. The application of brain homogenate 
was performed with low loading velocities (0.1 ml/min), whereas washing and elution was 
under faster buffer flow (0.5 ml/min). For washing, two different buffers with high salt/high 
pH-content and non salt/low pH, respectively, were used. The elution was achieved by acidic 
glycine buffer pH 2.7 and eluates were collected in fractions of small volume and neutralized 
immediately. All acidic fractions were subjected to SDS-PAGE and visualized by silver 
staining. 
 
IV.7.19. Immunoprecipitation 
 
For immunoprecipitations, either activated sepharose beads covalently coupled with anti 
CHL1 IgG fraction or ProteinA beads with pre-absorped anti CHL1 antiserum were used. The 
incubation of brain homogenates with antibody-conjugated beads was performed overnight at 
4°C with constant agitation. Beads were pelleted at 200 x g at 4°C, supernatant was removed 
quantitively and the beads were subsequently washed five times for 5 min at RT with ice-cold 
homogenisation buffer containing 0.1 % Triton X-100 without protease inhibitors. Only in 
case of immunoprecipitations with crude homogenates or crude membrane fractions, 
antibodies were absorbed to magnetic ProteinA Dynabeads (Dynal). Purification was obtained 
by placing the gel suspension into the magnetic tube holder to collect dynabeads on one side 
of the Eppendorf tube. The supernatant was carefully removed without disturbing the bead 
clot and washing was performed analogously to the immunoprecipitation with sepharose 
beads. Bound protein was eluted with 45 µl of acidic glycine buffer pH 2.7, neutralized with 5 
µl 1 M Tris pH 8.0 and applied to SDS-PAGE. 
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V. Results 
 
V.1. Production of recombinant CHL1-Fc and CHL1-ICDhis6 
 
The extracellular portion of CHL1 and the intracellular domain of CHL1 were produced in 
order to obtain an in vitro binding assay. For this purpose, stably transfected CHO cells were 
cultured to express recombinant CHL1-Fc that was secreted into the cell supernatant. Cell 
culture supernatants were harvested successively and collected in four independent pools 
(Figure 1A, lanes 1 – 4). The extracellular portion of CHL1 was isolated from these 
supernatants via the human Fc-tag using a ProteinA column. After purification of the fusion 
protein a single band of approximately 200 kDa was seen in the Coomassie stained gels 
(Figure 1A, lane 5). M15 E.coli bacteria were transformed with a procaryotic expression 
vector coding for CHL1-ICDhis6. Protein expression was induced by application of IPTG to 
the bacterial suspension. IPTG-induction led to the production of a his-tagged fusion protein 
that comprised the intracellular domain of CHL1 revealing a molecular mass of 
approximately 18 kDa (Figure 1B, lanes 1,2). For the purification of CHL1-ICDhis6, proteins 
which were soluble after lysis of bacteria under native conditions (Figure 1B, lane 3) were 
applied to a Ni-NTA column. Purification of the CHL1-ICDhis6 fusion protein using the hexa 
histidine tag was quantitive since the flow through of the Ni-NTA column was completely 
lacking the fusion protein (Figure 1B, lane 4). After competitive elution of CHL1-ICDhis6 with 
high concentrations of imidazole, the purified intracellular domain of CHL1 was isolated as a 
predominant band. The purified CHL1-ICDhis6 showed an apparent molecular weight of 
approximately 18 kDa in the Coomassie stained gels (Figure 1B, lanes 7,8). This protein 
emerged previously in whole bacteria lysates after induction of protein expression (Figure 1B, 
lanes 2,3). 
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Figure 1: Purification of CHL1-Fc and CHL1-ICDhis6 
(A): Cell culture supernatants of stably transfected CHO cells producing CHL1-Fc were harvested and collected 
in four independent pools (lanes 1 – 4). For isolation of the extracellular portion of CHL1, they were 
successively applied to a ProteinA sepharose column. After washing, specifically bound CHL1-Fc was eluted 
using an acidic acetate buffer (lane 5). All samples were subjected to SDS-PAGE and stained with Coomassie-
Blue. M: Molecular weight marker. Molecular weights are indicated on the left. Note, that the purification 
revealed a single protein of approximately 200 kDa (lane 5). 
(B): M15 bacteria transformed with the pQE30 expression vector encoding CHL1-ICDhis6 were lysed before 
(lane 1) and after induction (lane 2) of protein expression and analyzed by SDS-PAGE. After IPTG-induction, a 
protein appeared with an apparent molecular mass of approximately 18 kDa (lane 2). Proteins which were 
soluble after lysis under native conditions were applied to a Ni-NTA column (lane 3). The flow through of the 
Ni-NTA column was collected (lane 4) and specifically bound fusion protein was eluted using high imidazole 
concentrations (lanes 6 – 9). A predominant band of approximately 18 kDa was isolated by Ni-NTA column 
purification (lanes 7,8). The soluble protein fraction, the flow through and the elution fractions were applied to 
SDS-PAGE. Gels were stained with Coomassie-Blue after separation. M: Molecular weight marker. Molecular 
weights are indicated on the left. 
 
V.2. Affinity chromatography of brain homogenates using immobilized   
CHL1-Fc and CHL1-ICDhis6 
 
For isolation of putative binding partners of CHL1, the recombinant proteins CHL1-Fc and 
CHL1-ICDhis6 were immobilized. CHL1-Fc was conjugated to CNBr-activated sepharose 
while the intracellular portion was linked to NHS-activated sepharose containing a (CH2)12-
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spacer arm. Homogeneously packed columns were generated and brain homogenates were 
applied with the intention to segregate proteins which have bound specifically either to the 
extracellular portion or the intracellular domain of CHL1. Detergent extracts of brain 
membranes were applied to the CHL1-Fc column. After extensive washing, proteins were 
eluted using an acidic acetate buffer (Figure 2A). A non-detergent soluble fraction of a brain 
homogenate containing proteins which were soluble under native conditions was allowed to 
bind to the CHL1-ICDhis6 column. Non-specifically bound proteins were removed by 
extensive washing and proteins bound to CHL1-ICDhis6 were eluted using an acetate buffer at 
pH 2.7 (Figure 2B). Representative elution profiles of either CHL1-Fc or CHL1-ICDhis6 
column are presented below. Obviously, in non of these binding approaches specifically 
bound proteins were isolated, neither from the CHL1-Fc column (Figure 2A, lanes 2 – 11) nor 
from the CHL1-ICDhis6 column (Figure 2B, lanes 2 – 11). In both affinity chromatography 
assays a quite even elution pattern was observed without a remarkable enrichment of one or 
more distinct bands indicating that no putative binding partner was isolated by this approach. 
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Figure 2: Affinity chromatography of brain homogenates using CHL1-Fc or CHL1-ICDhis6 conjugated 
sepharose columns 
(A): Detergent-solubilized brain membranes were prepared for the isolation of putative CHL1-Fc binding 
proteins. The extract was applied to the CHL1-Fc column (approximately 20 mg per approach). The flow 
through (lane 1) contained non-bound proteins and was discarded after the binding assay. Following extensive 
washing, bound proteins were eluted using an acetate buffer and collected in fractions (lanes 2 – 11). The flow 
through and the elution fractions were subjected to SDS-PAGE and silver staining was performed after 
separation. M: Molecular weight marker. Molecular weights are indicated at the left margin. 
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(B): 20 mg of a non-detergent soluble fraction from a brain homogenate was applied to the CHL1-ICDhis6 
affinity column. Proteins were allowed to interact with the immobilized fusion protein, afterwards the column 
was washed and bound proteins were eluted using an acidic acetate buffer. The flow through (lane 1) and the 
elution fractions (lanes 2 – 11) were subjected to SDS-PAGE and gels were silver stained after separation.         
M: Molecular weight marker. Molecular weights are indicated on the left. 
 
V.3. One-dimensional overlay of brain fractions using soluble CHL1-ICDhis6, 
L1-ICDhis6 and NCAM 180-ICDhis6  
 
The affinity chromatography using immobilized CHL1-ICDhis6 was repeated in a modified 
manner. CHL1-ICDhis6 was conjugated non-covalently to Ni-NTA beads and a brain 
homogenate was allowed to bind to the fusion protein in a fluid phase (“batch approach”). 
Consistent with the elution profiles which were received from the column affinity 
chromatography, no protein that specifically bound to CHL1-ICDhis6 was isolated using the 
batch approach (data not shown). The elution fractions of the batch affinity chromatography 
were further subjected to SDS-PAGE and transferred to nitrocellulose membrane. 
Immobilized proteins were then incubated with soluble CHL1-ICDhis6 in an overlay approach. 
Non of the proteins which were isolated using CHL1-ICDhis6 beads in a batch 
chromatography, showed binding to the soluble fusion protein in an overlay approach. Thus, 
non of the proteins which were slightly enriched by the batch approach were confirmed to 
bind to CHL1-ICDhis6 using an alternative method. Additionally to the elution fractions 
isolated from the batch approach, brain homogenate fractions were subjected to the same 
SDS-PAGE as a positive control. In those particular lanes, a remarkable interaction of CHL1-
ICDhis6 to a protein of approximately 60 – 70 kDa appeared (data not shown). To verify the 
specificity of the binding of CHL1-ICDhis6 to this protein, the same approach was used with 
two further cell adhesion molecules, namely with the intracellular domain of L1 (L1-ICDhis6) 
and the intracellular portion of the 180 kDa-isoform of NCAM (NCAM180-ICDhis6). Both 
proteins were also applied as hexa histidine tagged fusion proteins. Only following CHL1-
ICDhis6 incubation, a signal appeared that was predominantly observed in the non-detergent 
soluble fraction (Figure 3A, lane 1, indicated by an arrow). Neither after incubation using L1-
ICDhis6 (Figure 3B) nor after incubation using NCAM180-ICDhis6 (Figure 3C) this signal was 
detectable indicating that it was specific for CHL1-ICDhis6. A further strong signal of 
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approximately 40 kDa was present in the Triton X-100 insoluble fraction after all incubations 
(Figure 3, A – C, lane 3). Using the anti RGS his6 antibody alone without prior incubation of 
a fusion protein demonstrated that this signal was due to unspecific binding of the anti RGS 
his6 antibody (Figure 3D, lane 3). 
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Figure 3: Overlay analysis of fractions from a brain homogenates using the intracellular domains of 
different cell adhesion molecules  
Fractions of a brain homogenate including the non-detergent soluble fraction (lane 1), the Triton X-100 soluble 
membrane fraction (lane 2) and the Triton X-100 insoluble membrane fraction (lane 3) were subjected to SDS-
PAGE (20 µg/lane) and transferred to nitrocellulose membrane after separation.  
(A): Brain fractions were incubated with CHL1-ICDhis6 (f. c. 0.02 mg/ml). As negative controls, the same 
fractions were incubated with L1-ICDhis6 (f.c. 0.02 mg/ml) (B) and with NCAM 180-ICDhis6 (f.c. 0.02 mg/ml) 
(C). Bound fusion protein was detected with the anti RGS his6 antibody (1/1000) and the anti mouse IgG-HRP 
secondary antibody (1/10000). The anti RGS his6 antibody was used without previous incubation of fusion 
protein (D) to demonstrate unspecific binding of the detection antibody to a protein of approximately 40 kDa. 
Arrows indicate bound protein (A) and non bound proteins (B – D). Molecular weights are presented on the left. 
 
 61
V. Results 
   
 
 
V.4. Overlay approach of CHL1-ICDhis6 after two-dimensional separation of a 
brain homogenate 
 
In order to isolate the protein that binds to soluble CHL1-ICDhis6, it was necessary to improve 
the separation of the brain homogenate. Therefore, proteins of a brain homogenate which 
were soluble under native conditions in a non-detergent lysis buffer were aceton-precipitated 
and subjected to an isoelectric focusing which allows the separation of proteins according to 
their isoelectric point. Subsequently, focused proteins were further separated in the second 
dimension on a SDS-PAGE according to their molecular weights and transferred to 
nitrocellulose membrane. The immobilized proteins were then incubated with soluble CHL1-
ICDhis6 and the detection of bound fusion protein was performed as described for the one-
dimensional overlay approach using the anti RGS his6 antibody. As seen in that binding 
assay, the protein that specifically bound CHL1-ICDhis6 was also detectable in the two-
dimensional overlay approach. The molecular weigth of the CHL1-ICDhis6 binding protein 
was confirmed to be approximately 70 kDa and a slightly acidic isoelectric point of 
approximately 5.5 – 6.0 could be assigned to the signal (Figure 4A). Negative controls were 
carried out using L1-ICDhis6 and NCAM180-ICDhis6 (data not shown) showing no specific 
binding to that particular protein or any other protein. Because of the high number of proteins 
with a molecular weight of approximately 70 kDa and a slightly acidic isoelectric points 
(Figure 4B), a further separation was recommended for the isolation of the CHL1-ICDhis6 
binding protein. 
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Figure 4: Overlay analysis of separated soluble brain proteins after two-dimensional gel electrophoresis 
using CHL1-ICDhis6 
The non-detergent soluble proteins from a brain homogenate (200 µg protein per approach) were acetone-
precipitated and subjected to an isoelectric focusing on an IPG stripe of 7cm and a pH-gradient of 3 – 10. 
Afterwards, the IPG stripes were subjected to SDS-PAGE for separation of proteins in the second dimension 
according to the molecular weight. Molecular weights are indicated on the left. The pH values are indicated 
below the figures. 
(A): After separation, proteins were transferred to nitrocellulose membrane and incubated with CHL1-ICDhis6 
(f.c. 0.02 mg/ml). Detection of bound fusion protein was performed using the anti RGS his6 antibody (1/1000) 
and the secondary anti mouse IgG-HRP antibody (1/10000). 
(B): After SDS-PAGE, gels were silver stained in order to assign a distinct protein spot to the signal that was 
observed in the overlay approach. 
 
To further advance the separation of the soluble brain proteins for isolation of the CHL1-
ICDhis6 binding protein, the two-dimensional gel electrophoresis was carried out on longer 
IPG stripes within a pH range of pH 4 – 7. By this enhancement of separation, a distinct 
single spot in the silver stained gel was identified to correspond to the signal that was 
observed in the overlay approach. The particular protein that was assigned to the signal is 
indicated by a red circle in the silver stained gel (Figure 5B). 
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Figure 5: Overlay analysis of separated soluble brain proteins after enhanced two-dimensional gel 
electrophoresis using CHL1-ICDhis6 
The non-detergent soluble fraction of a brain homogenate was acetone-precipitated using 400 µg per 
precipitation and separated on IPG stripes with 18cm in length and a more limited pH gradient ranging from pH 
4 – 7. After isoelectric focusing, proteins were further seperated in the second dimension on large SDS-PAGE. 
Molecular weights are indicated on the left. The pH values are indicated below the figures. 
(A): Afterwards, proteins were transferred to nitrocellulose membrane and incubated with soluble CHL1-ICDhis6 
(f.c. 0.02 mg/ml). For analysis of bound fusion protein, the anti RGS his6 antibody was applied (1/1000) and 
detected with an anti mouse IgG-HRP secondary antibody (1/10000). 
(B): After separation, gels were silver stained. The protein that corresponds to the CHL1 binding protein in an 
overlay approach is indicated by a red circle. 
 
V.5. Isolation and identification of the CHL1-ICDhis6 -binding protein 
 
The two-dimensional gel electrophoresis of a brain homogenate was repeated and the silver 
staining was performed according to Shevchenko (Shevchenko et al., 1996) in order to isolate 
and identify the 70 kDa protein that showed binding to the intracellular domain of CHL1. The 
silver stained protein spot that correlated to the signal that was observed in the two-
dimensional overlay approach was cut out and the protein was sequenced using the matrix-
assisted laser desoption/ionization – mass spectroscopy (MALDI-MS) (Jensen et al., 1997; 
Mortz et al., 1994). The protein sequencing was carried out by Dr. Bernhard Kuster in the 
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laboratory of Prof. Matthias Mann, Odense, DK. The protein that bound to CHL1-ICDhis6 in 
the overlay binding assay was identified as the murine heat shock cognate 70, further 
abbreviated as hsc70 (GenBankTM accession number M19141) (Giebel et al., 1988). The 
molecular weight of 70 kDa and the isoelectric point of 5.5 that are described for hsc70 
(Pelham, 1986) correspond to those of the protein which were determined here for the CHL1-
ICDhis6 binding protein. 
 
V.6. Verification of the CHL1-hsc70 interaction by co-immunoprecipitation 
 
Since the interaction of CHL1 and hsc70 was identified under denaturing conditions of an 
overlay approach, CHL1 binding of hsc70 was analyzed in a more native system. The 
detergent extract of a brain homogenate containing CHL1 (Figure 6A, lane 1) as well as hsc70 
(Figure 6C, lane 1) was incubated with either an anti CHL1 antibody or an anti hsc70 
antibody for immunoprecipitation. Immunocomplexes were isolated using ProteinA beads. 
Bound proteins were eluted using an acidic acetate buffer and analyzed for co-precipitation of 
hsc70 or CHL1, respectively. As negative control, a polyclonal antibody against L1 was 
applied for precipitation. The analysis of the immunoprecipitates revealed that neither after 
precipitation of CHL1 a co-precipitation of hsc70 was detectable (Figure 6A, lane 4) nor after 
precipitation of hsc70 a co-precipitation of CHL1 occurred (Figure 6C, lane 3). Thus, in this 
particular binding study using a co-immunoprecipitation approach the interaction between 
CHL1 and hsc70 could not be confirmed. In the negative control using the anti L1 antibody 
for immunoprecipitation, no co-precipitation of hsc70 was detected (Figure 6B, lane 4). In 
principle, the immunoprecipitation worked since CHL1 and L1 were present in the 
immunocomplexes that were eluted from ProteinA sepharose beads after precipitation of 
CHL1 or L1 (Figure 6 A/B, lane 3). Hsc70 was detectable in the brain fraction utilized for 
immunoprecipitation (Figure 6 A/B, lane 6) as well as in the supernatant after precipitation 
(Figure 6 A/B, lane 5). CHL1 was also present in the homogenate before and after 
precipitation of hsc70 (Figure 6C, lane 5 and lane 4). 
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Figure 6: Immunoprecipitation of CHL1, L1 and hsc70 and analysis of co-precipitation of hsc70 and 
CHL1 
A detergent extract of a brain homogenate was incubated with a polyclonal anti CHL1 antibody (A), a polyclonal 
anti L1 antibody (B) and a polyclonal anti hsc70 antibody (C) for immunoprecipitations. Immunocomplexes 
were purified using ProteinA sepharose and analysis of a putative co-precipitation was carried out using anti 
hsc70 antibody (A/B, lane 4) and anti CHL1 antibody (C, lane 3), respectively. Brain fractions which were used 
for the immunoprecipitation (A/B, lanes 1,6 and C, lanes 1,5), supernatants of ProteinA sepharose after 
immunoprecipitation (A/B, lanes 2,5 and C, lanes 2,4) and the eluates from ProteinA sepharose (A/B, lanes 3,4 
and C, lane 3 ) were subjected to SDS-PAGE and further transferred to nitrocellulose membrane. 
(A): Detection of CHL1 was carried out using a polyclonal rabbit antibody against the extracellular domain of 
CHL1 (A, lanes 1 – 3), hsc70 presence was analyzed by the use of a polyclonal goat anti hsc70 antibody (A, 
lanes 4 – 6). (B): Detection of L1 was performed using a polyclonal rabbit anti L1 antibody (B, lanes 1 – 3) 
while hsc70 detection (B, lanes 4 – 6) was carried out as described in (A). (C): Hsc70 was detected using a 
polyclonal goat anti hsc70 antibody (C, lanes 1,2) while CHL1 presence was analyzed using the polyclonal 
rabbit anti CHL1 antibody (C, lanes 3 – 5). The ProteinA eluates are indicated by an arrow where a putative co-
precipitation was expected (A/B, lane 4 and C, lane 3). 
 
V.7. Binding study of recombinant CHL1-ICDhis6 and hsc70his6 using an ELISA 
approach 
 
To prove a direct binding of CHL1 and hsc70, recombinant proteins were produced in a 
procaryotic expression system. Recombinant BAG-1 that is known to bind to hsc70 
(Kanelakis et al., 1999; Luders et al., 2000) was used as a positive control. CHL1-ICDhis6, 
BAG-1his6 and hsc70his6 were coated on absorbent plastic surfaces and incubated with the 
respective putative binding partner. The immobilization of the fusion proteins was previously 
controlled by incubation of coated proteins with anti RGS his6 antibody or penta his antibody, 
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respectively, without preceded incubation of the putative binding protein. Detection of the 
potential interaction partner was carried out using specific antibodies against hsc70, the 
intracellular domain of CHL1 and BAG-1. The immobilization on a plastic surface worked 
well for all analyzed fusion proteins since they were detected following coating to plastic 
surface using antibodies against the fusion tag (Figure 7, pink square, green square and blue 
square indicating the detection of coated CHL1-ICDhis6 , BAG-1his6 or hsc70his6 , respectively). 
The interaction of CHL1 and hsc70 could not be confirmed in the ELISA assay since binding 
of hsc70his6 to immobilized CHL1-ICDhis6 was not observed (Figure 7, pink diamonds). Vica 
versa, binding of soluble CHL1-ICDhis6 to immobilized hsc70his6 was also not detectable 
(Figure 7, blue diamonds). In contrast to this, the interaction between the previously known 
binding partners BAG-1his6 and hsc70his6 was confirmed in the ELISA assay. Interestingly, the 
binding of BAG-1 and hsc70 was only detectable after immobilization of hsc70his6 (Figure 7, 
blue triangles) and application of soluble BAG-1his6 while in the reciprocal approach, when 
BAG-1his6 was coated and subsequently incubated with soluble hsc70his6, no interaction was 
observed (Figure 7, green triangles). 
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Figure 7: ELISA binding assay for the evaluation of CHL1– hsc70 interaction 
CHL1-ICDhis6 was immobilized (1 ng/µl to 0.2 µg/µl) to a plastic surface and coating was controlled using the 
anti RGS his6 antibody (pink squares). Immobilized CHL1-ICDhis6 was incubated with hsc70his6 (0,2 mg/ml) and 
binding to hsc70his6 was analyzed with polyclonal anti hsc70 antibody (pink diamonds). 
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BAG-1his6 was coated in the same range of dilutions as described for CHL1-ICDhis6 and the immobilization was 
controlled using the anti penta his antibody (green squares). Coated BAG-1his6 was incubated with hsc70his6 
(concentration as above) and bound hsc70his6 was detected with a polyclonal anti hsc70 antibody (green 
triangles). 
Hsc70his6 was immobilized in the same dilutions as CHL1-ICDhis6 and BAG-1his6 were coated. Hsc70his6 was 
detected with anti RGS his6 antibody for control of immobilization (blue squares). Coated hsc70his6 was 
incubated with CHL1-ICDhis6 (blue diamonds) and BAG-1his6 (blue triangles). Detection of bound proteins was 
carried out using the monoclonal antibody 2C2 against the intracellular domain of CHL1 (kindly provided by Dr. 
M. Grumet) and a polyclonal antibody against BAG-1 (provided by Dr. F. Hartl, Munich). 
 
V.8. Confirmation of hsc70 as CHL1-ICDhis6 binding protein performing a two-
dimensional overlay approach 
 
Three different binding approaches namely the immunoprecipitation, the ELISA assay and a 
BIAcore SPR analysis (data not shown) failed to confirm the interaction between CHL1 
and hsc70. Thus, a confirmation of the CHL1-hsc70 binding in the overlay approach was 
strongly recommended. It was also intended to verify that the correct protein spot in the 
silver-stained gel was correlated to the signal observed in the overlay and that the accurate 
protein was isolated for MALDI-MS analysis. For this purpose, a non-detergent soluble brain 
fraction was separated in a two-dimensional gel electrophoresis and transferred to 
nitrocellulose membrane. This was done three times in parallel. One membrane was subjected 
to an overlay approach using soluble CHL1-ICDhis6 (Figure 8A). The other membranes were 
analyzed with either the anti hsc70 antibody (Figure 8B) or the anti hsp70 antibody that was 
used as a negative control (Figure 8C). The signal of the protein that bound to soluble CHL1-
ICDhis6 was reproducible in the two-dimensional overlay approach (Figure 8A). Soluble 
CHL1-ICDhis6 bound to a protein of 70 kDa and the isoelectric point of 5.5. The hsc70 
antibody recognized a protein with an identical molecular weight and isoelectric point 
whereas the hsp70 antibody detected a protein with a comparable molecular weigth but a 
slightly more basic isoelectric point of approximately 5.8 (Figure 8C). These different 
isoelectric points are coincide with isoelectric points of hsc70 and hsp70 described in the 
literature (Pelham, 1986). These experiments supported the MALDI-MS analysis which 
identified hsc70 as a CHL1 binding protein. In a further approach, purified recombinant hsc70 
expressed in bacteria was separated in a two-dimensional gel electrophoresis and transferred 
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to nitrocellulose membrane. The assay was carried out in two independent approaches for a 
CHL1-ICDhis6 overlay (Figure 8D) and for detection of hsc70 by the specific antibody (data 
not shown). Consistent with the CHL1-ICDhis6 overlay of brain homogenate, this approach 
also confirmed the binding of CHL1-ICDhis6 to hsc70 since the soluble fusion protein bound 
to recombinant hsc70 (Figure 8D). Due to the fact that CHL1 binds to hsc70 only in an 
overlay approach and not in an ELISA assay (Figure 7), the question did arise whether the 
interaction of CHL1 and hsc70 was only an artefact due to the quite denaturing conditions of 
an overlay approach or whether hsc70 must be presented in a distinct conformation that 
allows an interaction to CHL1. This status could be mimicked under conditions prevailing 
during electrophoresis. Within the cell, a specific conformation of a particular protein can be 
supported by assistant proteins. These proteins could modify the folding of nearby proteins 
and mediate interactions to other binding proteins by the conformational alteration. 
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Figure 8: Confirmation of hsc70 - CHL1-ICDhis6 binding in a two-dimensional overlay approach 
(A – C): Non-detergent soluble brain proteins were aceton-precipitated (200 µg per precipitation) and separated 
in a two-dimensional gel electrophoresis including first an isoelectric focusing on IPG stripes (7cm / pH 4 – 7) 
and afterwards separation in a SDS-PAGE. After separation, proteins were transferred to a nitrocellulose 
membrane and incubated with soluble CHL1-ICDhis6 (f.c. 0.02 mg/ml) in an overlay approach (A). Detection of 
bound fusion protein was carried out using the anti RGS his6 antibody (1/1000) and anti mouse IgG-HRP 
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secondary antibody (1/10000). (B): Analysis of hsc70 was performed using a specific goat anti hsc70 and an anti 
goat IgG-HRP secondary antibody (1/10000). (C): Hsp70 was detected using a specific mouse anti hsp 70 
antibody and a secondary anti mouse IgG antibody that was HRP-conjugated (1/10000). 
(D): Recombinant hsc70 was separated using the same conditions as described for (A – C) and transferred to a 
nitrocellulose membrane. Afterwards, the immobilized protein was incubated with CHL1-ICDhis6 (f.c. 0.02 
mg/ml) in an overlay approach. Detection of bound fusion protein was performed as described in (A). 
Molecular weights are indicated on the left. The pH values are indicated below the figures. Arrows emphasize 
the pH of detected proteins. 
 
 
V.9. Co-localization and co-capping of CHL1 and hsc70 in primary 
hippocampal cultures 
 
Since non of the biochemical approaches showed an interaction between CHL1 and hsc70 
under native conditions, a cellular system was used to confirm the CHL1 – hsc70 binding. A 
co-localization of both proteins could be indicative for an interaction. Thus, the localization of 
CHL1 and hsc70 in primary cell cultures was analyzed. Hippocampi of new born or postnatal 
4-day old mice were prepared, dissociated and cultured for three days. Afterwards, cells were 
stained either with a polyclonal antibody against hsc70 (Figure 9A) or with a purified 
polyclonal antibody against CHL1 (Figure 9B). The overlay of both stainings displayed an 
obvious co-localization of CHL1 and hsc70 that was indicated by a yellow staining (Figure 
9C). Interestingly, this co-localization was distributed in a very distinct pattern over the whole 
length of neurites (Figure 9C, indicated by arrows). In a further approach, hippocampi from 
newborn mice were prepared and cultured for only one day. In these younger cultures, the co-
localization of CHL1 and hsc70 was less pronounced and also the distinct distribution pattern 
of hsc70 that was seen in older cultures was not observed (Figure 10A). For co-capping of 
CHL1 and hsc70, the cells from newborn mice were pre-incubated with a polyclonal rabbit 
anti CHL1 antibody. Primary antibodies were clustered with a secondary anti rabbit antibody 
and afterwards cells were stained with a polyclonal anti hsc70 antibody. Initiated by the pre-
clustering of CHL1, hsc70 accumulated in defined areas (Figure 10, B/C). A yellow staining 
was revealed that indicated a co-localization of CHL1 and hsc70 (Figure 10B).  
Although hsc70 is described to be a cytosolic protein (Pelham, 1986; Hartl, 1996) and a 
widespread expression of the protein all over the cell was expected, only a very restricted 
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distribution pattern was observed in older cultures or after co-capping of younger cultures 
indicating a localization of this protein in particular cellular subdomains (Figure 9A). The 
distinct distribution of CHL1 and hsc70 suggests that the interaction takes place in a strongly 
regulated manner and only under particular conditions which were probably occuring under 
the denaturing conditions prevailing during and after electrophoretic separation. Both 
experiments together, namely the overlay assay showing a direct binding and the 
immunocytochemistry of primary hippocampal neurons demonstrating a co-localization of 
CHL1 and hsc70 in certain subdomains, may indicate that a specific conformation which 
might be a crucial factor for the interaction between CHL1 and hsc70 is probably only 
received in distinct membrane subcompartments. To verify this assumption, further 
biochemical analyses were carried out to define the localization of CHL1 – hsc70 interaction 
and to identify conditions that facilitate the binding of CHL1 and hsc70. 
 
A B C
 
 
Figure 9: Co-localization of CHL1 and hsc70 in primary hippocampal neurons  
Hippocampal neurons from 4-day old mice (3 days in culture) were stained either with anti hsc70 antibody 
(green, A) or with anti CHL1 antibody (red, B). Double labeling with anti hsc70 antibody and anti CHL1 
antibody resulted in an overlay image (C). Yellow staining indicates co-localization of CHL1 and hsc70 
(arrows). Scale bar represents 20 µm. 
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Figure 10: Co-capping of CHL1 and hsc70 in primary hippocampal neurons 
(A): Dissociated hippocampal neurons from newborn mice (1 days in culture) were double-labeled with anti 
hsc70 antibody (green) and with anti CHL1 antibody (red). 
(B/C): For co-capping, cells were pre-incubated with the polyclonal rabbit anti CHL1 antibody and primary 
antibodies were clustered with a secondary anti rabbit antibody. Afterwards, cells were stained with polyclonal 
anti hsc70 antibody. Co-localization of CHL1 and hsc70 is indicated by yellow staining (arrows). Scale bar 
represents 20 µm. 
 
V.10. Analysis of the hsc70 and CHL1 distribution in membrane subfractions 
 
The results of the immunocytochemistry of primary hippocampal neurons suggest that CHL1 
and hsc70 may interact only in distinct membrane subdomains indicated by a co-localization 
of both proteins in restrictive areas. This putative co-distribution of CHL1 and hsc70 in 
particular cellular subfractions was addressed by biochemical analyses and it turned out that 
CHL1 and hsc70 were only co-distributed in fractions of enriched synaptosomes (data not 
shown, personal communication Dr. Ralf Kleene). The immunocytochemical study further 
indicated that the age of the cells influences the localization between CHL1 and hsc70 and 
probably also the interaction between both proteins. Cells prepared from newborn mice 
showed a quite widespread distribution of hsc70 and the co-localization of CHL1 and hsc70 
was only detectable after co-capping of CHL1 while in neurons prepared from 4-day old 
animals, the hsc70 distribution was observed in a distinct pattern and co-localization was seen 
without preceded co-capping. This observation may indicate that the localization of CHL1 
and hsc70 to certain subdomains and thereby the interaction is dependent or regulated during 
developmental stages in mice. Thus, a biochemical analysis of CHL1 and hsc70 distribution 
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in subdomains from 7-day old mice compared to adult mice were carried out. Enriched 
synaptosomes were prepared by subsequent sucrose gradient centrifugation steps. Further 
ultracentrifugation procedures allowed to separate synaptosomal membranes which were 
either mock-treated or alkali treated. Afterwards, the membranes were solubilized in Triton 
X-100 containing buffer in the cold and separated in Triton X-100 soluble and insoluble 
material. The Triton X-100 insoluble fraction was further separated in a so-called raft fraction 
and a non-raft fraction. A typical property of rafts is the floating to low density fractions 
within a sucrose gradient. It has been shown that a preceding alkaline treatment of the 
membranes increases the yield of rafts (personal communication, Dr. Ralf Kleene). This alkali 
treatment presumably removes extracellular matrix (ECM) proteins and proteins of 
intracellular structures such as cytoskeleton components from proteins of the raft fraction. 
The loss of the interactions to ECM or cytoskeletal proteins confers a lower density to the 
rafts that allows the floating within a sucrose gradient to a layer of lower density. Without 
alkali treatment, typical raft proteins are detectable in the non-raft fraction that is sedimented 
within the sucrose gradient. 
Hsc70 and CHL1 were detectable in the total synaptosomal membrane fraction that was used 
as the starting material (Figure 11, A – D, lanes 1,6). Both proteins were observed in the 
Triton X-100 soluble fraction (Figure A – D, lanes 5,10) as well as in the Triton X-100 
insoluble fraction (Figure 11, A – D, lanes 2,7). In the case of 7-day old animals, both 
proteins were only present in the non-raft fraction when membranes were mock-treated 
(Figure 11, A/C, lane 4) but in the raft fraction neither hsc70 nor CHL1 were detectable 
(Figure 11, A/C, lane 3). After alkali treatment, hsc70 and CHL1 appeared exclusively in the 
raft fraction that showed floating to the sucrose layer of low density (Figure 11, A/C, lane 8) 
whereas expression of hsc70 or CHL1 was completely diminished in the non-raft fraction in 
young animals (Figure 11, A/C, lane 9). In adults, hsc70 and CHL1 were detectable in the 
non-raft fraction as well as in the raft fraction without alkali treatment (Figure 11, B/D, lanes 
3,4) whereas floating within the sucrose gradient to a layer of low density (“raft fraction”) 
was observed after alkali treatment (Figure 11, B/D, lane 8). As it was seen for younger 
animals, hsc70 and CHL1 were no more detectable in the non-raft fraction following alkaline 
treatment (Figure 11, B/D, lane 9). These results suggest that CHL1 and hsc70 are localized in 
raft subdomains with or without binding to extracellular matrix proteins and/or to cytoskeletal 
elements. 
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Figure 11: Distribution of hsc70 and CHL1 in membrane subfractions 
For the analysis of hsc70 and CHL1 distribution in particular membrane subdomains, a fraction of total 
synaptosomal membranes was prepared from 7-day old mice (A/C) and adult mice (B/D). Fractions were 
isolated without pre-treatment (A – D, lanes 1 – 5) or with pre-treatment of 0.15 M bicarbonate, pH 11 (A – D, 
lanes 6 – 10). The synaptosomal membrane fraction (lanes 1,6) was further separated to Triton X-100 insoluble 
material (lanes 2, 7) and Triton X-100 soluble material (lanes 5, 10). The Triton X-100 insoluble material was 
separated in a raft (lanes 3, 8) and non-raft fraction (lanes 4, 9) using a sucrose gradient. All fractions were 
subjected to SDS-PAGE and transferred to nitrocellulose membrane for detection of either hsc70 (A/B) using a 
polyclonal goat anti hsc70 antibody or CHL1 detection (C/D) using a polyclonal rabbit anti CHL1 antibody. 
 
V.11. Co-immunoprecipitation of CHL1 and hsc70 from a crude brain fraction 
 
The co-localization analysis of CHL1 and hsc70 in hippocampal neurons indicated that an 
interaction between both proteins may occur only in membrane subdomains. The co-
distribution of CHL1 and hsc70 in the Triton X-100 insoluble fraction and in the so-called raft 
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and non-raft fraction supported the assumption drawn from the co-localization assay that the 
interaction between the putative binding partners may be restricted to detergent-insoluble 
membrane subdomains. Taking these results in account and since a precededly performed co-
immunoprecipitation failed to confirm the interaction between CHL1 and hsc70, an 
immunoprecipitation of CHL1 was repeated, but the conditions for the precipitation were 
modified. This time, brain homogenates were prepared in the presence of 1 % Triton X-100 
and applied to the immunoprecipitation without any further centrifugation step in order not to 
remove Triton X-100 insoluble material. To avoid sedimentation of detergent-insoluble 
material during ProteinA sepharose centrifugation, magnetic ProteinA Dynabeads were used 
for purification of immunocomplexes from these crude detergent extracts. A further 
modification was the addition of ADP as a co-factor since other hsc70 interactions were 
previously described to be ADP-dependent (Frydman and Höhfeld, 1997). A co-
immunoprecipitation of hsc70 using the polyclonal anti CHL1 antibody was only detectable 
in the presence of ADP (Figure 12, lanes 3,4) but not in the presence of ATP (Figure 12, lanes 
1,2). In the negative control using brain extracts which were derived from CHL1 knock-out 
animals, no co-precipitation of hsc70 occurred at all, not in the presence of ATP (Figure 12, 
lane 9) and not even in the presence of ADP (Figure 12, lane 10). In a further control using a 
polyclonal antibody against L1 for immunoprecipitation, only a very weak background 
staining of hsc70 appeared in the immunoprecipitate in the presence of ADP (Figure 12, lanes 
6,8) whereas no detection of hsc70 was seen after precipitation of L1 in the presence of ATP 
(Figure 12, lanes 5,7). The background staining was possibly due to contaminations of Triton 
X-100 insoluble material in the precipitate. 
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Figure 12: Co-immunoprecipitation of CHL1 and hsc70 from wildtype and CHL1 deficient brain 
Crude brain homogenates were prepared from 7-day old wildtype mice (lanes 1 – 8) and CHL1 knock-out mice 
(lanes 9,10). The immunoprecipitation of CHL1 was performed using either 5 µl per approach (lanes 1,3) or 25 
µl per approach (lanes 2,4 and 9,10) of a polyclonal antiserum raised against the extracellular domain of CHL1. 
As a negative control, a polyclonal antibody against the extracellular domain of L1 was applied for precipitation 
using 5 µl per approach (lanes 5,6) or 25 µl per approach (lanes 7,8). Immunoprecipitations were carried out in 
the presence of 1 mM ATP (lanes 1,2; 5,7 and 9) or in the presence of 1 mM ADP (lanes 3,4; 6,8 and 10). 
Immunocomplexes were isolated using magnetic ProteinA Dynabeads. All eluates of the Dynabeads were 
subjected to SDS-PAGE and transferred to nitrocellulose. The analysis of a putative co-immunoprecipitation was 
carried out using a polyclonal goat anti hsc70 antibody. 
 
V.12. Co-immunoprecipitation of CHL1 and hsc70 from brain membranes 
derived from mice of different ages 
 
As mentioned before, the immunocytochemical detection of CHL1 and hsc70 in primary 
hippocampal neurons indicated that both proteins were co-localized in distinct membrane 
subdomains. In neurons derived from older animals this distribution was more pronounced 
than in cells prepared from younger animals. A biochemical analysis of subfractions isolated 
from an enriched synaptosomal membrane fraction showed that CHL1 and hsc70 were co-
distributed in the Triton X-100 insoluble fraction that was further divided in raft and non-raft 
fraction. The co-localization in subdomains and the co-distribution in detergent-insoluble 
subfractions could be indicative for an interaction of CHL1 and hsc70 that is restricted to 
particular membrane domains. Thus, an immunoprecipitation of CHL1 was carried out using 
a crude brain extract containing the Triton X-100 insoluble material and it was revealed that 
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hsc70 was detectable in the CHL1-immunocomplex when a crude homogenate was used for 
immunoprecipitation. As already mentioned, the co-distribution of CHL1 and hsc70 in 
primary hippocampal neurons further indicated that the age of the animal might be a crucial 
factor for the interaction between CHL1 and hsc70. Since the co-localization in restricted 
subdomains was only observed in neurons derived from older animals, a preceding pre-
clustering of CHL1 was required to show the co-localization of CHL1 and hsc70 in neurons 
derived from younger animals. Thus, a co-immunoprecipitation approach was carried out 
regarding the developmental stage of the animals that is proposed to influence the distribution 
of CHL1 and hsc70 in detergent-insoluble subdomains and thereby to influence the 
facilitation of an interaction between both binding proteins. A non-detergent soluble fraction 
and a crude membrane fraction containing Triton X-100 were prepared from 5-day old mice 
and from 3-weeks old mice. The crude fraction was further separated to Triton X-100 soluble 
and insoluble material. An immunoprecipitation of CHL1 was carried out in the presence of 
ADP and immunocomplexes were purified using magnetic ProteinA Dynabeads. The eluates 
were analyzed for co-precipitation of hsc70. In case of 5-day old animals, a co-
immunoprecipitation of hsc70 from the crude membrane fraction was only weakly detectable 
(Figure 13A, lane 2). In older animals, a more pronounced co-precipitation of hsc70 was 
obtained from the crude membrane fraction (Figure 13A, lane 6) and was additionally 
detectable when the Triton X-100 insoluble fraction was used for precipitation (Figure 13A, 
lane 8). CHL1 and hsc70 expression levels were controlled in all fractions which were applied 
to the precipitation (Figure 13, B/C). Although the CHL1 expression was remarkably higher 
in the crude membrane fraction prepared from 5-day old animals when compared to 3-weeks 
old animals (Figure 13B, lanes 2,6), a co-immunoprecipitation of hsc70 was much stronger 
seen in older animals (Figure 13A, lanes 2,6). No co-immunoprecipitation of CHL1 and hsc70 
was detectable in the Triton X-100 insoluble fraction in younger animals (Figure 13A, lane 4) 
whereas in older animals hsc70 was visible in the immunoprecipitate isolated from this 
particular fraction (Figure 13A, lane 8). Although, the expression level of CHL1 was 
definitively lower in the detergent-insoluble fraction prepared from older animals when 
compared to 5-day old animals (Figure 13B, lanes 4,8) the co-immunoprecipitation was 
remarkably intensive indicating that the developmental stage of the animal facilitates the 
interaction between CHL1 and hsc70. Furthermore, the results suggest that the localization of 
the CHL1 – hsc70 interaction is more restricted to detergent-insoluble subdomains with older 
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age of the animals since in younger mice no interaction at all was seen in the Triton X-100 
insoluble fraction. 
 
IP: anti CHL1
Expression:
 
 
Figure 13: Co-immunoprecipitation of CHL1 and hsc70 from several membrane fractions of brain 
homogenates derived from 5-day old or 3-weeks old mice 
Brains were prepared from 5-day old mice (lanes 1 – 4) and 3-weeks old mice (lanes 5 – 8) and a non-detergent 
soluble fraction (lanes 1,5) as well as a crude membrane fraction containing Triton X-100 (lanes 2,6) was 
isolated. The crude membranes were further separated to Triton X-100 soluble (lanes 3,7) and Triton X-100 
insoluble material (lanes 4,8). All fractions were incubated with a polyclonal antiserum against CHL1 for 
immunoprecipitation in the presence of ADP. The immunocomplexes were purified using ProteinA Dynabeads 
and the eluates were analyzed for co-precipitation of hsc70 (A). Fractions were also subjected to SDS-PAGE for 
analysis of either CHL1 expression (B) or hsc70 expression (C). 
 
V.13. Identification of a putative hsc70 binding motif in the intracellular domain 
of CHL1 
 
To address the question whether a putative binding site for hsc70 within the intracellular 
domain of CHL1 exist, published sequences of previously known hsc70 binding motifs were 
compared with the sequence of the intracellular portion of CHL1. The information of three 
conserved motifs described for the binding of hsc70 was considered. In detail, the 
tetratricopeptide repeat motif (Van Der et al., 2000; Liu et al., 1999), the tetrameric sequence 
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[EEX(4)], namely EEVD (Schneikert et al., 1999; Liu et al., 1999) and the well established J-
domain (Hennessy et al., 2000; Chamberlain and Burgoyne, 1997a; Cheetham et al., 1994) 
have been determined to be a hsc70 binding motif. The highly conserved tripeptide HPD of 
the J-domain was of particular interest since this short sequence was sufficient for hsc70 
binding and point mutations within this sequence caused a complete loss of hsc70 binding 
(Chamberlain and Burgoyne, 1997b). In fact, this tripeptide was identified in the intracellular 
domain of CHL1 (Figure 14, indicated by an arrow). Consistent with the observation that L1 
failed to bind to hsc70, this tripeptide was not present in the intracellular domain of L1 within 
a region of 5 amino acid residues (position 16 – 20) that is rather non-conserved comparing 
L1 and CHL1 (Kelley and Georgopoulos, 1997). 
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Figure 14: Alignment of the intracellular domain of CHL1 and L1 and identification of the HPD 
tripeptide only in the intracellular domain of CHL1 and not in the intracellular domain of L1. 
 
V.14. Site-directed mutagenesis of the putative hsc70 binding site in the 
intracellular domain of CHL1 
 
The highly conserved tripeptide HPD was previously described to be the most important 
sequence within the J-domain that can mediate hsc70 binding alone (Chamberlain and 
Burgoyne, 1997b). Analogous to the described point mutations that causes total loss of hsc70 
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binding (Chamberlain and Burgoyne, 1997a; Zhang et al., 1999), the HPD tripeptide in the 
intracellular domain of CHL1 was mutated using a site-directed mutagenesis. Four mutations 
were generated of which only two mutations affected the putative hsc70 binding site. In the 
first mutation, a single basepair exchange was generated resulting in an amino acid exchange 
of histidine to glutamine. The second mutation of the HPD tripeptide was a single basepair 
exchange of aspertate to adenine. A further mutation was generated possibly affecting the 
CHL1 distribution in Triton X-100 insoluble raft fraction. In this mutation, a putative 
palmityolation site (Ren and Bennett, 1998) was deleted by a single basepair exchange that 
led to the amino acid exchange of a cysteine residue to serine which cannot be palmityolated. 
Palmityolation was previously described to be involved in the localization of proteins to raft 
subdomains (Kabouridis et al., 1997; Zhang et al., 1998). By deletion of this particular 
cysteine residue, the distribution of CHL1 into rafts might be diminished including that this 
also could impair the interaction of CHL1 and hsc70. Finally, the same triplet was mutated in 
a fourth mutagenesis, that generated a stop codon instead of the transmembrane cysteine. 
Using this mutation, a CHL1 construct was generated lacking the entire intracellular domain 
that offers a convenient tool as a negative control. 
 
Mutation Amino acid exchange Affected basepairs Basepair exchange 
H 1121 Q histidine → glutamine 3361 - 3363 CAC → CAA 
D 1123 A aspertate → adenine 3367 - 3369 GAT → GCT 
C 1102 S cysteine → serine 3304 - 3306 TGC → TCC 
∆ ICD cysteine → stop 3304 - 3306 TGC → TGA 
 
For detailed information of mutagenesis and vector design see Methods, IV.6.12 and 
Appendix, VIII.3.3. 
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V.15. Co-precipitation of CHL1 and hsc70 from transfected CHO cells 
 
In order to establish a cellular system for the analysis of the CHL1 mutations, transfected 
CHO cells were tested to be an appropriate cell system for co-precipitation of CHL1 and 
hsc70. First, cells were transfected with the expression vector pcDNA3 encoding wildtype 
CHL1. Crude cell lysate as well as Triton X-100 soluble and insoluble fractions were 
analyzed either for co-precipitation and for co-distribution of CHL1 and hsc70 (Figure 15). 
Only in the crude cell lysate and the Triton X-100 soluble fraction, a co-precipitation of 
CHL1 and hsc70 was detectable (Figure 15A, lanes 1,2). A co-precipitation was not seen in 
the Triton X-100 insoluble fraction (Figure 15A, lane 3) and in non-transfected CHO cells 
(Figure 15A, lane 4). In contrast to brain homogenates, where CHL1 expression was 
remarkably high in the Triton X-100 insoluble fraction, only weak expression of CHL1 was 
found in that particular fraction of CHO cell lysates (Figure 15B, lane 3). Consistent with this 
observation, co-precipitation of CHL1 and hsc70 was only observed in the Triton X-100 
soluble fraction (Figure 15A, lane 2), but not in the Triton X-100 insoluble fraction of CHO 
cell lysates (Figure 15A, lane 3). In summary, CHO cells are considered to be an appropriate 
cell system for analysis of the CHL1 mutants for co-immunoprecipitation of hsc70. 
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Figure 15: Co-precipitation of CHL1 and hsc70 from CHL1-transfected CHO cells 
CHO cells were transiently transfected with the pcDNA3 expression vector coding for wildtype CHL1. After 
two days in culture, cells were harvested and lysed in a 1% Triton X-100 containing buffer. The crude cell lysate 
(lane 1), the Triton X-100 soluble (lane 2) and Triton X-100 insoluble fraction (lane 3) as well as a crude lysate 
of non-transfected CHO cells (lane 4) were incubated with a polyclonal anti CHL1 antiserum for 
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immunoprecipitation. The precipitation was carried out in the presence of ADP and the immunocomplexes were 
purified using magnetic Protein A Dynabeads. The eluates were analyzed for co-precipitation of hsc70 (A). 
Furthermore, all fractions were subjected to SDS-PAGE and transferred to nitrocellulose for detection of either 
CHL1 (B) using a rabbit polyclonal anti CHL1 antiserum or hsc70 (C) using a goat polyclonal anti hsc70 
antibody. 
 
V.16. Co-precipitation of CHL1 and hsc70 from CHO cells after transfection of 
wildtype CHL1 and mutant CHL1 
 
To demonstrate that the HPD tripeptide is the hsc70 binding domain within the intracellular 
portion of CHL1, wildtype CHL1 and mutant CHL1 deleted in the putative hsc70 binding site 
were transfected into CHO cells. Additionally, the mutants containing an amino acid 
exchange in the transmembrane cysteine residue at position 1102 were transfected. After two 
days in culture, cells were harvested and prepared for the immunoprecipitation of CHL1 
(Figure 16). To control that all constructs are equally expressed after transfection, cell lysates 
were also analyzed with regard to CHL1 presence using the polyclonal anti CHL1 antibody 
(Figure 16B). For control of endogenous hsc70 levels, cell lysates were analyzed using a 
polyclonal anti hsc70 antibody (Figure 16C). Only in cells expressing wildtype CHL1 and in 
cells transfected with CHL1 that was mutated in the putative palmityolation site, a remarkable 
co-precipitation of hsc70 was revealed (Figure 16A, lanes 1,4). Cells which were transfected 
with CHL1 constructs containing a deletion in the putative hsc70 binding site completely 
failed to co-precipitate with hsc70 (Figure 16A, lanes 2,3). Furthermore, both the CHL1 
construct lacking the entire intracellular domain and the non-transfected cells did not show 
any co-precipitation of CHL1 and hsc70 (Figure 16A, lanes 5,6). Interestingly, only CHL1-
∆ICD showed an expression as a single isoform since all other CHL1 mutants displayed 
expression of full length and processed isoforms (Figure 16B, lanes 1 – 4). The mutant 
lacking the complete intracellular domain was detectable as one predominant fragment with a 
molecular mass of approximately 140 kDa (Figure 16B, lane 5). 
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Figure 16: Co-precipitation of CHL1 and hsc70 from wildtype CHL1-transfected and mutant CHL1-
transfected CHO cells 
CHO cells were transiently transfected with pcDNA3 expression vector encoding wildtype CHL1 or mutant 
CHL1 constructs. After two days in culture, cells were harvested and lysed. A crude lysate was used for 
immunoprecipitations of CHL1 (A) and for detection of either CHL1 (B) or hsc70 expression (C). CHO cells 
were transfected with wildtype CHL1 (lane 1), H1121Q (lane 2), D1123A (lane 3), C1102S (lane 4) or 
C1102Stop (lane 5). Non-transfected cells were used as a negative control (lane 6). For immunoprecipitation of 
CHL1 from transfected CHO cell lysates, 25 µl of a polyclonal anti CHL1 antiserum was applied and 
immunocomplexes were purified using ProteinA Dynabeads. Eluates were subjected to SDS-PAGE and co-
precipitation of hsc70 determined using a polyclonal goat anti hsc70 antibody. Cell lysates were also subjected to 
SDS-PAGE in the same order as given in (A) and transferred to nitrocellulose membrane. Detection of CHL1 
(B) was carried out by the use of a polyclonal rabbit anti CHL1 antiserum. Hsc70 detection (C) was performed 
using a polyclonal goat anti hsc70 antibody. 
 
V.17. Co-precipitation of CHL1 and hsc70 from N2A cells after transfection of 
wildtype CHL1 and mutant CHL1 
 
For verification of the co-precipitation results obtained from transfected CHO cells, a further 
cell line was used for co-precipitation of wildtype versus mutated CHL1. N2A cells which did 
not express CHL1 endogenously were transfected with either wildtype or mutant CHL1 
constructs and were allowed to express the transfected protein for two days in culture. Cell 
lysates were utilized for precipitation of CHL1. Consistent with the precipitation from 
transfected CHO cells, a co-precipitation of hsc70 was only detectable in cell lysates derived 
from wildtype transfected (Figure 17A, lane 1) and C1102S transfected N2A cells (Figure 
17A, lane 4). Cells which were transfected with CHL1 constructs mutated in the putative 
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hsc70 binding site showed no remarkable co-precipitation of CHL1 and hsc70 (Figure 17A, 
lanes 2,3) indicating that the HPD tripeptide is a prerequisite for CHL1 binding of hsc70. 
Neither the ∆ICD mutant nor the non-transfected N2A cells which were applied for negative 
control showed any co-precipitation of hsc70 (Figure 17A, lanes 5,6). 
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Figure 17: Co-precipitation of CHL1 and hsc70 from wildtype CHL1- and mutant CHL1-transfected 
N2A cells 
N2A cells were transiently transfected with pcDNA3 expression vector encoding either wildtype or mutant 
CHL1. After two days in culture, cells were harvested and lysed in the presence of 1% Triton X-100 and 1 mM 
ADP. Crude lysates were used for immunoprecipitations of CHL1 (A) and for detection of either CHL1 (B) or 
hsc70 expression (C). Lysates of wildtype transfected N2A cells (lane 1), H1121Q mutant (lane 2), D1123A 
mutant (lane 3), C1102S mutant (lane 4), C1102Stop (lane 5) and non-transfected N2A were subjected to an 
immunoprecipitation of CHL1. Immunocomplexes were purified by ProteinA Dynabeads and eluates were 
subjected to SDS-PAGE and transferred to nitrocellulose membranes. Co-precipitation was analyzed using a 
polyclonal goat hsc70 antibody. Expression control of transfected CHL1 (B) and endogenous hsc70 (C) in N2A 
cell lysates was performed using a polyclonal rabbit anti CHL1 antiserum or the polyclonal goat anti hsc70 
antibody. 
 
V.18. Functional analysis of the interaction between CHL1 and hsc70  
 
For functional analysis of the CHL1 – hsc70 binding, the question was addressed whether the 
intracellular interaction between CHL1 and hsc70 is involved in neurite outgrowth after 
extracellular stimulation of CHL1. It was hypothesized that stimulation of CHL1 promotes 
neurite outgrowth that requires structural alterations of the cytoskeleton. This cascade starts 
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with an extracellular stimulus of CHL1 that is transduced via the transmembrane cell 
adhesion molecule into the cell. Intracellularly, proteins must be activated downstream of the 
transmembraneous CHL1 which initiate modulations in composition and structure of the 
cytoskeleton. The heat shock cognate 70 is considered to be a good candidate to transfer the 
extracellular stimulus into the inside of the cell resulting in reorganization processes of the 
intermediate filament, microtubuli assembly or the actin-based cytoskeleton (Napolitano et 
al., 1985; Whatley et al., 1986; Haus et al., 1993). For functional analysis of the CHL1 – 
hsc70 interaction, hippocampal neurons derived from CHL1 deficient mice were cultured and 
subsequently transfected either with wildtype CHL1 or with CHL1 mutants deleted in the 
hsc70 binding motif. Since no extracellular binding partner of CHL1 has been identified so 
far, a polyclonal antiserum raised against the extracellular domain of CHL1 was used for 
stimulation assumingly mimicking the interaction with a binding partner. CHL1-dependent 
stimulation of neurite outgrowth of CHL1 knock-out hippocampal neurons is only expected 
after transfection of wildtype CHL1. On the other hand, an impaired promotion of CHL1-
dependent neuritogenesis could be assumed following transfection of CHL1 mutants 
suggesting that the extracellular stimulus of CHL1 can only alter cytoskeletal structures when 
a functional interaction between CHL1 and hsc70 is present. As mentioned before, the heat 
shock cognate70 is regarded to be involved in the modification of filamentous components of 
the cytoskeleton which are required for morphological changes during neuritogenesis. Our 
hypothesis proposes that in neurons where the binding of CHL1 and hsc70 cannot take place 
the extracellular stimulus will not trigger structural changes of the cytoskeletal organization 
resulting in an impaired CHL1-dependent stimulation of neurite outgrowth. 
In preliminary studies, the specificity of the polyclonal anti CHL1 antibody for binding to 
CHL1 was investigated. First, the immunohistochemical detection of CHL1 in cerebellar 
sections was carried out and then cultured primary hippocampal neurons derived from 
wildtype versus CHL1 deficient mice were stained using the polyclonal anti CHL1 antibody. 
A further preliminary assay considered the question whether the polyclonal antibody raised 
against the extracellular domain of CHL1 has the potential to stimulate neurite outgrowth as it 
has been previously described for stimulation of neuritogenesis using antibodies in case of 
L1-dependent stimulation using the monoclonal antibody 557 (Appel et al., 1995). Finally, if 
the polyclonal anti CHL1 antibody stimulates neuritogenesis of hippocampal neurons, it 
should be used in neurons derived from CHL1 deficient mice after transfection of either 
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wildtype CHL1 or CHL1 mutants which were deleted in the hsc70 binding motif to 
investigate CHL1-dependent promotion of neurite outgrowth. 
 
V.18.1. Determination of the specificity of the polyclonal anti CHL1 antibody 
 
Specific binding of the polyclonal anti CHL1 antibody was analyzed using cerebellar cortex 
sections derived from wildtype mice and from CHL1 deficient mice. For the 
immunohistochemical analysis, the polyclonal anti CHL1 antiserum was affinity-purified. 
The purification was performed using first a human IgG pre-column and followed by an 
affinity chromatography column with immobilized CHL1-Fc fusion protein. A highly specific 
staining of CHL1 was detectable following incubation of cerebellar sections with the affinity-
purified anti CHL1 antibody. CHL1 expression was observed on distinct cells in the 
molecular layer which were probably basket and stellate cells (Figure 18, A/B, mol). The 
remarkable dense CHL1 staining in this particular layer on the other hand suggested an 
expression of CHL1 on dendrites of Golgi and granule cells which were present in the internal 
granular layer (Figure 18, A/B, igl). These certain cells showed high levels of CHL1 in their 
somata confirming previous results showing CHL1 mRNA expression in these particular cells 
by an in situ analysis (Holm et al., 1996). Golgi and granule cells develop extensive dendritic 
trees which were intensively stained for CHL1. Purkinje cells were negative for CHL1 
expression. These conspicuous cells showed no CHL1 expression in their somata (Figure 18, 
A/B, indicated by arrowheads) and no staining on dendrites (Figure 18, A/B, indicated by 
arrowheads labeled with a star). The immunohistochemical localization of the CHL1 protein 
was confirmed by an in-situ hybridization that revealed an overlapping expression pattern of 
CHL1 mRNA (Figure 18D) and CHL1 protein. However, the CHL1 mRNA expression level 
was very weak in cells of the molecular layer indicating that the intensive staining that was 
seen for protein expression in that particular layer was obviously more due to strong 
expression of CHL1 on dendrites of granule and Golgi cells than to the expression of CHL1 in 
basket or stellate cells. The specificity of the antibody was underlined by 
immunohistochemical detection of CHL1 using cerebellar cortex sections derived from CHL1 
deficient mice (Figure 18C). No binding of the affinity-purified antibody at all was observed 
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after incubation of this particular tissue. The preparation of cryosections and all 
immunohistochemical experiments were performed by Bettina Rolf. 
 
A B
mol
igl
fib
B
mol
igl
*
* *
*
*
*
C D
mol
igl
 
 
Figure 18: Localization of CHL1 in the cerebellar cortex by immunohistochemical detection using 
affinity-purified antibody and by in situ hybridization analysis 
Cerebellar cortices were isolated either from wildtype (A/B, D) or from CHL1 deficient mice (C). Sections were 
prepared and immunohistochemical detection of CHL1 was carried out using an affinity-purified anti CHL1 
antibody (A – C). In situ analysis was performed using a CHL1 specific anti sense probe (D). Molecular layer 
(mol); internal granular layer (igl); fiber layer (fib); somata of Purkinje cells are indicated by arrowheads (A/B); 
dendrites of Purkinje cells are depicted by arrowheads labeled with a star (A/B). Scale bars indicate 100 µm in 
(A) and 80 µm in (B).  
(C): Cerebellar sections derived from CHL1 deficient mice revealed no unspecific binding of the affinity-
purified antibody: Scale bar = 100 µm. 
(D): Localization of CHL1 mRNA in sections of cerebellar cortex by in situ analysis demonstrated CHL1 
mRNA expression in the internal granule layer (igl) and in the molecular layer (mol). Scale bar = 250 µm in (D). 
 
To further check the specificity of the antibody, dissociated hippocampal neurons were 
prepared and the staining of the affinity-purified antibody (Figure 19A) was compared to that 
of an IgG fraction that was only purified using ProteinA sepharose (Figure 19B). 
Hippocampal neurons derived from CHL1 deficient mice were used as control for the 
specificity of antibody binding (Figure 19C). Finally, wildtype neurons were only stained 
with the fluorescence-labeled anti rabbit IgG antibody as a negative control for the secondary 
antibody (Figure 19D). The immunocytochemical detection of CHL1 in primary hippocampal 
cultures revealed a specific staining of CHL1 only in distinct subpopulations of hippocampal 
neurons. The affinity-purified antibody and the IgG fraction that was only ProteinA-purified 
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showed a similar staining pattern. Cells which expressed CHL1 displayed a strong staining on 
somata as well as on dendrites (Figure 19, A/B, indicated by arrowheads labeled with a pound 
sign). Cells which were only weakly stained in their somata but not on dendrites were also 
observed (Figure 19, A/B, indicated by arrowheads labeled with a star). This staining was due 
to unspecific binding of the secondary antibody since poor staining of the somata was also 
seen in cells derived from CHL1 -/- mice (Figure 19C) and also after incubation of wildtype 
neurons with the secondary antibody alone (Figure 19D). Distinct expression of CHL1 in 
subpopulations of hippocampal neurons was previously described using an in situ analysis 
(Hillenbrand et al., 1999) and was confirmed here by the immunocytochemical detection of 
CHL1 using either the affinity-purified or the ProteinA-purified IgG fraction. Dissociated 
hippocampal cultures were kindly provided by Galina Dityateva. 
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Figure 19: Expression of CHL1 in dissociated primary cultures of hippocampal neurons derived from 
wildtype mice or CHL1 knock-out mice 
Dissociated hippocampal neurons were prepared either from wildtype mice expressing CHL1 (A/B and D) or 
from CHL1 deficient mice (C). Detection of CHL1 was carried out using an affinity-purified polyclonal antibody 
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(A) or a ProteinA-purified IgG fraction of the antibody (B). The secondary antibody was Cy3-conjugated and 
applied in a final dilution of 1/300. The specificity of the primary antibody was controlled by incubation of 
CHL1 deficient cells with the ProteinA-purified IgG fraction (C) and the secondary antibody was also tested for 
unspecific binding using wildtype cells as depicted in (D). Arrowheads labeled with a pound sign (A/B) 
emphasize CHL1 expressing neurons while cells which were negative for expression of CHL1 are indicated with 
arrowheads labeled with a star (A/B,). Scale bars = 80 µm. 
 
V.18.2. Stimulation of neuritogenesis of primary hippocampal neurons by the 
anti CHL1 antibody 
 
The antiserum that was raised against the extracellular domain of CHL1 was investigated for 
the potential to stimulate CHL1-dependent neurite outgrowth. As mentioned before, the 
antibody binding is considered to mimick the binding of an extracellular interaction partner. 
For neuritogenesis, the crude serum was purified using ProteinA sepharose and the IgG 
fraction was immobilized to 96-well dishes. Non-immune rabbit IgG fraction (Sigma) and 
poly-L-lysine were used as negative controls. Dissociated hippocampal neurons were 
prepared from wildtype mice expressing CHL1 and cultured on the substrate-coated plastic 
wells. One representative assay is shown in Figure 20. Once, hippocampal neurons derived 
from CHL1 deficient mice were also prepared and tested for CHL1-dependent stimulation of 
neurite outgrowth after growing on anti CHL1 IgG fraction (data not shown). Cells were 
allowed to grow for 20 hours and afterwards they were fixed and visualized by toluidine blue 
staining. Cells were selected for analysis and neurites were measured in length according to 
previous published criteria (Haspel et al., 2000). Neurons were only analyzed which had no 
cell-cell-contacts and the longest neurite was only measured in length when the neurite was as 
least as long as or longer than the diameter of the cell. The statistical analysis of CHL1-
dependent stimulation compared to negative controls was performed using the Mann Whitney 
test. The longest neurite of wildtype hippocampal neurons stimulated by the anti CHL1 
antibody showed a significant elongation ( P < 0.0001) to approximately 40 µm in length for 
the both highest concentrations (Figure 20, black bars) while the negative control using poly-
L-lysine showed a neurite length of only 20 µm (Figure 20, grey bar). A dose-dependent 
effect of CHL1-dependent stimulation was also observed since for concentrations of 0.1 
mg/ml and 0.01 mg/ml, a promotion of neurite outgrowth to 40 µm was seen, whereas using a 
concentration of only 0.001 mg/ml of anti CHL1 antibody still significant stimulation ( P < 
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0.0001) compared to poly-L-lysine was detectable, but compared to the higher antibody 
concentrations, only poor promotion of neurite outgrowth was visible. The non-immune 
rabbit IgG fraction also showed enhanced neurite outgrowth when it was coated with a 
concentration of 0.1 mg/ml. The stimulation was even weaker than stimulation with the 
lowest concentration of the anti CHL1 IgG fraction, but analyzed with the Mann Whitney test, 
the neurite length was still significantly enhanced ( P < 0.0001) compared to poly-L-lysine. 
No significant alterations in neurite length compared to PLL was detected after 
immobilization of non-immune IgGs with lower concentrations (Figure 20, transversal 
striped). Hippocampal neurons derived from CHL1 deficient mice cultured on anti CHL1 IgG 
fraction revealed a neurite length that was comparable to neurite outgrowth of cells growing 
on low concentrations of rabbit IgG fraction or on poly-L-lysine (data not shown). The 
positive control using laminin showed extensively enhanced neuritogenesis even when 
compared to the anti CHL1 IgG fraction emphazising that the stimulation of neurite 
outgrowth generated by the polyclonal antibody was not remarkably strong but significant 
when compared to poly-L-lysine and the non-immune Ig controls ( P < 0.0001). For all 
following CHL1-dependent neurite outgrowth assays, the ProteinA-purified anti CHL1 IgG 
fraction was used with a concentration of 0.01 mg/ml since strongly enhanced neuritogenesis 
was observed for this concentration but no significant alterations in neurite length were 
observed when non-immune rabbit IgG was immobilized with this particular concentration. 
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Figure 20: CHL1-dependent promotion of neurite outgrowth of primary hippocampal neurons 
Primary hippocampal neurons were prepared from wildtype mice expressing CHL1 and seeded on coverslips 
which were previously coated with either anti CHL1 IgG fraction, non-immune rabbit IgG fraction or only with 
poly-L-lysine. Three different concentrations of ProteinA-purified anti CHL1 IgG fraction (black filled bars) and 
the non-immune rabbit IgG fraction (transversal striped bars) were used for stimulation. As a negative control, 
poly-L-lysine (0.025 %) was immobilized (grey filled bar) while laminin (0.01 %) was used as a positive control 
for promotion of neurite outgrowth (straight stripped bars). Neurons were seeded with cell densities of 
approximately 5.000 – 7.500 cells/well and were allowed to extend neurites for 20 hours. Afterwards, neurite 
length was measured as described previously and analyzed using the Mann Whitney test. 
 
V.18.3. CHL1-dependent stimulation of neurite outgrowth of CHL1 -/- 
hippocampal neurons after transfection of either wildtype CHL1 or 
mutant CHL1 deleted in the hsc70 binding site 
 
Hippocampal neurons derived from CHL1 deficient mice were prepared and cultured on 
coverslips which were coated either only with poly-L-lysine or with the anti CHL1 IgG 
fraction. At least eight hours after preparation, cells were transfected using the CaPO4 method 
and afterwards cells were allowed to express the transfected protein overnight. On the second 
day, neurons were transfected again and cultured for further twelve hours. After this time 
period, cells were fixed and either stained with the anti CHL1 antibody to control CHL1 
expression or cells were analyzed without staining procedure. Only cells which were cultured 
on poly-L-lysine were tested for CHL1 expression since CHL1 detection of cells growing on 
the anti CHL1 IgG fraction evoked high background due to the immobilized antibody 
fraction. To identify transfected cells without detection of CHL1, neurons were co-transfected 
with an expression vector encoding the enhanced green fluorescence protein (EGFP) and co-
transfection was controlled on PLL coated coverslips. In Figure 21, a representative co-
transfected neuron is shown revealing expression of EGFP (Figure 21A, green) as well as 
expression of CHL1 (Figure 21B, red). The overlay image shows expression of both proteins 
and suggests a partially overlapping expression indicated by the yellow pattern (Figure 21C). 
The light microscopic image emphasizes that the expressed proteins were distributed over the 
whole cell instead of a particular expression e.g. on dendrites or in the somata. All images 
point out that the transfected neurons showed a rather unusually round morphology and that 
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neurite outgrowth was nearly missing suggesting that the transfection procedure might be a 
harmful stressor. 
 
A B
DC
 
 
Figure 21: Transfection of hippocampal neurons derived from CHL1 knock-out mice using either 
wildtype CHL1 or CHL1 mutants. 
Primary hippocampal neurons were prepared from CHL1 deficient mice and cultured on only poly-L-lysine 
coated coverslips for further detection of the CHL1 expression. Neurons were co-transfected twice using an 
expression vector encoding CHL1 and a further eucaryotic vector coding for the EGFP. After the second 
transfection, cells were allowed to grow for additional twelve hours. Afterwards, they were fixed and cells were 
either imaged only with a filter visualizing the green fluorescence generated by transfection of the EGFP (A) or 
detection of CHL1 was performed using the anti CHL1 IgG fraction derived from a polyclonal antiserum and 
further detected with Cy3-labeled secondary antibody (B). An overlay image confirms expression of both 
transfected proteins (C) while the light microscopic image (D) shows the transfected cell (indicated by an 
arrowhead) and also surrounding cells which were not transfected indicated by the fluorescence image. Pictures 
were analyzed using the Zeiss LSM510 argon-crypton confocal laser-scanning microscope. Scale bars = 50 µm. 
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To answer the question whether the interaction of CHL1 and hsc70 is involved in CHL1-
dependent neurite outgrowth, CHL1 deficient hippocampal neurons were transfected either 
with wildtype CHL1 or with the H1121Q mutant and D1123A mutant. These mutants were 
deleted in the hsc70 binding site provoking a disruption of the interaction of CHL1 and hsc70. 
Additionally, the CHL1 construct that is lacking the entired intracellular domain (CHL1 
∆ICD) was transfected as a negative control for the CHL1-dependent neurite outgrowth. 
Neurons were cultured on coverslips which were coated with the anti CHL1 IgG fraction as 
mentioned before and transfected twice. After fixation, cells were not stained for CHL1 
expression but were visualized with regard to the co-transfection of EGFP. In Figure 22, a 
representative image of a neuron transfected with wildtype CHL1 (Figure 22, A/B) and a 
neuron transfected with CHL1 ∆ICD (Figure 22, C/D) is shown. For this picture, cells were 
selected which had developed extensive neurites. Nevertheless, the measurement of neurite 
length indicated no significant differences of CHL1-dependent neurite outgrowth comparing 
wildtype CHL1 transfected and mutant CHL1 (∆ICD) transfected cells. No differences in 
neurite outgrowth were also observed after stimulation of cells which were transfected with 
CHL1 mutants deleted in the hsc70 binding site (images not shown). The summary of the 
results obtained from the neurite outgrowth stimulation reveals that in non of the stimulation 
assays an altered promotion of CHL1-dependent neurite outgrowth was observed. CHL1-
dependent stimulation of neurite outgrowth after transfection of CHL1 mutants (Figure 22, 
C/D) did not show an impaired neuritogenesis when compared to wildtype transfected cells 
(Figure 22, A/B). 
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Figure 22: Transfection of primary hippocampal neurons derived from CHL1 -/- mice and subsequent 
CHL1-dependent stimulation of neurite outgrowth 
Primary hippocampal neurons were prepared from CHL1 deficient mice, cultured as described before and 
transfected twice with either wildtype CHL1 (A/B), CHL1 mutants deleted in the hsc70 binding motif (images 
not shown) or transfected with the CHL1 mutant that was lacking the entired intracellular domain (C/D). 
Transfected neurons were visualized by the expression of the enhanced green fluorescence protein to avoid 
immunocytochemical detection of coated CHL1. Images were analyzed using the Zeiss LSM510 argon-crypton 
confocal laser-scanning microscope. Scale bars indicate 50 µm. 
 
The analysis of neurite outgrowth following transfection of either wildtype or mutant CHL1 
could not confirm the hypothesis that the functional binding between CHL1 and hsc70 is 
required for the promotion of neuritogenesis in this experimental approach. But, since neurons 
were observed presenting an unusual morphology after transfection of these particular CHL1-
constructs, an involvement of the functional interaction of both proteins in CHL1-dependent 
neurite outgrowth could not be excluded for the intact animal situation. This experimental 
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approach emerged to be not the appropriate system for analyzing the influence of a functional 
interaction between CHL1 – hsc70 on reorganization processes of the cytoskeleton since 
transfection of CHL1 constructs seemed to affect the vitality and thereby the morphology of 
the primary hippocampal neurons. In contrast to this, transfection of comparable constructs 
such as the pcDNA3/NCAM vector did not affect the appearance of primary neurons 
(Niethammer et al., 2002). After NCAM-transfection, such massive alterations in morphology 
were not observed as it was seen after transfection of primary neurons using the CHL1 
constructs. In addition, an enhanced NCAM-dependent neurite outgrowth has been 
demonstrated following transfection of these constructs. This suggests that, in principle, the 
transfection did not affect basic cellular conditions of primary hippocampal neurons. Thus, 
the biological relevance of the CHL1 – hsc70 interaction remains to be elucidated with regard 
to a putative involvement in structural reorganization processes of the cytoskeleton followed 
by CHL1-dependent stimulation of neurite outgrowth in hippocampal neurons. 
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VI. Discussion 
 
In the present work, a binding analysis of the neuronal cell adhesion molecule CHL1 was 
carried out in order to isolate an intracellular interaction partner. After separation of a non-
detergent soluble fraction of a mouse brain using a two-dimensional gel electrophoresis, a 
single protein was observed that bound to the soluble intracellular domain of CHL1 (CHL1-
ICDhis6) in an overlay assay. This particular protein revealed an apparent molecular mass of 
approximately 70 kDa and a slightly acidic isoelectric point of 5.5. The isolation of the 
protein from a silver stained gel and the analysis of the protein sequence by MALDI-MS 
identified this protein as the murine heat shock cognate 70, further abbreviated as hsc70 
(GenBankTM accession number M19141) (Giebel et al., 1988). 
 
VI.1. The heat shock cognate 70 
 
The heat shock cognate 70 is a member of a subfamily of heat shock proteins which are 
induced in their expression by heat shock and other environmental stress. Members of the 
hsp70 family are subgrouped according to their molecular mass of approximately 70 kDa and 
they are highly conserved among a diverse number of organisms including bacteria like 
Escherichia coli, insects like Drososphila melanogaster as well as mammals. The hsp70 
family has been recently reported to be composed of four members (Pelham, 1986), namely 
the hsp70, a protein that is strictly heat-inducible and that is predominantly localized in the 
nucleus and only rarely expressed in the cytoplasm of the cell. Furthermore, the hsx70 protein 
is also heat-inducible but shows high basal levels in the nucleus without cellular stressors. 
The third family member is the grp78 which is a glucose-regulated protein that has been 
identified only in secretory cells where it is restricted to the lumen of the ER. Finally, the 
fourth member of the hsp70 subfamily is the heat shock cognate 70 that was identified in the 
present work as a binding partner of the cell adhesion molecule CHL1.  
The hsc70 protein implicates several functional features providing a variety of interesting 
opportunities with regard to the function of the CHL1 – hsc70 interaction. Hsc70 is the only 
heat shock protein of the 70 kDa subfamily that is expressed constitutively with high 
expression levels in growing cells and only poor expression in resting cell. Following heat 
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shock, the hsc70 expression is only slightly enhanced when compared to unstressed cells 
suggesting important functions of hsc70 during normal growth conditions of cells. One 
general feature of the hsc70 that is shared by other members of the hsp70 subfamily and 
additionally by other heat shock responding proteins such as hsp90, hsp40, Hip/Hap46, 
p60/Hop or p23 is the function as a molecular chaperone. Chaperones were originally defined 
as a group of unrelated proteins that mediate the acquisition of a distinct tertiary structure as 
well as the protein assembly including the formation of protein complex of either newly 
synthesized proteins or misfolded substrates. By definition, they are not themselves 
components of the final functional complex. Chaperone-mediated conformational changes are 
involved in protein folding as well as in protein translocation and degradation. Furthermore, 
the conformational alterations can regulate certain signal transduction pathways under normal 
growth conditions (Hartl, 1996). Studies on the mode of action of an individual chaperone 
revealed that in many cases, regulatory co-factors and related chaperones are involved 
indicating that different chaperone systems might cooperate in one folding mechanism. 
Recent findings emphasized that the substrate-binding of hsc70 is facilitated by the co-factor 
hsp40 in mammalian cells. The complex formation is regulated by the binding of ATP and the 
subsequent ATP-hydrolysis including the release of an ortho-phosphate residue from the 
hsc70 - hsp40 complex. Afterwards, hsp40 is detached and the hsc70 - substrate complex is 
stabilized by a further co-factor, the Hip/Hap46 protein. Subsequent complex dissociation 
appears to be initiated by the Hop/p60 protein that stimulates ADP/ATP nucleotide exchange 
resulting in the recycling of hsc70 and in the release of a folded substrate (Frydman and 
Höhfeld, 1997). Many of the hsc70 binding co-chaperones prossess a so-called J-domain, a 
scaffold of four α-helices with an accessible loop that exposes the highly conserved HPD 
tripeptide that is essential for the binding of hsc70. They are termed DnaJ-like proteins 
according to the bacterial chaperone DnaJ that was originally identified as a J-domain-
containing molecular chaperone. Others include structurally related tetratricopeptide repeats 
(TPR) which are involved in chaperone binding (Frydman and Höhfeld, 1997). Molecular 
chaperones occur ubiquitously and many of them are classified as stress proteins although 
some of them, as mentioned before for the hsc70, have essential functions under normal 
growing conditions. 
Besides the function as a molecular chaperone, hsc70 is described to be involved in certain 
interactions with cytoskeletal structures. Both direct binding to microtubuli (Green and Liem, 
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1989) has been demonstrated for hsc70 and an indirect binding implicating an interaction of 
hsc70 with stathmin, a microtubuli (MT)-associated protein that is involved in the regulation 
of MT assembly (Manceau et al., 1999). Interestingly, the expression of stathmin was 
previously described to be growth-dependent emphasizing a possible function of the hsc70 – 
stathmin interaction during development (Balogh et al., 1996). Furthermore, a direct 
interaction between hsc70 and the intermediate filament protein vimentin was observed which 
was restricted to the Triton-insoluble fraction in diverse mammalian cell types (Napolitano et 
al., 1985). Finally, in procaryotic cells, hsc70 was identified as a component of an actin-
related protein preparation that also contained alpha-actinin and spectrin (Guerrero-Barrera et 
al., 1999).  
The subcellular localization of hsc70 to neuronal and non-neuronal vesicles and a synaptic 
localization of hsc70 in the nervous system provide novel insights in the function of the heat 
shock cognate. The analysis of the uncoating process of clathrin-coated vesicles (CVs) from 
various mammalian tissues revealed that the 70 kDa uncoating ATPase (UA) was identical to 
the hsc70 protein (Paddenberg et al., 1990). Further investigations confirmed the formation of 
a complex which includes clathrin and the UA/hsc70 with a binding stoichiometry of one 
molecule hsc70 per molecule of free clathrin (Prasad et al., 1994). The functional role of the 
UA/hsc70 in receptor-mediated endocytosis was addressed by an antibody raised against the 
putative clathrin-binding site that blocked the hsc70-mediated release of clathrin from isolated 
CVs. It was shown that the antibody interfered with the endocytosis of the ligand-receptor 
complex indicating that hsc70 is essential for the normal receptor-mediated endocytosis and 
that the heat shock cognate is presumably involved in the uncoating of CVs preceding their 
fusion with endosomes (Honing et al., 1994). Synaptic localization of hsc70 was investigated 
previously showing that hsc70 is a component of a rat brain synaptic junctional protein 
preparation (Langnaese et al., 1996). The presence of the heat shock cognate was 
immunohistochemically demonstrated in postsynaptic structures of rat brains (Suzuki et al., 
1999) while a presynaptic localization of hsc70 has been confirmed by other studies 
(Bechtold et al., 2000). More recently, a functional role of hsc70 in the presynaptic release of 
neurotransmitter was investigated. In the presynapse, hsc70 does not function by itself but 
requires assistance from co-factors as mentioned before regarding chaperone functions. Hsc70 
complexes with a further DnaJ-like protein that is localized in the presynapse, the cysteine-
string protein (CSP), while other hsps like hsp60 or hsp90 do not interact with CSP (Stahl et 
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al., 1999). CSPs are evolutionarily conserved proteins which are associated with synaptic 
vesicles and other secretory organelles and which are implicated in the regulation of 
exocytosis. Furthermore, CSPs are proposed to be involved in the modulation of presynaptic 
calcium channel activity. They may act as molecular chaperones in association with hsc70 to 
direct the assembly or dissociation of multiprotein complexes at the calcium channel and 
thereby mediate the activity of presynaptic calcium channels (Seagar et al., 1999). A novel 
synapse-specific chaperone complex which is composed of the cystein string protein, the heat 
shock cognate70 and a small glutamine-rich tetratricopeptide repeat (TPR)-containing protein 
(SGT) was recently identified. Alterations in the composition of the trimeric complex inhibit 
neurotransmitter release suggesting that the CSP/hsc70/SGT complex is important for the 
maintenance of a functional synapse (Tobaben et al., 2001). 
Further insights in the functional role of hsc70 during nervous system development are 
revealed by the analysis of the expression pattern of hsc70 during neuronal differentiation. In 
very early studies, the F9 teratocarcinoma cell line was used as a model for murine 
development. It was clearly demonstrated that a down-regulation of hsc70 during F9 
differentiation occurs at the transcriptional level. RNA and protein analyses of murine brains 
and of 14-day old embryos further suggest that hsc70 is very actively transcribed during early 
mouse embryogenesis whereas at later developmental stages a down-regulation of hsc70 
RNA and protein levels was observed (Giebel et al., 1988). A more recent publication 
considered the distribution of hsc70 in the developing mouse brain between E9.5 and E17.5 
demonstrating a specific spatial and temporal distribution pattern of hsc70 during embryonic 
mouse brain development (Loones et al., 2000). Interestingly, only hsc70 is expressed at 
significant levels in specific brain regions at early stages of the development (E9.5) whereas 
hsp70, hsp90α or hsp25 were not detectable suggesting the importance of hsc70 during early 
neuronal development that was also shown in previous studies. The expression of hsc70 was 
observed in regions where the migration of longitudinal tracts appeared and at later 
developmental stages an enrichment of hsc70 expression was seen in descending and 
longitudinal fasciculi. These results indicated that hsc70 might be involved in the remodeling 
processes of cells during migration, adhesion or differentiation of the developing tissues. The 
extensive architectural alterations lead to structural reorganizations of the cytoskeleton in 
particular during migration processes. Since hsc70 has been shown to bind to cytoskeletal 
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elements, it was suggested that the heat shock cognate may regulate those filamentous 
reorganizations during early mouse brain development. 
As mentioned before, the conformational alterations of substrate proteins generated by hsc70 
can regulate signal transduction pathways. The involvement of hsc70 in certain signalling 
cascades was intensively investigated regarding the interaction of hsc70 with the anti-
apoptotic protein Bag-1 (Takayama et al., 1997). It was shown that the formation of the 
hsc70/Bag-1 complex can regulate the activity of raf-1 by competetive binding of this 
serine/threonine kinase and subsequently the activity of the downstream extracellular signal-
regulated kinases erk1 and erk2 is affected (Song et al., 2001). The hsc70 binding protein 
Bag-1 was also described to interact with the adaptor protein 14-3-3 that modulates signalling 
events between components of different pathways (Fountoulakis et al., 1999). Disruption of 
the 14-3-3 function revealed an impaired activation of the erk kinases but increases basal 
activation levels of the JNK1 kinase and the stress kinase p38 (Xing et al., 2000) suggesting a 
further signalling pathway that might be influenced by hsc70 in cooperation with Bag-1 and 
14-3-3. 
 
VI.2. Characterization of the CHL1 – hsc70 interaction 
 
The identification of hsc70 as a binding partner of the neuronal cell adhesion molecule CHL1 
was not expectable and not even reasonable since functional interactions between cell 
recognition molecules and heat shock proteins were not described before. Furthermore, the 
interaction between a cell adhesion molecule that is developmentally expressed during mouse 
brain development starting at rather late embryonic stages and a protein that is expressed in 
response to heat shock and other cellular stress was not obviously supposable. But, regarding 
the functional features of the heat shock cognate presented above, a putative interaction 
between these proteins became likely and interesting since hsc70 was identified as a 
constitutively expressed heat shock protein that showed an elevated expression level during 
early neuronal embryogenesis indicating an involvement of the heat shock cognate in 
developmental processes. 
The specificity of the CHL1-binding to the heat shock cognate 70 was checked using the 
intracellular domains of L1 and NCAM180 as negative controls in the overlay binding assay. 
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Furthermore, the co-immunoprecipitation of hsc70 was additionally carried out by the use of a 
polyclonal anti L1 antiserum. Neither using L1-ICD nor using the intracellular domain of 
NCAM180 in the overlay assay and also not after immunoprecipitation of L1, an interaction 
with hsc70 was observed. A sequence analysis of CHL1 revealed the presence of the HPD 
tripeptide that is a highly conserved motif exposed in the J-domain of molecular chaperones 
within the intracellular portion of CHL1. This putative binding motif was identified to be the 
essential structure for the binding of CHL1 to hsc70 using a site-directed mutagenesis that led 
to a single amino acid exchange of the histidine or the aspertate residue. Deletion of only one 
amino acid in the HPD tripeptide resulted in a complete loss of hsc70 binding by mutant 
CHL1. An alignment of the intracellular domains of several L1-related molecules showed that 
the HPD binding motif is exclusively present in the sequence of CHL1 and not in the 
sequences of L1, NrCAM, NgCAM, neurofascin, neuroglian or the zebrafish L1-homologues 
L1.1 and L1.2 (Holm et al., 1996) suggesting that the interaction between a neuronal cell 
adhesion molecule and the heat shock cognate is an exclusive property of CHL1. 
Furthermore, the interaction of CHL1 and hsc70 was identified to be strictly ADP-dependent 
since no co-immunoprecipitation of hsc70 and CHL1 was observed in the presence of ATP 
but in the presence of ADP. Hsc70 includes an ATPase function and binding of either ADP or 
ATP was previously described as a functional feature of hsc70 for the recruitment of 
substrates or further co-chaperones that can influence the binding properties of the heat shock 
cognate. 
Although the conditions prevailing during the binding assay that was used for the isolation of 
the CHL1 binding protein were rather denaturing, a strong and direct binding between CHL1 
and hsc70 was observed in this approach. Interestingly, the direct binding under native 
conditions using recombinant fusion proteins failed to confirm the CHL1 – hsc70 association 
whereas the co-localization of both proteins that was observed in a distinct distribution pattern 
in hippocampal neurons was presumed as an indication for the binding between these 
proteins. The interaction was confirmed in an alternative binding approach using a co-
precipitation of CHL1 and hsc70 from a crude cell lysates. Finally, the interaction of CHL1 
and hsc70 was shown to be restricted to a distinct detergent-insoluble membrane subdomain 
that was assumingly a so-called raft fraction. Taking these results together, a specific 
conformation of CHL1 was proposed to be required for the binding to hsc70 that was 
mimicked by the denaturing conditions prevailing during the electrophoretic separation. 
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Interestingly, such a particular binding assay was used to verify the interaction of hsc70 with 
another binding partner indicating that the electrophoretic separation under denaturing 
conditions did not interfere with the binding properties of hsc70. The interaction between 
hsc70 and the anti-apoptotic protein Bag-1 was also revealed by this approach using ligand 
blotting of hsc70 and subsequent incubation of purified Bag-1 as a soluble probe (Höhfeld, 
1998). The ELISA binding assay that was carried out in the present study to confirm the 
interaction of hsc70 and CHL1 also supported the assumption that the conformational status 
of the interaction partners might be a crucial factor for the binding. Recombinant Bag-1 and 
hsc70 were applied as a positive control. An interaction between these known binding 
partners was only seen when hsc70 was immobilized and Bag-1 was incubated as a soluble 
protein, whereas after immobilization of Bag-1 and subsequent incubation of soluble hsc70, 
no interaction was detectable. This result suggests that on one hand a distinct three-
dimensional conformation of Bag-1 is an important prerequisite for the binding of hsc70 that 
is altered after the immobilization to the plastic surface (personal communication, Dr. U. 
Hartl, Munich). On the other hand, the immobilization of hsc70 also modifies the 
conformation of the protein without disturbing the binding to Bag-1 indicating that the 
immobilization even may contribute to a specific conformation of hsc70 that first provides the 
binding as it was previously seen in the overlay approach. In the cellular environment, this 
specific conformation of hsc70 is thought to be generated and also regulated by assisting 
proteins which may be co-chaperones of the hsc70. This presumption is supported by the 
immunocytochemical detection of hsc70 in primary hippocampal neurons revealing a distinct 
distribution pattern of the cytoplasmic protein in cellular subdomains. The co-localization of 
hsc70 and CHL1 was also detectable in specific areas indicating that the binding might be 
facilitated only in those distinct subdomains. The distribution analysis of hsc70 and CHL1 in 
membrane subfractions separated from an enriched synaptosomal preparation further 
supported the assumption that the binding of hsc70 and CHL1 may occur only in restricted 
subdomains since both proteins showed an overlapping distibution pattern in all subfractions 
which were analyzed. Finally, a co-immunoprecipitation of hsc70 and CHL1 that was 
exclusively observed in crude membranes as well as in the detergent-insoluble fraction of 
brain membranes confirmed the observation that the interaction of hsc70 and CHL1 is 
restricted to cellular subcompartment. The localization of the CHL1 – hsc70 interaction to 
subdomains may indicate that further proteins assist the interaction since in the non-detergent 
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soluble as well as in the Triton-soluble fraction both binding partners were present but no 
interaction was detectable, whereas in the detergent-insoluble fraction the expression of 
CHL1 was lower when compared to the soluble fractions but the co-precipitation was 
remarkably pronounced. An identification of such assisting proteins would be of outstanding 
interest for the further understanding by which mechansims a complex formation containing 
hsc70 can promote and/or regulate the in vivo binding of CHL1 and hsc70.  
Palmityolation of serine residues that can influence the translocation of a fluid membrane 
protein to rafts (Kabouridis et al., 1997; Zhang et al., 1998) was addressed to be involved in 
the localization of CHL1 in cellular subdomains. A serine residue is not present in the 
intracellular domain of CHL1 but is localized immediately beyond the cytoplasmic part at 
position three within the transmembrane portion. This particular serine residue was affected 
by a site-directed mutagenesis. A decreased translocation of CHL1 to the detergent insoluble 
fraction was assumed that may reduce the facilitation of the CHL1 – hsc70 interaction since 
decreased levels of CHL1 should be present in the Triton X-insoluble fraction. Although 
CHL1 was only weakly detectable in the detergent insoluble fraction of CHO cell lysates and 
co-immunoprecipitations of CHL1 and hsc70 were performed using a Triton X-100 soluble 
fraction, the effect of the serine residue exchange was revealed indicated by a slightly reduced 
co-precipitation of hsc70. A decrease in the co-precipitation of hsc70 and the mutant affecting 
palmityolation was seen in CHO cells as well as in N2A cells. In both cellular systems, the 
co-precipitation was carried out using either a detergent soluble or a crude lysate indicating 
that the localization of the binding partners to detergent insoluble subdomains is no 
prerequisite for the interaction of CHL1 and hsc70 in those particular cells. Nevertheless, the 
effect of the serine mutation that presumably reduces the translocation of CHL1 to rafts 
suggest that the interaction is also facilitated by a localization of CHL1 in the detergent 
insoluble fraction. 
The conformation of the binding partners and thereby the translocation of both proteins to 
cellular subdomains obviously is a crucial factor for the facilitation of the CHL1 – hsc70 
interaction. In addition to this, the immunocytochemical analysis of hippocampal cells 
demonstrated that the interaction between CHL1 and hsc70 depends on the developmental 
stage of the cells since a co-localization of CHL1 and hsc70 in distinct areas was only 
observed in hippocampal neurons derived from 4-day old animals and after culturing for three 
days, whereas in cells prepared from newborn animals cultured for only one day, co-
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localization was only seen after co-capping of CHL1. This assumption was further 
investigated by biochemical analysis performing a co-immunoprecipitation of CHL1 and 
hsc70 from membrane fractions which were derived from either 5-day old or 3-weeks old 
mice. It was shown that the co-precipitation using crude membranes was much more 
pronounced in older animals when compared to younger animals although the expression 
levels of CHL1 were remarkably higher in the 5-day old mice. The crude membranes were 
further separated in detergent-soluble and insoluble fractions and the subsequent 
immunoprecipitation of CHL1 revealed a co-precipitation of hsc70 only in the detergent-
insoluble fraction that was prepared from 3-weeks old animals. The co-immunoprecipitation 
using membrane fractions derived from animals of different ages confirmed the assumption 
that not only the conformation of the binding partners but also the developmental stage of the 
animals facilitate the interaction of CHL1 and hsc70. As mentioned before, hsc70 shows an 
elevated expression during early neuronal development, whereas CHL1 becomes weakly 
detectable at embryonic day 13 and shows the highest expression levels at rather late 
developmental stages from embryonic day 18 to postnatal day 7 (Hillenbrand et al., 1999). 
Furthermore, the biochemical analysis of the CHL1 – hsc70 binding that was carried out with 
regard to the age of the animals indicated that the interaction between both proteins was more 
pronounced in older animals than in 5-day old animals. Taken these observations together, a 
hsc70 function during early developmental stages in mice without an involvement of CHL1 is 
assumed whereas a functional interaction of CHL1 and hsc70 is facilitated at later 
developmental stages including the postnatal development in up to 3-weeks old animals and 
probably also in adults. Thereby, a possible function of the CHL1 – hsc70 interaction is 
proposed suggesting that the binding of both proteins at later developmental stages may 
confers stability and/or maintainance of cellular structures to neurons whereas during early 
development of the mouse brain, hsc70 is probably more involved in alterations of structural 
elements including conformational changes of cytoskeletal components. 
 
VI.3. Functional analysis of the CHL1 - hsc70 interaction 
 
Regarding the chaperone function that is implicated by hsc70, a functional analysis of the 
CHL1 – hsc70 interaction was carried out that addressed morphological and structural 
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reorganization processes of the cytoskeleton following CHL1-dependent neurite outgrowth. 
Primary hippocampal neurons derived from CHL1-deficient mice were transfected with either 
wildtype CHL1 or with CHL1 mutants which were deleted in the hsc70 binding site and 
neurite outgrowth of transfected cells was stimulated using the anti CHL1 antibody. Although 
no significant differences in CHL1-dependent neurite outgrowth after transfection of either 
wildtype or mutant CHL1 were observed in this cellular system, a participation of the 
interaction between CHL1 and hsc70 in structural alterations of the cytoskeleton can not be 
excluded. The experimental approach used in this work, namely the transfection of primary 
neurons using certain CHL1 constructs followed by CHL1-dependent neurite outgrowth, 
emerged to be a harmful stressor of the transfected neurons. Transfection of CHL1 constructs 
resulted in massive morphological changes of the cells including a round appearance and the 
lack of extended neurites that makes a functional analysis of the CHL1 – hsc70 interaction 
with regard to structural reorganization processes of the cytoskeleton impossible. The 
question whether the CHL1 – hsc70 interaction is involved in alterations of structure and 
composition of cytoskeletal elements is still open since this approach could not elucidate the 
requirement of a functional binding between CHL1 and hsc70 for the promotion of CHL1-
dependent neurite outgrowth in primary hippocampal neurons. 
As mentioned before, a putative role of the CHL1 – hsc70 interaction was assumed according 
to the observation that the interaction of both proteins is more facilitated with later 
developmental stages of the animals and that the localization of the binding is the more 
pronounced in detergent-insoluble cellular subdomains the older the animals are. Due to this 
results a functional role of the CHL1 – hsc70 binding was proposed that emphasized an 
involvement of the interaction in generating stability of intracellular structures. Further 
evidence that the maintainance of a neuron might be supported by the intracellular interaction 
of the transmembrane CHL1 with cytoskeletal elements mediated by the heat shock cognate 
70 was provided since the interaction between L1 and the 440-kDa-isoform of ankyrinB 
(ankB) implicates such a function. L1 and ankB are co-localized in premyelinated axon tracts 
of the developing nervous system, a concomitant down-regulation of both proteins is revealed 
after myelination and ankB knock-out mice have reduced L1 expression levels in 
premyelinated axons of long fiber tracts. A functional importance of L1 and ankyrinB in these 
particular structures is strongly supposed. In fact, analysis of the ankB deficient mice revealed 
that the optic nerve fibers become dilated and degenerate by day 20 suggesting that the 
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ankyrinB – L1 interaction is essential for the maintainance of premyelinated axons in vivo 
(Scotland et al., 1998). Unfortunately, the hsc70 knock-out mouse is not available so far such 
that an involvement of the CHL1 – hsc70 interaction to the maintainance of cellular structures 
or the degradation of particular neurons is not accessible.  
The overlapping distribution pattern of CHL1 and hsc70 in membrane subfractions which 
were derived from an enriched synaptosomal preparation provide further evidence for a 
putative functional role of the CHL1 – hsc70 interaction in synapses. In 7-day old animals and 
in adults, both proteins were present in a so-called raft fraction that was separated from the 
detergent-insoluble subfraction of synaptosomal membranes. Only in younger animals, a raft 
localization was identified that solely implicated further interactions to extracellular matrix 
and/or cytoskeletal structures whereas in adults CHL1 and hsc70 were detectable in rafts with 
but also without such interactions. Thereby, different functions were suggested for CHL1 and 
hsc70 in synapses according to the age of the animal. In younger animals, a linkage to 
structural elements like ECM proteins or cytoskeleton components was more pronounced for 
CHL1 and hsc70 whereas in adults both proteins implicate a further function that did not 
involve the interactions with such structural elements. The contribution of hsc70 to 
presynaptic complexes which are modulatory involved in the neurotransmitter release and the 
recycling of synaptic vescicles indicates that the interaction between CHL1 and hsc70 may 
participate in the generation or maintenance of a functional synapse. 
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VII. Summary 
 
In the present study, a binding analysis of the neural cell adhesion molecule CHL1 (close 
homologue of L1) was carried out in order to isolate putative interaction partners of this 
recently described new member of the L1-related subfamily. An identification of an 
extracellular or intracellular receptor of CHL1 would provide novel insights in CHL1-
mediated cell-cell contacts or in CHL1-dependent intracellular signalling mechanisms. 
The extracellular and intracellular domains of CHL1 were subjected as recombinant fusion 
proteins to several biochemical binding studies. A single protein of the non-detergent soluble 
fraction of a mouse brain was observed to bind to soluble CHL1-ICDhis6 in an overlay 
approach. This protein revealed a molecular mass of 70 kDa and an isoelectric point of 5.5. 
The putative binding partner of CHL1 was identified as the murine heat shock cognate 70 
using MALDI-MS. 
Co-immunoprecipitation of CHL1 and hsc70, ELISA binding assay and BIAcore SPR 
analysis failed to confirm the interaction of CHL1 and hsc70 under native conditions. 
However, localization studies of the putative binding partners in primary hippocampal 
neurons showed a distinct cellular co-distribution pattern of CHL1 and hsc70 indicating a 
facilitated interaction in membrane subdomains. In such domains, a specific conformational 
stage of the putative binding partners was assumed mediated by further assistant proteins and 
that has been mimicked under the prevailing conditions of the overlay approach. The co-
localization in such subdomains was more pronounced in cells prepared from older animals 
than from newborn animals. This suggests that the developmental stage of the animal 
influences the localization of CHL1 and hsc70 to cellular subdomains and thereby the 
facilitation of the binding between CHL1 and hsc70.  
CHL1 and hsc70 showed an overlapping distribution pattern in detergent-insoluble 
subfractions of enriched synaptosomal membranes. Taking all these observations into 
account, it was finally possible to co- precipitate CHL1 and hsc70 using crude fractions of a 
brain homogenate. Furthermore, hsc70 co-precipitated only in the presence of the co-factor 
ADP, but not in the presence of ATP. A precipitation of CHL1 using crude fractions from 5-
day old mice and 3-weeks old mice demonstrated that the co-precipitation of hsc70 was more 
 108
VII. Summary 
   
 
 
pronounced in older animals and that the interaction was more translocated in a detergent-
insoluble fraction in 3-weeks old mice. 
Taking these results together, an ADP dependent interaction of CHL1 and hsc70 was 
identified that was localized in cellular subdomains where the interaction was assumingly 
facilitated by a specific conformational stage of the binding partner. The translocation of the 
CHL1 – hsc70 binding in detergent-insoluble fractions was further dependent on the 
developmental stage of the animals. 
A putative binding site of hsc70 within the intracellular domain of CHL1 was identified, 
namely a HPD tripeptide that was originally described to be a hsc70 binding motif exposed in 
the J-domain of bacterial chaperones. Using a site-directed mutagenesis resulting in an amino 
acid exchange of either the histidine or the aspartate residue, it was demonstrated that the 
HPD tripeptide is essential for the binding of hsc70. 
An involvement of the CHL1 – hsc70 interaction in structural alterations of the cytoskeleton 
was considered by CHL1-dependent neuritogenesis of primary hippocampal neurons of  
CHL1 -/- mice stimulated after transfection with either wildtype or mutant CHL1. Evidence 
that the functional binding of CHL1 and hsc70 affects structural reorganization processes of 
the cytoskeleton during neuritogenesis could not be excluded since transfection of primary 
hippocampal neurons dramatically altered the morphology and vitality of the neurons. Thus, it 
was not possible to analyze the functional role of the CHL1 – hsc70 interaction. 
This study could demonstrate for the first time a specific interaction between a cell adhesion 
molecule and a heat shock protein via the HPD tripeptide that is localized within the 
intracellular domain of CHL1. The interaction was characterized to be dependent on ADP as a 
co-factor for the binding. The binding was restricted to cellular subdomains and the 
localization was temporally dependent on the developmental stage of the animal. An 
involvement of the CHL1 – hsc70 in structural alterations of the cytoskeletal could not be 
excluded providing further opportunities for the investigation of the functional role of this 
interesting interaction between CHL1 and hsc70. 
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VII Zusammenfassung 
 
In der vorliegenden Arbeit wurden Bindungsanalysen des neuronalen Zelladhäsionsmoleküls 
CHL1 (close homologue of L1) durchgeführt, die Interaktionspartner dieses kürzlich 
beschriebenen neuen Mitgliedes der L1-verwandten Unterfamilie isolieren sollten. Eine 
Identifizierung extra- oder intrazellulärer Rezeptoren von CHL1 könnte neue Einsichten in 
CHL1-vermittelte Zell-Zell-Kontakte oder in CHL1-abhängige intrazelluläre Signalkaskaden 
liefern. 
Die extra- und intrazellulären Domänen von CHL1 wurden als rekombinante Fusionsproteine 
in verschiedene biochemische Interaktionsanalysen eingesetzt. Ein einzelnes Protein, das an 
die lösliche intrazelluläre Domäne von CHL1 in einem overlay Ansatz gebunden hat, konnte 
in der detergenz-freien löslichen Fraktion eines Maushirns nachgewiesen werden. Dieses 
Protein wies ein Molekulargewicht von 70 kDa und einen Isoelektrischen Punkt von 5.5 auf. 
Der mögliche Bindungspartner von CHL1 wurde mittels MALDI-MS als murines 
Hitzeschockprotein hsc70 identifiziert. 
Ko-Immunpräzipitation von CHL1 und hsc70, ELISA Bindungsansatz und BIAcore SPR 
Analyse konnten die Interaktion von CHL1 und hsc70 unter nativen Bedingungen nicht 
bestätigen. Die immunzytochemische Lokalisation der beiden möglichen Bindungspartner in 
primären Hippokampus-Neuronen zeigte jedoch eine charakteristische distinkte Ko-
Verteilung, die auf eine verstärkte Interaktion in membranösen Subdomänen hinweist. In 
solchen Domänen wurde eine bestimmte Konformation der Bindungspartner vorausgesetzt, 
die durch assistierende Proteine generiert werden kann und die durch die im overlay 
vorherrschenden Bedingungen kopiert wurde. Die Ko-Lokalisation in Subdomänen zeigte 
sich stärker in Zellen, die von älteren Tieren präpariert wurden als in Zellen von 
neugeborenen Tieren. Daraus lässt sich ableiten, dass der Entwicklungsstand des Tieres die 
Lokalisation der CHL1 – hsc70 Interaktion beeinflusst und damit auch die Interaktion fördert.  
CHL1 und hsc70 zeigten eine übereinstimmende Verteilung in detergenz-unlöslichen 
Subfraktionen angereicherter synaptosomaler Membranen. Unter Berücksichtigung aller 
vorherigen Beobachtungen war es schließlich möglich, CHL1 mit hsc70 aus einem kruden 
Homogenat zu präzipitieren. Hsc70 ko-präzipitierte allerdings nur, wenn ADP als Ko-Faktor 
der Bindung anwesend war, aber nicht in der Gegenwart von ATP. Eine Präzipitation aus 
kruden Homogenaten 5-Tage alter und 3-Wochen alter Mäuse zeigte, dass die Interaktion in 
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alten Tieren verstärkt war und die Präzipitation aus der detergenz-unlöslichem Fraktion nur 
bei 3-Wochen alten Tieren möglich war.  
Zusammengefasst zeigen diese Ergebnisse eine ADP-abhängige Interaktion von CHL1 und 
hsc70. Diese konnte auf zelluläre Subdomänen beschränkt werden, in denen die Interaktion 
möglicherweise durch eine bestimmte Konformation der Bindungspartner erleichtert wurde. 
Die Translokalisation der Bindung in detergenz-unlöslichen Fraktionen hängt von dem 
Entwicklungsstand der Tiere ab. 
Ein mögliches Bindungsmotiv für hsc70 in der intrazellulären Domäne von CHL1 konnte 
identifiziert werden: Ein HPD-Tripeptide, das ursprünglich als hsc70-Bindestelle in der J-
Domäne von molekularen Faltungsproteinen beschrieben wurde. Eine gerichtete Mutagenese, 
die zum Aminosäureaustausch des Histidin- beziehungsweise Aspartatrestes führte, konnte 
zeigen, dass das HPD-Tripeptide essentiell für die Bindung von hsc70 ist.  
Eine Beteiligung der CHL1 – hsc70 Interaktion an strukturellen Veränderungen des 
Zytoskeletts wurde anhand einer CHL1-abhängigen Stimulation des Neuritenwachstums 
primärer CHL1 -/- Hippokampus-Neurone untersucht, die entweder mit Wildtyp- oder mit 
mutiertem CHL1 transfiziert wurden. Hinweise, dass die Bindung von CHL1 und hsc70 an 
strukturellen Re-Organisationen des Zytoskeletts beteiligt ist, können nicht ausgeschlossen 
werden. Weil aber die Transfektion die Morphologie und Vitalität der Neurone dramatisch 
beeinflusste, war eine funktionelle Analyse der CHL1 – hsc70 Interaktion nicht möglich. 
In dieser Arbeit konnte zum ersten Mal eine Interaktion zwischen einem 
Zelladhäsionsmolekül und einem Hitzeschockprotein demonstriert werden, die generiert wird 
über ein HPD-Tripeptid in der intrazellulären Domäne von CHL1. Diese Interaktion ist 
abhängig von dem Ko-Faktor ADP. Die Bindung konnte in zellulären Subdomänen lokalisiert 
werden und die Translokalisation der Interaktion war zeitlich abhängig vom 
Entwicklungsstand des Tieres. Eine Beteiligung der CHL1 – hsc70 Bindung an strukturellen 
Veränderungen des Zytoskeletts konnte nicht ausgeschlossen werden, wodurch sich 
interessante Möglichkeiten zur weiteren funktionellen Erforschung dieser Interaktion bieten. 
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VIII. Appendix 
 
VIII.1. Oligonucleotides 
 
 Oligonucleotides Sequence Remarks 
N°1 CHL1-CT/SacΙ up 5’-CCC GAG CTC AAG AGG AAC 
AGA GGT-3’ 
amplification of 
intracellular domain
N°2 CHL1-CT/HindΙΙΙ-
dn 
5’-CCC AAG CTT TCA TGC CCG 
GAG TGG-3’ 
amplification of 
intracellular domain
N°3 pQE primer 
„promotor region“ 
5’-CCC GAA AAG TGC CAC CTG-3’ 
 
for sequencing 
N°4 L1-ICD/5’-NdeΙ 5’-GGA ATT CCA TAT GAA ACG 
CAG CAA GGG TGG-3’ 
amplification of 
intracellular domain
N°5 L1-ICD/3’-BamHΙ 5’-GGG GGA TCC ACT ATT CTA 
GGG CTA-3’ 
amplification of 
intracellular domain
N°6 T7 promotor primer 5’-TAA TAC GAC TCA CTA TAG G-
3’ 
for sequencing 
N°7 T7 promotor primer 5’-TAA TAC GAC TCA CTA TAG G-
3’ 
amplification of 
CHL1/5’ fragment 
in pcDNA3 
N°8 CHL1 pos2665 
Eco-dn 
5’-TAA GTG GAA TTC ACT AAA 
GGG GTC TAG-3’ 
amplification of 
CHL1/5’ fragment 
N°9 CHL1 pos2665 
Eco-up 
5’-TTT AGT GAA TTC CAC TTA ACA 
GTC TTA-3’ 
amplification of 
CHL1/3’ fragment 
in pcDNA3 
N°10 CHL1 Stop Not-dn 5’-TTT GCG GCC GCT TCA TGC CCG 
GAG TGG GAA GGT-3’ 
amplification of 
CHL1/3’ fragment 
N°11 H1121Q-up 5’-AAG GAA GAT TTA CAA CCA 
GAT CCA GAA-3’ 
mutagenesis 
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N°12 H1121Q-dn 5’-TTC TGG ATC TGG TTG TAA ATC 
TTC CTT-3’ 
mutagenesis 
N°13 D1123A-up 5’-GAT TTA CAC CCA GCT CCA 
GAA GTT CAG-3’ 
mutagenesis 
N°14 D1123A-dn 5’-CTG AAC TTC TGG AGC TGG 
GTG TAA ATC-3’ 
mutagenesis 
N°15 C1102S/new-up 5’-TTG TTA ACT ATT TCC TTT GTG 
AAG AGG-3’ 
mutagenesis 
N°16 C1102S/new-dn 5’-CCT CTT CAC AAA GGA AAT 
AGT TAA CAA-3’ 
mutagenesis 
N°17 C1102S/stop-up 5’-TTG TTA ACT ATT TGA TTT GTG 
AAG AGG-3’ 
mutagenesis/deletion 
of intracellular 
domain 
N°18 C1102S/stop-dn 5’-CCT CTT CAC AAA TCA AAT 
AGT TAA CAA-3’ 
mutagenesis/deletion 
of intracellular 
domain 
N°19 CHL1 pos366-up 5’-A ATA GAG TTC ATA GTA CCA 
GGG GTT-3’ 
sequencing of full 
length clone 
N°20 CHL1 Ι (BS)/522 5’-TGA ACA AGA TGA GAG AGT 
ATA CAT GAG C-3’ 
sequencing of full 
length clone 
N°21 CHL1 pos976-up 5’-CAG TAG AAG AGC CTC CAG 
GCT GGA-3’ 
sequencing of full 
length clone 
N°22 CHL1 ΙΙ (BS)/1133 5’-GTG ACT TTA TGT TCC CCA 
GGG-3’ 
sequencing of full 
length clone 
N°23 CHL1 pos1626-up 5’-CAT TTG AAA CAC AGT TTG 
AAG TTG-3’ 
sequencing of full 
length clone 
N°24 CHL1 ΙΙΙ (BS)/1823 5’-TCC TTG GTG TTG GAG ATC 
CGC CAG-3’ 
sequencing of full 
length clone 
N°25 CHL1 pos2273-up 5’-GAA GAG TGG GAA GAA ATA 
GTT-3’ 
sequencing of full 
length clone 
N°26 U-CHL1-3000 (BS) 5’-TCA CTT AAC AGT CTT AGC sequencing of full 
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CTA-3’ length clone 
N°27 Sp6 reverse primer 
(Invitrogen) 
5’-TAG TGT CAC CTA-3’ sequencing of full 
length clone 
 
VIII.2. Accessionnumbers 
 
Protein Organism Accession N° 
CHL1 mouse X94310 
L1 mouse X12875 
NCAM 140 rat X06564 
NCAM 180 rat not available 
hsc 70 mouse M19141 
 
VIII.3. Plasmids 
 
VIII.3.1. pQE30 constructs 
 
The intracellular domain of CHL1 was amplified with primers referring to VIIΙ.1, primers   
N° 1 and N° 2. Restriction sites were introduced by PCR and CHL1-ICD was ligated to 
pQE30 after digestion with the appropriate restriction enzymes BamHΙ/HindΙΙΙ. Three 
additional pQE30 constructs were used for production of recombinant proteins which were 
provided as mentioned before. Inserts used for cloning into pQE30 are figured with terminal 
restriction sites. 
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pQE30/CHL1-ICD
       3749 bp
CHL1 intracellular domain
6xHis-tag coding sequence
RGS epitope
T5 promotor
lambda t  transcriptional termination region0
ColE1 origin of replication
ampR
EcoR I (3363)
Hind III (1)
Xba I (977)
Xho I (3276)
Sac I (3436)
BamH I (3420)
BamH I (3696)
 
 
 
CHL1-ICD SacI/HindIII
            324 bp
BamH I (266) Hind III (320)Sac I (6)
 
mhsc70 BamHI/SalI
         1953 bp
BamH I (2) Bst XI (433) Sal  I (1949Sac I (1389)
Sac I (1897)
 
NCAM140 BamHI/BamHI
              372 bp
Apa I (84)
Bsp MI (23)
BamH I (2) BamH I (368)
 NCAM180 BamHI/BamHI             1173 bp
Bsp EI (766)
Pst I (1012)
Pvu II (680)
Stu  I (653)
Apa I (84)
Apa I (1055)
BamH I (2) BamH I (1169)
Bsp MI (23)
Bsp MI (1015)
Nhe I (548) Nhe I (830)
 
 
VIII.3.2. pET28 construct 
 
L1 intracellular domain was originally cloned into pQE30, but L1-ICD was unable to be 
produced in that particular expression system. L1-ICD was thereby sub-cloned into pET28 
after amplification and introduction of appropriate restriction sites with regard to pET 28. The 
target vector was digested with the corresponding restriction enzymes NdeΙ/BamHΙ and re-
ligated with insert DNA. 
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pET28/L1-ICD
    5681 bp
L1 intracellular domain
pBR322 origin
f1 origin
kanR
his tag coding sequence
T7 promotor
Apa I (4242)
BamH I (1)
Eag I (33)
EcoR I (7)
Eco RV (3999)
Hind III (26)Nde I (5332)
Not I (33)
Sac I (17)
Sal I (20)
Xba I (5233) Xho I (41)
Bgl I (3388)  
 
 
VIII.3.3. Site-directed mutagenesis 
 
As a template for the site-directed mutagenesis of CHL1, a pcDNA3/full length CHL1 
construct provided by Dr. Birthe Schnegelsberg was used. A large 5’end fragment (position 1 
– 2660 bp) was amplified by PCR by introduction of a new EcoRΙ restriction site at position 
2659 to 2664. The 5’end fragment was re-cloned in pcDNA3 after BamHΙ/EcoRΙ digestion. 
The 3’end fragment of approximately 1000 bp was re-amplified and subcloned into 
pBluescript after digestion with EcoRΙ and NotΙ. Competent DH5α were transformed with 
pcDNA3/CHL1/5’fragment construct, plasmids were amplified and afterwards digested with 
EcoRΙ/NotΙ. The modified vector DNA was stored at –20°C until ligation with mutated 
CHL1/3’fragment. 
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pcDNA3/CHL1/5`fragment
               8081 bp
CHL1/ 5'fragment
ampR
neoR
SV40 origin of replication
BGH polyA
CMV promotor
SV40 promotor
SP6 P
T7 promotor
Apa I (56)
BamH I (5416)
EcoR I (1)
Not I (28)
Xba I (46)
Bst XI (23)
Eco RV (13)
Eco RV (7467)
Hind III (5398)
Hind III (7093)
Xho I (34)
Xho I (6201)
 
 
The 3’end fragment of approximately 1000 bp was amplified and subcloned into pBluescript 
after digestion with EcoRΙ and NotΙ. Competent DH5α were transformed with the pBluescript 
construct, plasmids were amplified and purified and used as template for the site-directed 
mutagenesis. 
pBluescript SK (+)
 CHL1/3'fragment
         3898 bp
CHL1/3'fragment
ampR
lacZ promotor
f1 (+) origin
ColE1 origin
Apa I (2887)
BamH I (3843)
EcoR I (2925)
Eco RV (2921)
Hind III (2913)
Kpn I (2881)
Not I (1)
Sac I (22)
Sal I (2898)
Xho I (2892)
Bst XI (14)
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Four different single amino acids were mutated in the intracellular domain of CHL1 (3x) and 
once in the transmembrane domain. For introduction of a single base pair mutation, primers 
were designed for each particular construct as cited in VIII.1 N° 11 – 18. 
 
CHL1 / H1121Q
       981 bp
H1121Q (705)
Avr II (376)
BamH I (920)
Eag I (976)EcoR I (2)
Mfe I (612) Not I (976)
Pvu II (273)
 
CHL1 / D1123A
      981 bp
D1123A (710)
Avr II (376)
BamH I (920)
Eag I (976)EcoR I (2)
Mfe I (612) Not I (976)
Pvu II (273)
 
CHL1 / C1102S
       981 bp
C1102S (648)
Avr II (376)
BamH I (920)
Eag I (976)EcoR I (2)
Mfe I (612) Not I (976)
Pvu II (273)
 
CHL1 / C1102Stop
        981 bp
C1102Stop (649)
Avr II (376)
BamH I (920)
Eag I (976)EcoR I (2)
Mfe I (612) Not I (976)
Pvu II (273)
 
Inserts were digested with EcoRΙ/NotΙ as indicated and re-ligated to the previously digested 
pcDNA3/CHL1/5’fragment. The resulting construct is presented below after introduction of 
the mutations as mentioned before: 
 
 
pcDNA3/mutant CHL1/
         full length
           9028 bp
C1102Stop
C1102S
H1121Q
D1123A
full length mutant CHL1
ampR
neoR
SV40 polyA
BGH polyA
CMV promotor
SV40 promotor
SP6 P
T7 promotor
Apa I (29)
EcoR I (8055)
Eco RV (7440)
Not I (1)
Xba I (19)
BamH I (5389)
BamH I (8973)
Hind III (5371)
Hind III (7066)
Xho I (7)
Xho I (6174)
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VIII.4. Abbreviations 
 
µ micro (10-6) 
× g g-force 
°C grad celsius 
aa amino acid 
A adenine 
Acc.  accession number 
Amp ampicillin 
APS ammoniumperoxodisulfate 
ADP adenosine diphosphate 
ATP adenosine triphosphate 
BCA bicinchoninacid disodium salt 
bp base pairs 
BSA bovine serum albumine  
C cytosine 
cDNA complementary deoxyribonucleic acid 
CHL1 close homologue of L1 
CHO Chinese Hamster Ovarian 
CMV cytomegalie virus 
CTP cytosine triphosphate 
Da dalton 
dATP 2’-desoxyadenosinetriphosphate 
dCTP 2’-desoxycytidinetriphosphate 
DEPC diethylpyrocarbonate 
dGTP 2’-desoxyguanosinetriphosphate 
DMSO dimethylsulfoxide 
DNA deoxyribonucleic acid 
DNase desoxyribonuclease 
dNTP 2’-desoxyribonucleotide-5’-triphosphate 
DTT dithiothreitol 
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E. coli Escherichia coli 
EDTA ethylendiamintetraacetic acid 
EGFP enhanced green fluorescent protein 
ELISA enzyme-linked immunosorbent assay 
erk 1/2 extracellular regulated kinases 1/2 
f.c. final concentration 
FCS fetal calf serum 
g gram 
G guanosine 
h human, hour 
HBSS Hank’s buffered sodium chloride solution 
HEPES 2-(4-(2-Hydroxyethyl)-piperzino)-ethansulfonic acid 
his6 hexa histidine tag 
HPD histidine-proline-aspartate tripeptide 
hsc70 heat shock cognate 70 
hsp70 heat shock protein 70 
ICD intracellular domain 
IEF isoelectric focussing 
IgG immunoglobuline subclass G 
IPG immobilized pH gradient 
IPTG isopropyl-β-D-thiogalactoside 
Kan kanamycin 
kb kilo base pairs 
l litre 
LB Luria Bertani 
m milli (10-3) 
MEM minimal essential medium 
MESNa 2-mercaptoethanesulfonic acid 
min minute 
MOPS (4-(N-morpholino)-propan)-sulfonic acid 
mRNA messenger ribonucleic acid 
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n nano (10-9) 
N2A mouse neuroblastoma cell line 2A 
NCAM neural cell adhesion molecule 
Nt nucleotide(e) 
ODx optic density 
ORF open reading frame 
PAGE polyacrylamide gel electrophoresis 
PBS phosphat-buffered saline 
PCR polymerase chain reaction  
PEG polyethylenglycol 
PMSF phenylmethylsulfonylfluoride 
rpm rounds per minute 
RGS arginine-glycine-serine tripeptide 
RNA ribonucleic acid 
RNase ribonuclease 
RT room temperature 
s second 
SDS sodium dodecyl sulfate 
SPR surface plasmon resonance 
T thymine 
TABS (N-tris(Hydroxymethyl)methyl-3-aminopropane-sufonic acid 
TE tris-EDTA 
TEMED N,N,N’,N’-tetraethylenamine 
Tet tetracycline 
Tm melting temperature 
Tris tris(-hydroxymethyl)-aminomethane 
U unit (emzymatic) 
V volt 
v/v volume per volume 
Vol. volume 
w/v weight per volume 
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